10-K 1 d413106d10k.htm FORM 10-K Form 10-K
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-K

(Mark One)

 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended September 30, 2012

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to             

Commission file number 333-89756

 

 

Alion Science and Technology Corporation

(Exact name of registrant as specified in its charter)

 

Delaware   54-2061691

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

1750 Tysons Boulevard, Suite 1300, McLean, VA 22101

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (703) 918-4480

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Name of each exchange on which registered

None   N/A

Securities registered pursuant to Section 12(g) of the Act:

None

(Title of class)

 

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

¨   Yes     x   No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

x   Yes     ¨   No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   ¨   Yes     x   No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    x   Yes     ¨   No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   x  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).   ¨   Yes     x   No

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold as of the last business day of the registrant’s most recently completed second fiscal quarter was: None

The number of shares outstanding of Alion Science and Technology Corporation common stock as of December 17, 2012 was 6,731,404.

 

 

DOCUMENTS INCORPORATED BY REFERENCE:

None

 

 

 


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

FORM 10-K

TABLE OF CONTENTS

PART I

 

Item 1. Business

     1   

Item 1A. Risk Factors

     12   

Item 1B. Unresolved Staff Comments

     23   

Item 2. Properties

     24   

Item 3. Legal Proceedings

     24   

Item 4. Mine Safety Disclosures

     24   
PART II   

Item  5. Market for Registrant’s Common Equity, Related Stockholders Matters and Issuer Purchases of Equity Securities

     25   

Item 6. Selected Financial Data

     25   

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     27   

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

     44   

Item 8. Financial Statements and Supplementary Data

     45   

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

     87   

Item 9A. Controls and Procedures

     87   

Item 9B. Other Information

     87   
PART III   

Item 10. Directors, Executive Officers and Corporate Governance

     88   

Item 11. Executive Compensation

     95   

Item  12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters

     107   

Item 13. Certain Relationships and Related Transactions, and Director Independence

     108   

Item 14. Principal Accountant Fees and Services

     109   
PART IV   

Item 15. Exhibits and Financial Statement Schedules

     110   


Table of Contents

PART I

Item 1. Business

Certain information included or incorporated by reference in this annual report on Form 10-K and in press releases, written statements or other documents filed with the United States (U.S.) Securities and Exchange Commission (SEC), and in our investor calls may not address historical fact and thus constitute “forward-looking statements” under the Private Securities Litigation Reform Act of 1995 and other federal securities laws and involve certain known and unknown risks and uncertainties. All statements in this annual report on Form 10-K other than statements of historical fact are statements that could be deemed forward-looking statements, including projections of financial performance, assertions of strategies and objectives, comments on future development, statements concerning future economic performance and projections of our future performance under existing contracts as well as any assumptions underlying any of the foregoing. These forward-looking statements relate to our future plans, objectives, expectations and intentions and are for illustrative purposes only. These statements may be identified by the use of words such as “believe,” “expect,” “intend,” “plan,” “anticipate,” “likely,” “forecast,” “projections,” “could,” “estimate,” “may,” “potential,” “should,” “would” and similar expressions.

Factors that could cause actual results to differ materially from anticipated results include, but are not limited to:

 

   

implementation of automatic U.S. governmental spending reductions known as sequestration pursuant to the Budget Control Act of 2011;

 

   

lack of future credit or an inability to refinance our debt on acceptable terms as it matures;

 

   

ERISA law changes affecting the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan;

 

   

tax law changes affecting treatment and deductibility of goodwill and/or our effective tax rate;

 

   

changes to SEC rules and corporate governance requirements including costs to comply with the Dodd-Frank Act;

 

   

government customer failures to exercise contract options;

 

   

government project funding decisions;

 

   

government contract procurement risks, such as award protests and contract terminations;

 

   

uncertainties related to U.S. government shutdowns and threatened shutdowns;

 

   

competitive pricing pressures and/or difficulty in hiring and retaining employees;

 

   

current and/or future legal or government agency proceedings arising from our operations or our contracts and the risk of potential fines, penalties and contract liabilities, suspension or debarment;

 

   

material changes in laws or regulations affecting our business;

 

   

any future inability to maintain adequate control over financial reporting;

 

   

limits on our financial and operational flexibility given our substantial amount of debt and debt covenants;

 

   

business acquisitions that increase costs or liabilities, are disruptive or which we fail to integrate;

 

   

material changes in other laws or regulations affecting our business;

 

   

incurrence of additional debt;

 

   

general volatility in the debt and securities markets;

 

   

our ability to meet existing and future debt covenants; as well as

 

   

other risks discussed elsewhere in this annual report.

Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s view only as of the date of filing of this annual report on Form 10-K. Any such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ materially from those envisaged by such forward-looking statements. We undertake no obligation to update any of these factors or to publicly announce any change to our forward-looking statements in this annual report on Form 10-K, whether as a result of new information, future events, changes in expectations or otherwise.

Overview

Alion Science and Technology Corporation (Alion, the Company, we, our) is an employee-owned company. We provide scientific, engineering, program management and information technology solutions for problems relating to national defense, homeland security, and energy and the environment. We serve the U.S. Department of Defense, federal civilian agencies, commercial customers, and state and foreign governments.

 

1


Table of Contents

Our fiscal year 2012 revenue was $817 million, a 3.8% increase over our fiscal year 2011 revenue of $787 million. For the past three fiscal years, prime contracts accounted for more than 80% of our revenue. Both this year and last year, over 97% of our revenue came from federal government prime contracts and subcontracts; with 92% from Department of Defense contracts.

We provide professional engineering and program management services, and scientific expertise, in a range of specialized core business areas described below. Annual revenue by core business area for the past three fiscal years was:

 

     Revenue by Fiscal Year  

Core Business Area

   2012     2011     2010  
                  (In thousands)  

Naval Architecture and Marine Engineering

   $ 361,069         44.2   $ 332,007         42.2   $ 338,609         40.6

Technology Design and Other Services

     190,151         23.3     112,825         14.3     115,003         13.8

Defense Operations

     175,711         21.5     203,159         25.8     216,226         25.9

Modeling and Simulation

     90,273         11.0     139,323         17.7     164,150         19.7
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 817,204         100.0   $ 787,314         100.0   $ 833,988         100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Naval Architecture and Marine Engineering. We provide cradle-to-grave technical expertise for total ship and systems design. We are involved from the initial phase of mission analysis and feasibility trade-off studies through contract and detailed design. We offer production supervision, testing, delivery and life-cycle engineering support to commercial and naval markets both domestically and internationally.

 

   

We provide systems engineering/design integration, hull form development and performance analysis, structural design and analysis, weight engineering and intact and damage stability analysis.

 

   

We design and engineer ship systems including propulsion, electrical, fluids/piping, auxiliary, HVAC, deck machinery, and machinery automation and control systems. We provide expertise for machinery integration, test and trials, failure analysis, modeling and simulation, and integrated logistics support.

 

   

We provide mission and threat analysis, evaluate warfare and combat systems, and develop specifications and installation drawings for topside and below-deck interface requirements, and ship modernizations.

 

   

We provide ship alteration life-cycle engineering support for modernization, flight upgrades, and service-life extensions.

 

   

During construction we provide owner’s representative services, including on-site construction program management, shipyard liaison, field engineering, and test verification; we support ship trials and inspections.

 

   

We design, develop and deploy submarine and surface combatant technologies for tactical and non-tactical systems. We have acoustic anti-submarine warfare, torpedo defense, and real-time sonar and imaging expertise.

Technology Design, Engineering, Integration and Assessment. We provide services and technologies to government and commercial customers to reduce cost, enhance performance and safety of complex systems and improve information flow across networks and organizations.

 

   

We use our reliability engineering expertise to develop and integrate processes for rapid prototype production and flexible manufacturing. We maintain our own rapid prototyping and limited production manufacturing facilities.

 

   

We provide spectrum management services and analyze radio frequency propagation and network coverage profiles. We use advanced wireless design and evaluation techniques to optimize systems designs.

 

   

We develop information technology design concepts, perform trade off analyses and improve process designs. We create detailed enterprise and data architectures and implement commercial software to manage content and achieve data interoperability. Our human systems integration products and technical services help the Defense Department operate and maintain its systems.

 

2


Table of Contents
   

We develop design concepts and requirements and perform trade off analyses to improve energy production processes and equipment. We perform nuclear safety analyses for the Department of Energy, National Laboratories, and commercial customers.

 

   

We develop and evaluate methods for detecting chemical, biological, and other toxic agents and testing methods for measuring air quality. We determine the constituents and properties of wastes and effluents and develop and validate analytical methods and instruments. We evaluate potential health effects of various substances for the Environmental Protection Agency and the National Institutes of Health.

 

   

We provide Operational Test and Evaluation support to the military services, DISA, and DHS including: test planning, test execution, data management, analysis, and reporting.

Defense Operations. We perform military and policy analyses, assess logistics management readiness and operational support training, and analyze critical infrastructure risks for the Department of Defense.

 

   

We analyze major programs and issues related to joint warfare training, mission rehearsal, experimentation and other transformational activities. We develop net-centric initiatives and integrate C4I (command, control, communication, and computer intelligence) initiatives.

 

   

We support strategic planning efforts and operational exercises. We analyze, plan and implement base realignments and assess the defense industrial base.

 

   

We provide program, systems and legislative analyses to Office of the Secretary of the Air Force (Acquisition). We deliver management, technical and engineering support to the Program Executive Officer for the Joint Strike Fighter.

 

   

We help develop education programs for the military. We compile courseware and translate it into electronic and web-based distance learning media.

 

   

We provide the tools and support to assess vulnerabilities to protect ports, power plants, communications nodes and other infrastructures.

 

   

We collaborate with communities of interest to produce Joint Capabilities Integration and Development System analysis and capabilities documents.

 

   

We provide futures analysis requirements and concepts integration analysis.

 

   

We provide full life-cycle engineering support to the Tank Automotive Research, Development and Engineering Center for all ground combat and combat support weapons and vehicle systems.

Modeling and Simulation. We use our modeling and simulation expertise to examine event outcomes and identify technical failures and operational risks. We recommend solutions to mitigate risk and improve performance.

 

   

We design and conduct strategic and operations analytic war games to evaluate future operational concepts and force transformation initiatives. We create and implement multi-dimensional simulation system tactical training scenarios for the multi-national experiment series.

 

   

We manage the Defense Department Modeling and Simulation Information Analysis Center. We develop modeling and simulation tools to support integration and federation of stand-alone simulator-based training and large scale distributed training events.

 

   

We develop phenomenological models for nuclear, chemical, biological and electromagnetic environments.

 

   

We develop multi-dimensional visualization files to simultaneously display actual improvised explosive device events, terrain databases and scenario scripts to replay events and allow units to adjust tactics, techniques, and procedures.

 

   

We use gaming technology to develop proprietary and open source solutions for customers who use “serious” gaming for training and education.

 

   

We maintain a threat generation library to support world-wide Air Force and Joint training and mission rehearsal operations.

 

   

We provide modeling and simulation, C4I and operational support for the U.S. Navy’s Fleet Synthetic Continuous Training Environment which delivers distributed, on-demand training.

 

3


Table of Contents
   

We use advanced physics-based modeling techniques to assess ship and offshore system survivability and safety. We simulate damage events and scenarios, and predict operational response effectiveness to these events. We simulate personnel movement and responses to events to minimize operational impacts.

 

4


Table of Contents

Corporate History

Alion was organized in October 2001 as a for-profit Delaware corporation to acquire substantially all the assets and liabilities of IITRI, a not-for-profit Illinois corporation. Alion was an S-corporation from its formation until March 2010 when the Company issued common stock warrants constituting a second class of stock and became a C-corporation. Alion is entirely owned by an employee stock ownership plan (ESOP). The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Trust (the ESOP Trust) owns all of Alion’s issued and outstanding common stock. In December 2002, some eligible IITRI employees directed funds from qualifying retirement account balances into Alion’s ESOP. State Street Bank and Trust Company, the ESOP Trustee, used those proceeds to purchase Alion common stock. The Company used the ESOP proceeds, together with funds from bank loans and other debt to complete the IITRI purchase.

The Alion ESOP

The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan, is a KSOP — a qualified retirement plan that includes an ESOP invested in Alion common stock and a non-ESOP component invested in mutual funds. The ESOP Trust owns all outstanding shares of our common stock. Eligible employees can purchase beneficial interests in our common stock by:

 

   

rolling over an eligible retirement account balance from another plan into the ESOP;

 

   

transferring funds to the ESOP from the non-ESOP component of the KSOP during semi-annual election periods; and/or

 

   

directing a portion of pre-tax earnings to the ESOP.

The ESOP Trust uses the money employees invest in the ESOP to purchase Alion common stock and allocates ESOP interests to employee accounts according to the Plan’s terms. We make retirement plan contributions to the ESOP component for all eligible employee participants. We also make matching contributions to the ESOP for eligible employees based on their pre-tax salary deferrals.

The ESOP Trust holds record title to all shares of Alion common stock allocated to ESOP accounts. Except in certain limited circumstances, the ESOP Trustee must vote those shares as directed by the ESOP committee. The ESOP committee consists of four members of Alion’s management team and three other Alion employees; it is responsible for financial management and administration of the ESOP.

By law, Alion is required to value the common stock held in the ESOP component at least once a year. Alion currently has the ESOP Trustee value the common stock in the ESOP twice a year — as of March 31 and September 30. The terms of the KSOP permit the ESOP Trust to use employee-directed funds to purchase shares of Alion common stock at the lesser of the then-current or the immediate prior fair market value of a share of Alion common stock. All other ESOP transactions occur at the current fair market value of a share of Alion common stock. Semi-annual valuations permit employees to invest in Alion common stock twice a year and permit former employees and beneficiaries to request ESOP distributions at mid-year and year end.

Business Strategy

This year we were able to deliver on our plan to grow organically. We plan to grow further by retaining our existing customers, increasing our work for them and seeking out new customers to use our services. We expect to do this through targeted business development efforts and by capitalizing on our skilled work force and our solutions competencies. We have several key strategies.

Broaden existing core competencies. We plan to expand our expertise to keep pace with technological developments. We hire skilled employees, engage in business development initiatives and invest in projects to expand our employees’ skill sets. We work to extend our core capabilities to new markets and new customers and focus on enhancing our ability to serve existing customers. We increase our employees’ technological and program management skills through training, internally funded projects and mentoring. Our Alion University offers programs in engineering, program management, and finance and administration to maintain and enhance our employees’ skills and advance Alion’s reputation in the commercial technology solutions markets.

 

5


Table of Contents

Expand market share by leveraging experience and reputation. We perform a variety of services for a broad base of more than 300 customers, including Cabinet-level government departments and agencies, and state and foreign governments. We plan to use our advanced technological capabilities and our customer relationships to expand our market presence by offering a broader range of services to our existing customers and by delivering our solutions to new customers. We intend to use our customer relationships and our technology expertise to strategically expand our Department of Homeland Security (DHS) customer base. For over five years, Washington Technology, Defense News and Military Training Technology have continued to rank us among the top professional services government contractors. And for the past two years, Military Times EDGE has voted us a “Best for Vets Employer.” Washington Business Journal continues to rank Alion in its top twenty technology employers and government contractors.

Improve financial performance and increase revenue. Despite federal budget uncertainties and expected lower Department of Defense spending levels, we remain focused on growing our business and striving to achieve operating efficiencies. We increased topline revenue 3.8% this year and reduced operating expenses (including general and administrative expense) by 3.0% compared to last year. Over the past five years our revenues grew organically at a 2% compound annual rate from $737.6 million in 2007 to $817.2 million in 2012. We intend to strengthen our financial performance by continuing to grow organically and controlling operating costs. We believe we can achieve an even more competitive cost structure than we currently have which will enhance our ability to win business and improve our operating results. We believe Alion’s size and expertise position us to continue to bid on larger government programs and broaden our customer base.

Market and Industry Background

In January 2012, President Obama and Secretary of Defense Panetta jointly outlined a new national defense strategy driven by three realities: the winding down of a decade of war in Iraq and Afghanistan, a fiscal crisis demanding hundreds of billions of dollars in Pentagon budget cuts, and a rising threat from China and Iran. This new strategy establishes cyberspace defense and offense; Special Operations forces; and intelligence, surveillance and reconnaissance (ISR) as priorities. Cyberwarfare and unmanned drones will continue to grow in priority, as will countering rogue nations’ efforts to interfere with the United States’ ability to project military force into an operational area and sustain power in the face of armed opposition in areas like the South China Sea and the Straits of Hormuz. This new federal strategy focuses on addressing the need to retain and sustain military superiority over an adversary in cyberspace as well as on land and sea and in the air and space.

Alion’s market development strategy is focused upon the Department of Defense’s (DoD) highest priorities that seek to make RDT&E investments to sustain and in some limited areas to expand national security capability by 2020 and beyond. A cornerstone of this market strategy is mindful of pending Defense Budget reductions to include sequestration that are most likely to impact major end-item equipment and platform programs and operation and maintenance (O&M) costs – minor Alion market areas. Accordingly, Alion’s marketing strategy is formulated in recognition of DoD’s increasing dependence upon information technology for business applications, wireless command and control, ISR platforms and remote autonomous sensors. Lastly, Alion’s market strategy seeks to expand the current Alion chemical, biological, nuclear and radiation market service offerings.

In the Defense Budget Priorities and Choices, Jan 2012, Defense Secretary Panetta offered a first glimpse into coming cuts coming and said that he would be requesting $525 billion for fiscal year 2013 base budget—the first budget to be implemented since last year’s Budget Control Act mandated nearly $500 billion to be cut from the defense spending over the coming 10 years. It’s $6 billion less than 2012’s requested base budget and part of the $259 billion in cuts to take place in the next five years.” Secretary Panetta acknowledged the U.S. is facing technological as well as conventional threats. He said, “We have to be prepared to be able to leap ahead technologically in order to be able to confront those kinds of adversaries. We have to retain a decisive technological edge. . . [T]o protect vital investments in the future, we’ve protected science and technology programs.”

Alion’s marketing development strategy further recognizes the opportunity associated with DoD’s expanding presence of more-highly capable smart phones, tablets, wireless networks and other sophisticated communication technologies as a means to rapidly enhance the way warfighters access, use and exchange information. This is challenging the DOD to place greater emphasis on situational awareness and enterprise IT initiatives to develop and improve command and control technologies to make warfighters more effective. The Defense Information Systems Agency (DISA) is leading the effort to optimize DOD’s fragmented IT structure and services into a single joint platform that can be leveraged for all DOD missions. The goal is to reduce total cost of ownership, reduce network vulnerability and enable more efficient information access “from any authorized IT device from anywhere in the world.”

In DISA’s 2012-3 Strategic Plan, Director LTG Ronnie Hawkins stated that DISA seeks “to provide modern armed forces with reliable information and communications networks and assured access to the cyber domain.” However, as communication options multiply, so do the problems of getting disparate technologies to work together efficiently and securely. “Communication integration is now one of the top challenges facing military technology leaders,” said Chris Herndon, chief technologist at MorganFranklin and former director of the tactical technologies development lab at the Naval Research Laboratory.

 

6


Table of Contents

It is becoming increasingly important and much more difficult for the DOD to address and balance the dilemma of limited investment resources, demands from increasing threats, and the need for expanded capabilities while ensuring the DOD sustains a decisive advantage. Alion’s long-standing core business competencies are well aligned with the DOD’s current and future needs. Our expertise in Naval Architecture and Marine Engineering; System Analysis, Design and Engineering; and Modeling, Simulation and Training continues to be in high-demand, sought after by DOD customers at all levels.

The Budget Control Act established a joint bipartisan committee of Congress responsible to recommend various significant cuts in federal government spending. The joint committee did not meet the November 23, 2011 deadline for proposing recommended legislation. Due to that failure, unless Congress passes and the President signs during its current lame-duck session legislation amending the Budget Control Act, additional automatic spending cuts (referred to as sequestration) totaling $1.2 trillion in DOD and discretionary spending over a 10 year period will be triggered. Alion is evaluating the potential effect sequestration could have on our business and our industry, which is now unclear. However, if sequestration were to occur, federal spending cuts on the magnitude contemplated by the Budget Control Act would materially and adversely affect our future revenue.

We are primarily a government contractor.

For the past three years, over 97% of our sales were from federal government contracts; more than 83% of our revenue comes from our prime contracts. The Department of Defense is our largest customer. We expect most of our revenue will continue to come from federal government contracts on which we work as a prime contractor or subcontractor. As a prime contractor, we have direct contact with our government customer. As a subcontractor, we work for a prime contractor, which serves as the point of contact with the government agency customer.

Our federal government contracts are normally multi-year contracts funded on an annual basis based on congressional budget authorizations and appropriations. Each year Congress appropriates funds for authorized programs for the coming government fiscal year. Budget delays and uncertainties have continued to push the approval process later into the fiscal year. The annual congressional appropriations process means a contract is usually only partially funded at the outset of a major program. Normally a procuring agency commits additional money to a contract only as Congress makes appropriations in future fiscal years. The government can modify or discontinue any contract at its discretion or due to contractor default. The government can terminate or modify a contract for any of a variety of reasons, including funding constraints, changing government priorities or changes in program requirements. If the government terminates one of our contracts at its discretion, it typically pays us for all the services we performed and costs we incurred prior to termination, our termination-related costs, and a negotiated contract fee.

Contract Types. We have a diverse contract base including many task order and multiple-award contract vehicles (ID/IQ—indefinite delivery/indefinite quantity type contracts). Many customers utilize our ID/IQ contracts to hire us. Four of our six largest contracts are ID/IQ delivery order contracts; they accounted for 47% of this year’s revenues. Our largest individual contract accounted for 10% of our revenues. We had a portfolio of over 400 individual active contracts and task orders as of September 2012.

We have three contract pricing structure types: cost-reimbursement, fixed-price and time-and-material. Cost-reimbursement contracts allow us to recover expenses for direct labor and materials, a share of indirect expenses, and a fixed or variable fee depending on contract terms. Government contract rules permit us to recover certain, though not all, of our operating expenses (indirect costs). Fixed-price contract customers pay a stated amount intended to cover all direct and indirect costs, and profit. We assume the risk of any cost overruns and receive the benefit of any cost savings on fixed price contracts. Time-and-material contracts have fixed hourly billing rates designed to cover our labor costs, indirect expenses and profit, with cost reimbursable provisions for materials and other direct costs. We have traditional closed-end contracts and multiple award contracts which require sustained post-award effort to realize revenue. The following table summarizes our revenue by contract type for the years ended September 30, 2012, 2011, and 2010.

 

7


Table of Contents
     Revenue by Fiscal Year  

Contract Type

   2012     2011     2010  
     (In thousands)  

Cost-reimbursement

   $ 676,744         82.8   $ 649,754         82.5   $ 644,756         77.3

Fixed-price

     63,190         7.7     50,148         6.4     80,719         9.7

Time and material

     77,270         9.5     87,412         11.1     108,513         13.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 817,204         100.0   $ 787,314         100.0   $ 833,988         100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

We try to reduce our financial and performance risks at each stage in the contracting process. However, sometimes we begin providing services before a U.S. government agency has actually signed or funded a contract or task order. We are at risk for costs we incur before a new contract is executed or an existing contract is modified. The practice is customary in our industry, particularly where a company has oral notification of a contract award, but has not received required contract documents. We designed our internal procedures to provide services “at risk” only when we believe funding is highly probable and delays are administrative or technical in nature. In most cases, we get paid for all our costs when a contract is ultimately executed or modified. However, we cannot be certain, when we work at risk, that we will receive an executed contract or that we will be paid for all our costs. As of September 30, 2012, we had $19 million in contract costs at risk; nearly 40% of that amount represents award fees we believe we have earned where we had yet to receive permission to bill our customers.

We compete for key contracts from various U.S. government agencies. Our business development and technical personnel target contract opportunities and analyze each customer’s priorities and overall market dynamics. Depending upon whether a targeted contract is a renewal or a new opportunity, it can take as little as three months and up to three years to develop and execute our strategy before a customer ultimately issues a contract. When we decide to pursue a potential contract, we mobilize a core group of employees with the requisite expertise to lead our bidding and proposal preparation efforts. We supplement our internal capabilities with a network of consultants and other industry experts as necessary. To enhance our prospects of winning a contract, we team with other contractors, frequently our competitors, who have complementary technical strengths.

When we win a contract or task order, we assign a project manager and a task leader to ensure we timely deliver high-quality services. Program managers regularly interface with customers to evaluate Alion’s performance and customer satisfaction levels. Managers use our financial management and information systems to compare costs to funding ceilings and measure performance and profitability.

Government Oversight. Federal government auditors and technical specialists regularly review our administrative procedures and our cost accounting policies and practices. Costs on flexibly-priced federal government contracts are subject to Defense Contract Audit Agency (DCAA) and other audits and negotiated adjustments. An audit may reveal that some costs charged to a government contract are not allowable, either in whole or in part. In these circumstances, we must repay the federal government any money it paid us for unallowable costs, plus interest and possible penalties. The government considers Alion a major contractor and maintains an onsite audit office. DCAA is currently auditing our 2006 and 2007 claimed indirect costs. We are negotiating our 2005 indirect rates and have settled our rates through 2004. We timely submitted our indirect cost proposals for all open fiscal years and expect to submit this year’s incurred cost proposal next March as required. We have recorded revenue on federal government contracts in amounts we expect to realize.

Backlog. Contract backlog represents our estimate, as of a given date, of the remaining future revenue we expect from existing contracts. Funded backlog is the value of executed contract funding less previously recognized revenue. Unfunded backlog is the estimated value of additional funding not yet authorized by customers on our existing contracts. On September 30, 2012, we had $2.4 billion in backlog on existing contracts and executed delivery orders of which $480 million was funded.

The U.S. government operates under annual appropriations; departments and agencies typically fund contracts on an incremental basis. Thus, only a portion of total contract backlog is “funded.” Funded backlog varies based on procurement and funding cycles and other factors beyond our control. Future funding from executing new contracts and extending or renewing existing contracts increases our backlog; completed contracts, early terminations, and reductions in estimated future revenue on existing contracts reduce backlog. Estimates of future revenue from contract backlog are by their nature inexact. Timing and receipt of future revenue are subject to various contingencies, many of which are outside our control. Accordingly, year over year comparisons are not necessarily indicative of future revenue trends. The table below shows the value of our contract backlog as of September 30, 2012, 2011 and 2010.

 

8


Table of Contents
     September 30,  

Backlog:

   2012      2011      2010  
     (In millions)  

Funded

   $ 480.1       $ 403.8       $ 407.8   

Unfunded

     1,919.2         2,158.7         2,366.8   
  

 

 

    

 

 

    

 

 

 

Total

   $ 2,399.3       $ 2,562.5       $ 2,774.6   
  

 

 

    

 

 

    

 

 

 

Corporate Culture, Employees and Recruiting

We strive to create a culture that promotes performance excellence; respects colleagues’ ideas and judgments; and recognizes the value of our professional staff’s unique skills and capabilities. We seek to attract highly qualified and ambitious employees. We strive to establish an environment in which all employees can make their best personal contribution and have the satisfaction of being part of a unique team. We believe we have a track record of successfully attracting and retaining highly skilled employees because of the quality of our work environment, the professional challenges of our assignments, and the financial and career advancement opportunities we offer.

At September 30, 2012, we had approximately 2,882 employees, and approximately 2,684 full-time employees. Approximately 28% of our employees have Ph.D.s or masters degrees, and approximately 80% of our employees have college degrees. More than 32% of our employees have Top Secret or higher level security clearances. We believe we have a good relationship with our employees. None of our employees is covered by a collective bargaining agreement.

We view our employees as our most valuable asset. Our success depends in large part on attracting and retaining talented, innovative, experienced professionals at all levels. We rely on the availability of skilled technical and administrative employees to perform our research, development and technological services for our customers. The market for certain technical skills in our core business areas is at times extremely competitive. This makes employee recruiting and retention in these and other specialized areas extremely important. We believe our benefits package, work environment, incentive compensation, and employee-ownership culture will continue to be important in recruiting and retaining highly skilled employees.

Our Customers

We provide scientific, research and development, technical expertise, and operational support to a diverse group of U.S. government customers. We also serve commercial, state, local and international government customers. As of September 30, 2012, we had 327 distinct customers, including U.S. government departments and agencies, state, and foreign governments. We have almost 400 Department of Defense contracts and delivery orders with the U.S. Navy, Army and Air Force; the Defense Information Systems Agency (DISA); the Defense Advanced Research Projects Agency (DARPA) and others representing approximately 91.6% of our 2012 revenue. Other federal civilian agencies and departments accounted for 5.7% of our revenue, including the National Institute of Environmental Health Sciences, the U.S. Department of Energy and the EPA. Commercial, state and local governments and international customers accounted for the remaining 2.7% of this year’s revenue. The table below shows revenue by customer category for our past three fiscal years.

 

     September 30,  
     2012     2011     2010  
            (In thousands)         

U.S. Department of Defense

   $ 748,418         91.6   $ 725,830         92.3   $ 774,807         92.9

Other Federal Civilian Agencies

     46,535         5.7     46,359         5.7     40,306         4.8

Commercial and International

     22,251         2.7     15,125         2.0     18,875         2.3
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 817,204         100.0   $ 787,314         100.0   $ 833,988         100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Competition

The U.S. government engineering and technology services industries consist of a large number of enterprises ranging from small, niche-oriented companies to multi-billion dollar corporations that serve many U.S. government customers. Corporations frequently form teams to pursue contract opportunities because large contracting initiatives are highly competitive and government customers have diverse requirements. Prime contractors leading large proposal efforts typically select team members based on particular capabilities and experience relevant to each opportunity. Companies that compete on one opportunity may be team members on another opportunity.

 

9


Table of Contents

We frequently compete against well-known firms in the industry as a prime contractor. Our competitors include Booz Allen Hamilton, BAE, CACI International Inc., Science Applications International Corporation, Engility, Computer Sciences Corporation, ITT, TASC, QinetiQ, ManTech International, URS, CGI-Stanley and the services divisions of Lockheed Martin, General Dynamics and Northrop Grumman.

We also compete at the task order level, where knowledge of the customer, its procurement requirements and its environment is often the key to winning business. We have been successful in ensuring our presence on numerous contracts and GSA Schedules, and in competing for tasks under those contracts. The variety of contract vehicles at our disposal, as a prime contractor or subcontractor, allows us to market our services to any U.S. government agency. We have experience providing services to a diverse array of U.S. government departments and agencies. We have first-hand knowledge of our customers and their goals, problems and challenges. Most government contracts we seek are competitive awards. We believe our customers typically consider the following key factors in awarding contracts: technical capabilities and approach; personnel quality and management capabilities; previous successful contract performance; and price.

In our experience, price and technical capabilities are a customer’s two most important considerations in contracts for complex technological programs. We believe our customer knowledge, our government contracting and technical capabilities, and our pricing policies enable us to compete effectively.

Change in Tax Status

From inception until March 22, 2010, Alion was an S-corporation and was not subject to federal or most state income taxes. All our subsidiaries were qualified S-corporation subsidiaries or disregarded entities. An S-corporation is a pass-through entity that can only have a single class of stock; no more than 100 shareholders; and only certain kinds of shareholders, such as individuals, trusts and certain tax-exempt organizations like ESOPs. Alion’s income and losses were allocated to the ESOP Trust, its tax-exempt shareholder.

On March 22, 2010, we issued deep-in-the-money warrants deemed to constitute a second class of stock. Once we had two classes of stock, we no longer qualified as an S-corporation and automatically became a C-corporation. Some of our subsidiaries are also subject to separate state income tax and reporting requirements. We are also subject to franchise and other business taxes unaffected by our change in federal tax status.

The Internal Revenue Code permits the IRS to impose significant penalties on a subchapter S employer that maintains an ESOP if the ESOP allocates stock to certain “disqualified persons” above statutory limits or if disqualified persons as a group own 50% or more of a company’s stock. For this purpose, a “disqualified person” is typically someone who owns 10% or more of the subchapter S employer’s stock (including deemed ownership through warrants, stock appreciation rights, phantom stock, and similar rights). The KSOP and our stock appreciation rights plan have provisions designed to prohibit allocations that violate these limits. Apart from the warrants related to the IIT subordinated note that formerly represented approximately 24% of our common stock, no one person ever held an ownership interest representing more than 5% of Alion while we were an S corporation. See Note 13 – Redeemable Common Stock Warrants in our audited financial statements elsewhere in this report.

Business Development and Promotional Activities

We promote our contract research services by meeting face-to-face with current and potential customers, obtaining new work from satisfied customers, and responding to requests for proposals (RFPs) and international tenders. We use our knowledge of and experience with U.S. government procurement procedures, and our relationships with government personnel, to try to maximize our ability to respond timely to RFPs and customer requests. We bid on contracts in our core business areas and related areas where we believe we have a good chance of winning. When we bid on a potential contract, we draw on our core business area expertise to display the technical skills we can bring to a particular contract.

Our business developers work face-to-face with customers, are experienced in marketing to government customers, know the services and products they represent, and understand each particular customer’s organization, mission and culture. These professionals possess a working knowledge of rules governing the marketing limitations that are unique to the government arena. They understand government funding systems, conflict of interest restrictions, procurement integrity directives, and the procedural requirements designed to establish a level competitive playing field to ensure appropriate use of public funds.

Our technical staff is an integral part of our promotional efforts. The customer relationships they develop through their work often lead to additional business and new research opportunities. We hold weekly company-wide business development meetings to review proposal opportunities and determine strategy in pursuing these opportunities. We also use independent consultants for promoting business, developing proposal strategies and preparing proposals as necessary.

 

10


Table of Contents

We focus most of our substantial research and development activities on customer-funded projects and internally-developed capital assets. We believe actively fostering an environment of innovation is critical to our ability to grow our business, allowing us to proactively address issues of national concern in public health, safety and national defense.

Resources

Most of our work relies on computer and laboratory equipment and other supplies readily available from multiple vendors. Disruption in availability from any particular vendor is not likely to materially affect our ability to perform our contracts. Some of our specialized laboratory work depends on special materials and equipment whose unavailability could adversely affect experimental laboratory tasks. However, we believe these kinds of delays or disruptions are not likely to materially affect our overall operations or financial condition.

Patents and Proprietary Information

As a normal course of business, Alion performs research and development, and engineering activities in support of our customers. Typically these services do not depend on patent protection. In accordance with applicable law, our U.S. government contracts often provide government agencies certain license rights to our inventions and copyright works. Government agencies, and other contractors including our competitors, can obtain the right to utilize our inventions. Similarly, our U.S. government contracts often license to us patents and copyright works owned by third parties. We maintain an active program to track and protect our intellectual property. We routinely enter into intellectual property assignment agreements with our employees to protect our rights to any patents or technologies they develop while employed by Alion. Costs for internal research and development, patents and intellectual property activities are not material to the Company’s financial statements.

Seasonality

Although our business is not seasonal, it does fluctuate with the number of working days in each quarter. The first and fourth quarters each year generally have fewer working days for our employees to generate revenue. In the weeks before the federal government’s September fiscal year end, it is not uncommon for government agencies to award additional tasks or complete contract actions to avoid losing unexpended fiscal year funds.

Foreign Operations

In each of the past three fiscal years, nearly all our revenue came from contracts with U.S.-based customers. We treat revenue from U.S. government customers as United States revenue regardless of where we perform our services.

Company Information Available on the Internet

Our internet address is www.alionscience.com. Information on the Company’s website is not incorporated by reference into this report.

Environmental Matters

We are subject to federal, state, local and foreign laws and regulations relating to, among other things, emissions and discharges into the environment, handling and disposal of regulated substances, and contamination by regulated substances and wastes. Some of our operations may require environmental permits and/or controls to prevent or reduce air and water pollution. Issuing authorities can renew, modify, or revoke these permits.

Operating and maintenance costs associated with environmental compliance and preventing contamination at our facilities are a normal, recurring part of our operations. These costs have not been material in the past and are not material to our total operating costs or cash flows. Such costs are usually allowable under government contracts. Based on information presently available to us and on current U.S. government environmental policies relating to allowable costs, all of which are subject to change, we do not expect environmental compliance to materially affect us. We also believe our facilities’ environmental compliance costs will continue to be allowable.

Under existing U.S. environmental laws, potentially responsible parties can be held jointly and severally liable. We could be potentially liable to the government or third parties for the full cost of investigating or remediating contamination at our sites or at third-party sites in the event contamination is identified and remediation is required. In the unlikely event that we were required to fully fund remediation of a site, the statutory framework might allow us to pursue rights of contribution from other potentially responsible parties.

 

11


Table of Contents

Item 1A. Risk Factors

Risks Related to Our Debt Structure

We have incurred a significant amount of debt; our debt load may limit our financial and operational flexibility which could prevent us from fulfilling our obligations under our debt agreements.

We have managed significant amounts of debt since December 2002. However, we continue to face challenges in functioning as a highly leveraged company in volatile and unfavorable credit markets. We borrowed money to acquire the IITRI assets in 2002. We refinanced that debt in 2004. We incurred substantial additional debt partly to fund acquisitions in 2005 and 2006. In 2007, we refinanced and restructured some of our debt by issuing $250 million in senior unsecured notes (Unsecured Notes). In 2010, we re-financed outstanding senior bank debt and subordinated debt by issuing $310 million in senior secured notes (Secured Notes). Secured Note principal will continue to increase over time through November 2014 as we issue notes for paid-in-kind (PIK) interest. As of September 2012, we owe lenders almost $589 million: approximately $326 million in Secured Note principal and accrued PIK interest; $245 million in Unsecured Note principal; and almost $18 million in accrued interest.

Our substantial debt has and could continue to:

 

   

make it more difficult for us to satisfy our debt-related obligations; any failure to comply with any of our debt instrument obligations, including restrictive and financial covenants, could result in an event of default under our debt agreements; which, if not cured, could accelerate our indebtedness;

 

   

make it more difficult for us to satisfy our repurchase obligations to ESOP participants;

 

   

increase our vulnerability to general adverse economic and industry conditions and make it more difficult for us to react to changing conditions;

 

   

limit our ability to obtain additional financing for working capital, capital expenditures, acquisitions, other business opportunities, new technologies or other general corporate requirements;

 

   

require a substantial portion of our operating cash flow to pay interest on our debt and thus reduce our ability to use our cash flow for future business needs;

 

   

limit our ability to execute on our business plans;

 

   

limit our flexibility to plan for, or react to changes in our business and the government contracting industry; and

 

   

place us at a competitive disadvantage compared to less leveraged companies.

Despite our current debt levels, we and our subsidiaries may still be able to incur more debt. This could further aggravate risks associated with our substantial leverage.

We have the ability to incur additional debt, subject to limitations imposed by covenants in our revolving credit facility, the indenture governing the Unsecured Notes, (Unsecured Note Indenture) and the indenture governing the Secured Notes (Secured Note Indenture). Secured Note PIK interest will increase our debt by the amount of PIK notes we issue. The Unsecured Note Indenture, the current revolving credit facility and the Secured Note Indenture do not completely prohibit us from incurring additional debt. The more we borrow, the more we, and in turn our security holders, become exposed to the risks described under “We have incurred a significant amount of debt and our debt load may limit our financial and operational flexibility which could prevent us from fulfilling our obligations under our debt agreements.” See Note 11 – Long-Term Debt in the Notes to the Audited Financial Statements, and Management’s Discussion and Analysis of Financial Condition and Results of Operations – Discussion of Debt Structure for additional information.

Our Unsecured Note Indenture, revolving credit facility and the Secured Note Indenture restrict our operations.

Our Unsecured Note Indenture, revolving credit facility, and the Secured Note Indenture contain, and our future debt agreements may contain, covenants that may restrict our ability to engage in activities that may be in our long-term best interest, including financing future operations or capital needs or engaging in other business activities. Our Unsecured Note Indenture, revolving credit facility and the Secured Note Indenture restrict, among other things, our ability and the ability of our subsidiaries to:

 

12


Table of Contents
   

incur additional debt other than permitted additional debt;

 

   

pay dividends or distributions on our capital stock;

 

   

purchase, redeem or retire capital stock other than to satisfy ESOP repurchase obligations;

 

   

pay certain amounts required under our equity-based and incentive compensation plans;

 

   

spend more than $8 million per year on capital assets;

 

   

make acquisitions and investments other than permitted acquisitions and permitted investments;

 

   

issue or sell preferred stock of subsidiaries;

 

   

create liens on our assets;

 

   

enter into certain transactions with affiliates;

 

   

merge or consolidate with another company; or

 

   

transfer or sell assets outside the ordinary course of business.

Our revolving credit facility requires us, and future debt agreements may require us, to maintain specified financial levels relating to, among other things, our minimum trailing twelve-month EBITDA. Future debt agreements may also impose other minimum financial performance requirements including, but not limited to, fixed charge coverage and net worth tests. Events beyond our control can affect our ability to meet these financial performance requirements; we cannot guarantee that we will meet these tests.

Default under the revolving credit facility, the Unsecured Note Indenture or the Secured Note Indenture could allow lenders to declare all amounts outstanding under the revolving credit facility, the Secured Notes and the Unsecured Notes to be immediately due and payable. We have pledged substantially all of our assets to secure our revolving credit facility and secured note debt. If credit facility lenders were to declare the revolving credit facility balance due, they could proceed against those assets. Any event of default could have a material adverse effect on our business, financial condition and operating results if creditors were to exercise their rights.

From time to time we may require consents or waivers from our lenders to permit actions prohibited by the revolving credit facility, the Unsecured Note Indenture or the Secured Note Indenture. If, in the future, lenders refuse to waive restrictive covenants and/or financial levels under the revolving credit facility, the Unsecured Note Indenture and/or the Secured Note Indenture, we could be in default on the revolving credit facility, the Unsecured Note Indenture and/or the Secured Note Indenture. We could be prohibited from undertaking actions necessary or desirable to maintain or expand our business. There is no guarantee we will be able to obtain additional consents or waivers from our lenders.

We may not be able to obtain financing in the future, and the terms of any future financings may limit our ability to manage our business. Difficulties in obtaining financing on favorable terms would have a negative effect on our ability to execute our business strategy.

We will need to seek additional capital in the future to refinance or replace existing long-term debt. We may also need to seek additional capital in the future to meet current or future business plans, meet working capital needs or for other reasons. Based on current market conditions, the availability of financing is, and may continue to be, limited. There can be no assurance that we will be able to obtain future financings on acceptable terms, if at all. The secured notes, the revolving credit facility and the unsecured notes mature between August 2014 and February 2015; this could further limit our ability to obtain additional financing on acceptable terms, if at all.

Moody’s lowered our corporate family credit rating from Caa1 to Caa2 in September 2012. This downgrade or further downgrades could increase our cost of capital, or limit any attempt to obtain additional financing in the future. An increase in our cost of capital would adversely affect our results of operations and our financial position.

If we are unable to obtain alternative or additional financing arrangements in the future, or if we cannot obtain financing on acceptable terms, we may not be able to execute our business strategies. Moreover, the terms of any such additional financing may restrict our financial flexibility, including the debt we may incur in the future, or may restrict our ability to manage our business as we had intended.

 

13


Table of Contents

If we breach our financial covenants, we could have to amend our revolving credit facility financial covenants which could materially affect our ability to finance our future operations, meet our capital needs or satisfy obligations to repurchase our common stock.

Our credit arrangements, including our unsecured and secured note indentures and our revolving credit facility include a number of covenants. We expect to be able to comply with our indenture covenants and our credit facility financial covenants for at least the next twenty-one months. If we were unable to meet financial covenants in our revolving credit facility in the future, we might need to amend the revolving credit facility on less favorable terms. If we were to default under any of the revolving credit facility covenants, we could pursue an amendment or waiver with our existing lenders, but there can be no assurance that lenders would grant an amendment or waiver. In light of current credit market conditions, any such amendment or waiver might be on terms, including additional fees, increased interest rates and other more stringent terms and conditions materially disadvantageous to us. If we were unable to meet these financial covenants in the future and unable to obtain future covenant relief or an appropriate waiver, we could be in default under the revolving credit facility. This could cause all amounts borrowed under it and all underlying letters of credit to become immediately due and payable, expose our assets to seizure, cause a potential cross-default under our indentures and possibly require us to invoke insolvency proceedings including, but not limited to, a voluntary case under the U.S. Bankruptcy Code. We may find it more difficult to obtain waivers or amendments to covenants in our indentures than our revolving credit facility because the process to obtain such a waiver or amendment is complicated and would in most cases involve the consent of the relevant portion of the affected class of our note holders.

Risks Related to Our Business and Operations

We expect to experience net losses in at least our next four years of operation.

We have had a net loss every year since our inception in late 2002. We expect to incur a net loss in at least our next four years of operation, fiscal years 2013 through 2016. Interest expense on existing debt, amortization of purchased contracts and future deferred income tax expense are among the most significant factors contributing to our estimated future net losses. The size of future losses and achieving profitability depend on achieving significant revenue growth and controlling expenses. We may not become profitable if revenue grows more slowly than we anticipate, or if operating expenses exceed our expectations. Even if we become profitable, we may not be able to sustain our profitability.

Our ability to meet our financial and other future obligations depends on our future operating results. We cannot be sure we will be able to meet these obligations as they come due.

Our ability to pay our debt, to comply with financial covenants, and to fund working capital and planned capital expenditures depends on our ability to generate cash flow in the future. We cannot be certain our business strategy will succeed or that we will achieve our anticipated financial results. Our financial and operational performance depends upon a number of factors, many of which are beyond our control. Risk factors include:

 

   

when and how much of our contract backlog our customers fund;

 

   

how long our customers take to pay us;

 

   

when and whether we win new contracts and how we perform on our contracts;

 

   

whether we can increase our annual revenue and/or operating income;

 

   

how much in payroll deferrals and rollovers our employees spend to purchase our common stock;

 

   

how much we have to spend to repurchase our stock from current and former employees;

 

   

current economic conditions and conditions in the defense contracting industry;

 

   

U.S. government spending levels, both generally and by our particular customers;

 

   

failure by Congress to timely approve budgets for federal departments and agencies we support;

 

   

operating difficulties, operating costs or pricing pressures;

 

14


Table of Contents
   

new legislation or regulatory developments that adversely affect us; and

 

   

any delays in implementing strategic projects.

These factors will also affect our ability to meet future ESOP re-purchase obligations. In August 2014, we must re-pay any outstanding revolving credit facility balance. We are required to pay all outstanding principal and accrued interest on our Secured Notes on November 1, 2014. Three months later on February 1, 2015, we are required to pay all outstanding principal and accrued interest on our Unsecured Notes.

During 2011, the federal government was unable to reach agreement on budget reduction measures required by the Budget Control Act of 2011 (Budget Act) passed by Congress. During the recent presidential election cycle, much was debated about sequestration, and unless Congress and the Administration take further action during the current lame-duck session of Congress, the Budget Act will trigger automatic reductions in both defense and discretionary spending in January 2013. If sequestration were to occur, automatic across-the-board cuts in the federal budget due to sequestration could have material consequences to our business and our industry.

We may not generate sufficient cash flow to comply with our financial covenants and meet our payment obligations when they become due. If we are unable to comply with our financial covenants, or if we are unable to generate sufficient cash flow or otherwise obtain the funds we need for required debt payments, we may have to refinance our debt. We cannot be certain we could refinance our obligations on favorable terms, or at all. Absent refinancing, our lenders would be able to accelerate our debt’s maturity. As a result, we could default under our other senior debt, expose our assets to seizure, or declare bankruptcy.

We face intense competition from many companies that have greater resources than we do. This could cause price reductions, reduced contract profitability, and loss of market share.

We operate in highly competitive markets and often encounter intense competition to win contracts. If we are unable to successfully compete for new business, our revenue may not grow and operating margins may decline. Many of our competitors are larger; have greater financial, technical, marketing, and public relations resources; have larger client bases; and have greater brand or name recognition than we do. Larger competitors include U.S. federal systems integrators such as Booz Allen Hamilton, Computer Sciences Corporation, CACI International Inc., Science Applications International Corporation, Engility Corporation, TASC, URS Corporation, CGI Group Inc., ManTech International, and the services divisions of large defense contractors such as Lockheed Martin Corporation, General Dynamics Corporation and Northrop Grumman Corporation.

Our larger competitors may be able to vie more effectively for very large-scale government contracts. Our larger competitors also may be able to provide clients with different or greater capabilities or benefits than we can provide in areas such as technical qualifications, past performance on large-scale contracts, geographic presence, price, and availability of key professional personnel. Our competitors have established relationships among themselves or with third parties, including through mergers and acquisitions, to increase their ability to address client needs. They may establish new relationships; new competitors or competitive alliances may emerge.

Our ability to compete for desirable contracts will depend on: the effectiveness of our internal and customer-funded research and development programs; our ability to offer better performance than our competitors at lower or comparable cost; the readiness of our facilities, equipment and personnel to perform the programs for which we compete; and our ability to attract and retain key personnel. If we do not continue to compete effectively and win contracts, our future business, financial condition, results of operations and our ability to meet our financial obligations may be materially compromised.

Historically, a few contracts have provided most of our revenue. If we do not retain or replace these contracts our operations will suffer.

The following six federal government contracts accounted for half of our revenue both this year and last year.

 

  1. Seaport-E Multiple Award Contract for the Naval Sea Systems Command (19%, 12%)

 

  2. Weapons System Technology Information Analysis Center for the Defense Information Systems Agency (17%, 8%)

 

  3. Technical and Analytical Support for the U.S. Air Force (10%, 11%)

 

  4. Modeling and Simulation Information Analysis Center for the Defense Information Systems Agency (8%, 14%)

 

15


Table of Contents
  5. Naval Sea Systems Command Surface Ships Life Cycle Program Management and Engineering Support (6%, N/A); and

 

  6. Naval Sea Systems Command Multiple Award Contract (3%, 11%)

Termination of these contracts or our inability to renew or replace them when they expire could cause our revenue to decrease and could have a material adverse effect on our business, financial condition, operating results or ability to meet our financial obligations.

If we are unable to achieve or manage growth, our business could be adversely affected.

Attempting to achieve long-term growth has placed significant demands on our management, and on our administrative, operational and financial resources. To achieve and manage growth, we must improve operational, financial and management information systems, and expand, motivate and manage our workforce. If we are unable to achieve and manage growth without compromising our quality of service and our profit margins, or if systems we implement to aid in managing our growth do not produce expected benefits, our business, prospects, financial condition, operating results or ability to meet our financial obligations could be materially adversely affected.

We depend on key management and may not be able to retain those employees due to competition for their services.

We believe that our future success will be due, in part, to the continued services of our senior management team. The loss of any one of these individuals could cause our operations to suffer. We do not maintain key man life insurance policies on any members of management.

Our business could suffer if we fail to attract, train and retain skilled employees.

Availability of highly trained and skilled professional, administrative and technical personnel is critical to our future growth and profitability. Even in the current economic climate, competition in our industry for scientists, engineers, technicians, management and professional personnel is intense and competitors aggressively recruit key employees. Competition for experienced personnel, particularly in highly specialized areas, has made it more difficult for us to timely meet all our staffing needs. We cannot be certain we will be able to attract and retain required staff on acceptable terms. Any failure to do so could have a material adverse effect on our business, financial condition, operating results and our ability to meet our financial obligations. Failure to recruit and retain a sufficient number of these employees could adversely affect our ability to maintain or grow our business. Some of our contracts require us to staff a program with personnel the customer considers key to successful performance. If we cannot provide these key personnel or acceptable substitutes, the customer may terminate the contract, and we may not be able to recover our costs.

In order to succeed, we will have to keep up with a variety of rapidly changing technologies. Various factors could affect our ability to keep pace with these changes.

Our success will depend on our ability to keep pace with changing technologies in our core business areas. These technologies can change rapidly. Even if we keep up with the latest developments and available technology, newer services or technologies could negatively affect our business. Integrating our research services’ diverse technologies is complex and often has not been previously attempted. Our success will depend significantly on our ability to develop, integrate and deliver technologically advanced services and solutions at the same or faster pace as our competitors, many of which have greater resources than we do. We are limited by our revolving credit facility in the amount of money we may spend annually on capital expenditures, and those limitations could restrict our ability to invest in new and developing technologies in one or more of our core business areas. Failure to make the appropriate investment could materially affect our business, financial condition and operating results.

A continued economic downturn could harm our business.

Our business, financial condition, operating results and ability to meet our financial obligations may be affected by various economic factors. Continued unfavorable economic conditions may make it more difficult for us to achieve or maintain revenue growth. In an economic recession, or under other adverse economic conditions which may arise from natural or man-made events, customers and vendors may be less likely to meet contractual terms and payment or delivery obligations. Continued weakness or further deterioration of economic conditions may have a material adverse effect on our business, financial condition, operating results and ability to meet our financial obligations. We believe that it is possible that an economic downturn could result in 2013 and beyond from the combination of a significant reduction in governmental spending due to sequestration and the potential for federal income tax rates to increase in 2013 as a result of current federal tax law.

 

16


Table of Contents

Further adverse changes in market conditions, the stock market, the merger and acquisition environment in our industry or federal government budget constraints could adversely affect the value of our reporting units which could cause us to recognize a goodwill impairment charge in the future.

If market conditions were to become more unfavorable, if merger and acquisition activity in our industry were to occur at significantly lower prices, or we are unable to increase revenue and operating profit, we might have to recognize an impairment charge to the significant goodwill we have from acquisitions. An impairment charge could have a material adverse effect on our operating results and financial position.

Our employees may engage in misconduct or other improper activities, which could harm our business.

We are exposed to the risk of employee fraud or other misconduct. Employee misconduct could include intentional failures to comply with U.S. government procurement regulations, unauthorized activities, attempts to obtain reimbursement for improper expenses, or submission of falsified time records. Employee misconduct could also involve improper use of our customers’ sensitive or classified information, which could result in regulatory sanctions against us and serious harm to our reputation. It is not always possible to deter employee misconduct, and the precautions we take to prevent and detect this activity may not be effective in controlling unknown or unmanaged risks or losses, which could harm our business, financial condition, operating results and our ability to meet our financial obligations.

The interests of the ESOP Trust and the ESOP Committee may not be aligned with the interests of participants in the ESOP component of the KSOP.

The ESOP Trust owns 100% of our outstanding shares of common stock. It can control the election of a majority of our directors, the outcome of most matters submitted to a vote of stockholders, and can change our management. The ESOP Committee, which consists of four members of Alion management and three employees, can direct the ESOP Trustee how to vote on most, but not all, matters. The interests of the ESOP Trust and the ESOP Committee may not be fully aligned with the interests of ESOP participants and this could lead to a strategy that are not in the best interests of those participants.

Environmental laws and regulations and our use of hazardous materials may subject us to significant liabilities.

Our operations are subject to U.S. federal, state and local environmental laws and regulations, as well as environmental laws and regulations in the various countries in which we operate. We are also subject to environmental laws and regulations relating to the discharge, storage, treatment, handling, disposal and remediation of regulated substances and waste products, such as radioactive, biochemical or other hazardous materials and explosives. We may incur substantial costs in the future because of: modifications to current laws and regulations; new laws and regulations; new guidance or new interpretation of existing laws or regulations; violations of environmental laws or required operating permits; or discovery of previously unknown contamination.

Our operations involve several risks and hazards, including potential dangers to our employees and to third parties that are inherent in aspects of our business. If we do not adequately insure against these risks, unanticipated losses could materially and adversely affect our financial condition and operating results.

We maintain insurance against risk and potential liabilities related to our operations. We believe we maintain reasonable levels of insurance that limit our likely exposure to unanticipated losses. Our insurance coverage may not be adequate to cover claims or liabilities, and we could be forced to bear significant costs from an accident or incident. Substantial claims in excess of our related insurance coverage could cause our actual results to differ materially and adversely from those anticipated.

Internal system or service failures could disrupt our business and impair our ability to effectively provide our services and products to our customers, which could damage our reputation and adversely affect our revenue, profitability and operating results.

Our information technology systems are subject to systems failures, including network, software or hardware failures, whether caused by us, third-party service providers, intruders or hackers, computer viruses, natural disasters, power shortages or terrorist attacks. Any such failures could cause loss of data and interruptions or delays in our business, cause us to incur remediation costs, subject us to claims and damage our reputation. Failure or disruption of our communications or utilities could cause us to interrupt or suspend our operations or otherwise adversely affect our business. Any system or service disruptions if not anticipated and appropriately mitigated, could have a material adverse effect on our business including, among other things, an adverse effect on our ability to bill our customers for work performed on our contracts, collect the amounts that have been billed and produce accurate financial statements in a timely manner. Our property and business interruption insurance may be inadequate to compensate us for all losses that may occur as a result of any system or operational failure or disruption and, as a result, our results of operations could be materially and adversely affected.

 

17


Table of Contents

Security breaches in sensitive U.S. Government systems could result in the loss of clients and negative publicity.

Many of the systems we develop, install and maintain involve managing and protecting information involved in intelligence, national security and other sensitive or classified U.S. Government functions. A security breach in one of these systems could cause serious harm to our business, damage our reputation and prevent us from being eligible for further work on sensitive or classified systems for U.S. Government clients. We could incur losses from such a security breach that could exceed the policy limits under our errors and omissions and product liability insurance. Damage to our reputation or limitations on our eligibility for additional work resulting from a security breach in one of the systems we develop, install and maintain could materially reduce our revenue.

Our business could be negatively impacted by security threats, including cybersecurity threats, and other disruptions.

As a defense contractor, we face various security threats, including cybersecurity threats to gain unauthorized access to sensitive information; threats to the safety of our employees; threats to the security of our facilities and infrastructure; and threats from terrorist acts. Cybersecurity attacks in particular are evolving and include, but are not limited to, malicious software; attempts to gain unauthorized access to data; and other electronic security breaches that could lead to disruptions in mission critical systems, unauthorized release of confidential or otherwise protected information and corruption of data.

We utilize various procedures and controls to monitor these threats and mitigate our exposure to such threats. We are subject to frequent and increasingly sophisticated attempts by unauthorized individuals and/or entities to obtain access to sensitive, protected, and even classified data. We regularly review our systems and cybersecurity protocols. We do not outsource our cybersecurity functions.

An unauthorized party was able to gain access to our computer network. Management retained an independent third-party expert data security firm to assess the nature and extent of unauthorized access, and to recommend remedial actions. We also asked the outside data security expert to recommend additional steps we could take to further enhance our ability to detect, monitor and defend against cybersecurity incidents.

We undertook remedial actions based on the data security expert’s recommendations. We are considering additional enhancements to our network security. We notified certain government authorities and outside parties based on information obtained from the data security expert’s investigation. Our insurance carrier has agreed, subject to the limits of our coverage and a full reservation of its rights, to cover the costs of our investigation The Company recognized $250 thousand in operating expense for our insurance policy deductible related to this cybersecurity incident.

Risks Related to Our Industry

We depend on U.S. government contracts for substantially all of our revenue. Changes in the contracting or fiscal policies of the U.S. government could adversely affect our business, financial condition or results of operations.

In each of the past three years, over 80% of our revenue came from U.S. government agency prime contracts. Over the same period, Department of Defense prime contracts and subcontracts accounted for more than 90% of our revenue. Contracts with other government agencies accounted for approximately 5% to 6% of our sales each year. We expect U.S. government contracts will to continue to account for most of our revenue in the future. Changes in U.S. government contracting policies could directly affect our financial performance. Factors that could materially adversely affect our U.S. government contracting business include:

 

   

budgetary constraints affecting U.S. government spending generally, or specific departments or agencies in particular;

 

   

changes in U.S. government fiscal policies or available funding;

 

   

changes in U.S. government defense and homeland security priorities;

 

   

changes in U.S. government programs or requirements;

 

   

U.S. government curtailment of its use of technology services firms;

 

18


Table of Contents
   

adoption of new laws or regulations;

 

   

technological developments;

 

   

U.S. government shutdowns, threatened shutdowns or budget delays;

 

   

competition and consolidation in our industry; and

 

   

general economic conditions.

These or other factors could cause U.S. government departments or agencies to reduce their purchases under contracts, to exercise their right to terminate contracts or fail to exercise options to renew contracts, any of which could have a material adverse effect on our business, financial condition, operating results and ability to meet our financial obligations.

Many of our U.S. government customers are subject to increasing constraints. We have substantial contracts in place with many U.S. government departments and agencies. Our continuing performance under these contracts, or the possibility of new contracts from these agencies, could be materially adversely affected by agency spending reductions or budget cutbacks. Such reductions or cutbacks could materially adversely affect our business, financial condition, operating results and ability to meet our financial obligations.

The Budget Control Act of 2011 could cause significant delays or reductions in federal government appropriations for our current and future programs and may negatively affect our revenue and materially adversely affect our financial position, operating results and cash flows.

In August 2011, Congress enacted the Budget Control Act intended to significantly reduce the federal deficit over ten years. The Budget Control Act established discretionary spending caps through 2021 and a Joint Committee of Congress to identify additional deficit reductions. The law’s passage also signaled the end of a decade of defense spending growth. The Joint Committee failed to agree on deficit reductions which triggered the sequestration provision of the Budget Control Act. Sequestration mandates substantial automatic spending cuts to defense and non-defense programs. By law, sequestration is scheduled to start in 2013 and continue over a nine-year period.

While the Administration has indicated that it intends to work with Congress during its lame-duck session to mitigate or eliminate the effects of sequestration, the outcome of these efforts remains uncertain. At this time, we cannot predict the effect that either identified or automatic cuts would have on funding for our individual programs. Long-term funding for certain programs in which we participate is likely to be reduced, delayed or cancelled. These cuts could materially and adversely affect the viability of our prime contractors and our subcontractors, and lead to further revenue reductions.

Although we believe that Alion may be well-positioned in areas the Department of Defense has indicated are the focus for future defense spending, the impact of the Budget Control Act remains uncertain and our business and industry could be materially adversely affected. Sequestration could also materially and adversely affect the business of our prime contractors and those with whom we team. Because we derive a material portion of our total revenue from the performance of subcontracts and teaming agreements, sequestration could have not only a direct effect, but also an indirect effect, on our business, financial condition and results of operation were the contracts we perform with prime contractors and teammates reduced.

Alion depends heavily on federal government contracts. Delays in the federal budget process, including actions related to the debt ceiling, sequestration, or a federal government shutdown, could delay procurement of the products, services and solutions we provide and adversely affect our sales, gross margin, operating results and cash flows.

Alion derives a significant portion of its revenue from the federal government and from prime contractors to the federal government. The Company expects to continue to derive significant sales from federal government contracts and prime contractors. Funding under those contracts is conditioned upon the continuing availability of Congressional appropriations and agency budgets. Congress usually appropriates funds on a fiscal year basis even though contract performance may extend over many years. The programs in which Alion participates must compete with other federal government programs and policies for funding during the budget and appropriation process. Concerns about increased deficit spending, along with continued economic challenges, continue to place pressure on federal customer budgets. While the Company believes that its programs are well aligned with national defense and other priorities, shifts in domestic spending and tax policy, changes in security, defense, and intelligence priorities, the affordability of the Company’s products and services, general economic conditions and developments, and other factors may affect a decision to fund or the level of funding for existing programs under which we perform contracts or proposed programs under which we might bid for future work.

 

19


Table of Contents

When the federal government does not complete its budget process before its September 30 fiscal year end, it typically funds operations through a continuing resolution that authorizes federal government agencies to continue operating, but does not authorize new spending initiatives. When the federal government operates under a continuing resolution, product and service procurement delays can occur, which in turn could cause delays in payments to Alion, which could negatively and materially affect our operating results, cash flow and liquidity.

Congress’s failure to agree on deficit reduction goals contemplated in the August 2011 agreement to increase the debt ceiling creates constraints on and uncertainties about the level of future federal spending. While specific budgetary decisions are not yet known, such constraints could delay or cancel key programs in which Alion is involved and could materially and adversely affect our cash flows, liquidity and operating results. If the federal budget process were to result in a prolonged federal government shutdown, we could incur substantial unreimbursed labor or other costs, or it could delay or cancel key programs, which could materially adversely affect our cash flows and operating results.

In addition, when the U.S. Government requires supplemental appropriations to operate or fund specific programs, and legislation to approve any supplemental appropriation bill is delayed, credit markets can react adversely to the uncertainty. Recently, Standard & Poor’s downgraded Alion’s corporate family credit rating from Caa1 to Caa2. Budgetary uncertainties and Alion’s lower credit rating could materially and adversely affect Alion’s access to credit and our overall liquidity. If we were to use our revolving credit facility to a greater extent and for greater amounts than we have in the recent past, this could also increase the cost of credit to Alion if our floating interest rates were to rise.

Failure by Congress to timely approve budgets for the federal agencies we support could delay or reduce spending and cause us to lose revenue.

Each year, Congress must approve budgets for each of the U.S. government departments and agencies we support. When Congress is unable to agree on budget priorities, and is unable to pass the annual budget on a timely basis, it typically enacts a continuing resolution. A continuing resolution allows U.S. government agencies to operate at spending levels equal to or less than levels approved in the prior budget cycle. This can delay funding we expect to receive from clients for work we are already performing. A continuing resolution can delay or even cancel new initiatives which could adversely affect our business, financial condition, operating results, cash flows and our ability to meet our financial obligations.

We may not realize the full amount of our backlog, which could lower future revenue.

The maximum contract value identified in a U.S. government contract does not necessarily determine the revenue we will realize from that contract. Congress normally appropriates funds for a given program each fiscal year, even when actual contract performance may take many years. As a result, U.S. government contracts ordinarily are only partially funded at the time of award. Normally a procuring agency commits additional money to a contract only as Congress makes subsequent fiscal year appropriations. Estimates of future revenue attributed to backlog are not necessarily precise. Receipt and timing of any of this revenue is subject to various contingencies such as changed U.S. government spending priorities and government decisions not to exercise existing contract options. Many contingencies are beyond our control. The backlog on a given contract may not ultimately be funded or may only be partially funded, which may cause our revenue to be lower than anticipated, and adversely affect our business, financial condition, operating results, cash flows and our ability to meet our financial obligations.

Many of our U.S. government customers procure goods and services through multiple delivery order type contracts under which we must compete for post-award orders.

Budgetary pressures and reforms in the procurement process have caused many U.S. government customers to purchase goods and services through ID/IQ, GSA Schedule contracts and other multiple award and/or GWAC contract vehicles. These contract vehicles increase competition and pricing pressure requiring us to make sustained post-award efforts to obtain awards and realize revenue. There can be no assurance that we will increase revenue or otherwise sell successfully under these contract vehicles. Our failure to compete effectively in this procurement environment could harm our business, financial condition, operating results, cash flows and our ability to meet our financial obligations.

U.S. government contracts contain termination provisions that are unfavorable to us.

U.S. government agencies can terminate contracts with suppliers at any time without cause. If a government agency terminates one of our contracts without cause, we are likely to be compensated for services we have provided and costs we have incurred through the termination date, and receive payment for termination-related costs and a negotiated contract fee. However, if the U.S. government terminates a contract because we defaulted under the terms of the contract, we may be liable for any extra costs the U.S. government incurs to procure undelivered services from another company. Termination of any of our large U.S. government contracts could negatively impact our revenue and adversely affect our business, financial condition, operating results, cash flows and our ability to meet our financial obligations.

 

20


Table of Contents

The U.S. government can suspend or debar a company from doing business with the government if a company violates certain laws or government procurement regulations.

Alion is subject to numerous federal government procurement procedures and regulations including cost accounting standards, conflict of interest rules, whistleblower protection rules, the False Claims Act, the Truth in Negotiations Act and the Foreign Corrupt Practices Act. If the government were to determine that we had failed to comply with our obligations, it could suspend or debar Alion from doing business with the federal government which could materially adversely affect our operating results, cash flows and financial position.

If we do not accurately estimate the expenses, time and resources necessary to meet our contractual obligations, our contract profits will be lower than expected.

The total price on a cost-reimbursement contract is primarily based on allowable costs incurred subject to a contract funding limit. U.S. government regulations require us to notify our customers of any cost overruns or underruns on a cost-reimbursement contract. We may not be able to recover cost overruns in excess of a contract’s funding limit and may not earn the profit we anticipated from the contract.

In a fixed-price contract, we estimate project costs and agree to perform services for a predetermined price regardless of our actual costs. We pay for any cost overruns. If we fail to anticipate technical problems, or accurately estimate or control costs, we may face a lower fixed-price contract profit margin or even a loss. Provisions in our financial statements for estimated contract losses may not be adequate to cover all our actual losses.

Our operating margins and operating results may suffer if cost-reimbursement contracts increase in proportion to our total contract mix.

Based on profit as a percentage of estimated standard costs, cost-reimbursement contracts are our least profitable type of contract because government regulations limit cost-reimbursement contract fee levels. Our U.S. government customers typically choose the type of contract they issue. To the extent that in the future cost-reimbursement contracts continue to increase as a percentage of our contract mix, operating margins and results may suffer.

If our fixed-price contract revenue continues to decline in total or as a proportion of our total business, or if profit rates on these contracts deteriorate, our operating margins and operating results may suffer.

We have historically earned higher profit margins on fixed-price contracts. If fixed-price contract revenue continues to decrease, or customers shift to other types of contracts, our operating margins and operating results may suffer. We cannot ensure we will be able to maintain our historic profitability levels on fixed-price contracts overall nor can we ensure that our percentage of total revenue generated from fixed-price contracts will remain the same or improve.

Our subcontractors’ failure to perform contractual obligations could damage our reputation as a prime contractor and our ability to obtain future business.

As a prime contractor, we often rely significantly upon other companies as subcontractors to perform work we are obligated to deliver to our customers. A failure by one or more of our subcontractors to timely perform services satisfactorily could cause us to be unable to perform our duties as a prime contractor. We have limited involvement in the work our subcontractors perform, and as a result, we may have exposure to problems our subcontractors cause. Subcontractor performance deficiencies could result in a government customer terminating our contract for default. A default termination could make us liable for customer re-procurement costs, damage our reputation, and hurt our ability to compete for future contracts.

Because U.S. government contracts are subject to government audits, contract payments are subject to adjustment and repayment which may result in lower than expected contract revenue.

Any U.S. government contract payments we receive that exceed allowable costs are subject to adjustment and repayment after the government audits our contract costs. DCAA has finished auditing 2005 and is currently auditing our 2006 and 2007 claimed indirect costs. We have settled indirect rates through 2004. We timely submitted our indirect cost proposals for all open fiscal years and expect to submit this year’s incurred cost proposal next March as required. We have recorded revenue on federal government contracts in amounts we expect to realize. If the estimated reserves in our financial statements are not adequate, future government contract revenue may be lower than expected.

 

21


Table of Contents

If we fail to recover at- risk contract costs, we may have reduced fees or losses.

We are at risk for any costs we incur before a contract is executed, modified or renewed. A customer may choose not to pay us for these costs. At September 30, 2012 we had $19 million in at-risk costs. While such costs were associated with specific anticipated contracts and funding modifications, we cannot be certain that our customers will execute these contracts or contract renewals or that they we pay us for all our related at-risk costs.

Actual or perceived conflicts of interest may prevent us from being able to bid on or perform contracts.

U.S. government agencies have conflict of interest policies that may prevent us from bidding on or performing certain contracts. When dealing with U.S. government agencies that have conflict of interest policies, we must decide, at times with insufficient information, whether to participate in the design process and lose the chance of performing the contract or to turn down the design opportunity for the chance of performing the future contract. We have, on occasion, declined to bid on particular projects because of actual or perceived conflicts of interest. We are likely to continue encountering such conflicts of interest in the future. Future conflicts of interest could cause us to be unable to secure key contracts with U.S. government customers.

As a U.S. government contractor, we must comply with complex procurement laws and regulations and our failure to do so could have a negative impact upon our business.

We must comply with and are affected by laws and regulations relating to the formation, administration and performance of U.S. government contracts, which may impose added costs on our business. If a government review or investigation uncovers improper or illegal activities, we may be subject to civil and/or criminal penalties and administrative sanctions, including contract termination, fines, forfeiture of fees, suspension of payment and suspension or debarment from doing business with U.S. government agencies, which could impair our ability to conduct our business.

We derive significant revenue from U.S. government contracts awarded through competitive bidding which is an inherently unpredictable process.

We obtain most of our U.S. government contracts through competitive bidding. We face risks associated with:

 

   

the frequent need to bid on programs in advance of the completion of their design, which can result in unforeseen technological difficulties and/or cost overruns;

 

   

the substantial time and effort, including design, development and promotional activities, required to prepare bids and proposals for contracts we may not win; and

 

   

the rapid rate of technological advancement and design complexity of most of our research offerings.

Upon expiration, U.S. government contracts may be subject to a competitive re-bidding process. We may not succeed in winning new contract awards or renewals in the future. Our failure to renew or replace existing contracts when they expire or win new contracts, would negatively impact our business, financial condition, operating results, cash flows and our ability to meet our financial obligations.

Our failure to obtain and maintain necessary security clearances may limit our ability to carry out confidential work for U.S. government customers, which could cause our revenue to decline.

As of September 30, 2012, we had approximately 370 Department of Defense contracts that required us to maintain facility security clearances at our 29 sites. Approximately 2,414 of our employees held security clearances needed to perform these contracts. Each cleared facility has a Facility Security Officer and Key Management Personnel whom the U.S. Department of Defense – Defense Security Service requires to be cleared to the level of the facility security clearance. Individual employees are selected to be cleared, based on specific classified contract task requirements and each employee’s technical, administrative or management expertise. Once an employee is cleared, he or she may access classified contract information, based on clearance level and a “need-to-know.”

 

22


Table of Contents

Protecting classified information is paramount. Loss of a facility clearance, or an employee’s failure to obtain or maintain a security clearance, could result in a U.S. government customer terminating an existing contract or choosing not to renew a contract. If we cannot maintain or obtain the required security clearances for our facilities and our employees, or obtain these clearances in a timely manner, we may be unable to perform certain U.S. government contracts. Lack of required clearances could also impede our ability to bid on or win new government contracts, which might result in terminating current research activities. This could damage our reputation and our revenue would likely decline, which would adversely affect our business, financial condition, operating results and ability to meet our financial obligations.

If we fail to establish and maintain important relationships with government entities and agencies, our ability to successfully bid for new business and retain existing business may be adversely affected.

To bid on new business, we rely in part on establishing and maintaining relationships with various government officials. These relationships enable us to provide informal input and advice to government agencies before we develop a formal proposal. We may be unable to maintain our relationships with government entities and agencies; any failure to do so could adversely affect our ability to bid successfully for new business or to retain existing business. This could adversely affect our operating results, cash flows and financial position and our ability to meet our obligations.

Failure to maintain strong relationships with other contractors could result in a decline in our revenue.

Approximately 14% of our revenue comes from our work as a subcontractor and from teaming arrangements with other contractors. As a subcontractor or teammate, we cannot control performance by our prime contractor or other teammates. Poor performance on a given contract could impact our customer relationship, even when we perform as required. We expect to continue to depend on relationships with other contractors for a portion of our revenue for the foreseeable future. Our revenue, operating results, financial position and cash flows could differ materially and adversely from what we anticipate if one or more of our prime contractors or teammates were to rely on one of our competitors or were to directly provide our customers the kind of services we provide.

The federal government’s appropriation process and other factors may delay the collection of our receivables, and our business may be adversely affected if we cannot collect our receivables in a timely manner.

We must collect our receivables to generate cash flow, provide working capital, pay debt and continue our business operations. If the federal government, or any of our prime contractors fails to pay or delays paying our invoices for any reason, our business and financial condition may be materially and adversely affected. The government may fail to pay outstanding invoices and DCAA could revoke our direct billing privileges, which would adversely affect our ability to timely collect our receivables. Contracting officers can also withhold payment of some portion or all of an outstanding invoice which could also adversely affect our ability to collect our receivables timely.

New government rules could limit our ability to get paid for the work we perform.

A new Defense Federal Acquisition Regulation interim rule became effective May 18, 2011, applying to solicitations issued on or after that date. The new rule requires Department of Defense contracting officers to impose contractual withholdings at no less than certain minimum levels if a contracting officer determines that one or more of a contractor’s business systems have one or more significant deficiencies. If a contracting officer were to impose such a withholding on Alion or even one of our prime contractors, it would increase the risk we would not be paid in full or paid timely. If we experience difficulties collecting receivables, it could adversely affect our operating results, cash flows and financial position and our ability to meet our obligations.

The U.S. Government may adopt new contract rules and regulations or revise its procurement practices in a manner adverse to us at any time.

The U.S. Government may face restrictions or pressure regarding the type and amount of services it may obtain from private contractors. Legislation, regulations and initiatives dealing with procurement reform, environmental responsibility or sustainability, and mitigation of potential conflicts of interest, as well as any resulting shifts in the buying practices of U.S. Government agencies could adversely affect us. Such changes could impair our ability to obtain new contracts or win a recompete of an existing contract. Any new contracting requirements or procurement methods could be costly or administratively difficult for us to implement and could materially and adversely affect our financial position, operating results or cash flows.

Item 1B. Unresolved Staff Comments

None.

 

23


Table of Contents

Item 2. Properties

Our headquarters in McLean, Virginia consists of 23,823 square feet of leased office space. We also lease approximately 69 additional office facilities totaling 962,533 square feet. Of these, our largest offices are located in Washington, DC; Fairfax, Alexandria, Vienna, Arlington, Norfolk, Portsmouth, and Newport News, Virginia; Pittsburgh and West Conshohocken, Pennsylvania; Huntsville and Mobile, Alabama; New London, Connecticut; Annapolis, Annapolis Junction and Lanham, Maryland; Orlando, Florida; Rome, New York; Pascagoula, Mississippi; Fairborn, Ohio; Mt. Clements, Michigan; Boulder, Colorado; Durham, North Carolina; Bath, Maine; San Diego, California; Albuquerque, New Mexico; and Burr Ridge, Illinois. We lease 22 facilities that contain laboratory space totaling approximately 114,202 square feet, for contract-related research. Our largest laboratories are located in Durham, North Carolina; Warrenville, Chicago and Geneva, Illinois; Annapolis Junction and Lanham, Maryland; West Conshohocken, Pennsylvania; Mount Clemens, Michigan and Louisville, Colorado. Lease terms vary in length from one to twelve years, and are generally at market rates.

Aggregate average monthly base rental expense for fiscal year 2012 was approximately $2.3 million for 2012 and 2011. We periodically enter into other lease agreements that are, in most cases, directly chargeable to current contracts. These obligations are usually either covered by currently available contract funds or cancelable upon termination of the related contracts. We consider our leased space to be adequate for our current and our reasonable anticipated future operations. If sequestration takes effect, we may find we have excess leased space. We cannot ensure that if we have excess capacity we will be able to sublease a portion of or assign our leases on terms and conditions favorable to us or at all.

Item 3. Legal Proceedings

We are involved in routine legal proceedings occurring in the ordinary course of business. We believe these routine legal proceedings are not material to our financial condition, operating results, or cash flows.

As a government contractor, from time to time we may be subject to DCAA audits and federal government inquiries. The federal government may suspend or debar for a period of time any federal contractor it finds has violated the False Claims Act, or any contractor indicted for or convicted of violating other federal laws. This could also result in fines or penalties. Given Alion’s dependence on federal government contracts, suspension or debarment could have a material effect on our business, financial condition, operating results, cash flows and our ability to meet our financial obligations. We are not aware of any such pending federal government claims or investigations.

Item 4. Mine Safety Disclosures

Not applicable.

 

24


Table of Contents

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

There is no established public trading market for Alion’s common stock.

Holders

As of September 30, 2012, the ESOP Trust was the only holder of our common stock. The ESOP Trustee is independent of Alion and its management. Consistent with its fiduciary responsibilities, the ESOP Trustee retains an independent third party valuation firm to assist it in determining the fair market value (share price) at which the Trustee may acquire or dispose of investments in Alion common stock. Alion’s transactions with the ESOP Trust during the past two years were based on the fair market value share prices and dates set out below.

 

Valuation Date

   Share
Price
 

September 30, 2012

   $ 16.45   

March 31, 2012

   $ 18.00   

September 30, 2011

   $ 20.95   

March 31, 2011

   $ 27.15   

Dividends

Alion has never declared any cash dividends. We are required to make “distributions” to purchase common stock from the ESOP to meet our repurchase obligations. We do not expect to pay any dividends in the future, and the terms of our credit agreements limit our ability to do so. We currently intend to retain future earnings, if any, to use in operating our business. Any determination to pay dividends in the future will be at the discretion of our Board of Directors and will depend on our operating results, our financial condition, contractual restrictions, applicable law and other factors our Board of Directors determines to be relevant. The Secured Notes, the Unsecured Notes and our revolving credit facility prohibit us in many instances from paying dividends without consent from the respective creditors.

Performance Graph

Not applicable.

Recent Sales of Unregistered Securities

In fiscal year 2012, Alion employees directed more than $2.4 million in pre-tax salary deferrals and rollovers to the ESOP Trust to purchase beneficial interests in Alion common stock. On March 31, 2012, the Company sold approximately $1.3 million of common stock to the ESOP Trust at $18.00 per share and on September 30, 2012 the Company sold approximately $1.1 million of common stock to the ESOP Trust at $16.45 per share. The Company did not use an underwriter and did not pay underwriter discounts or commissions. The shares of common stock were sold pursuant to an exemption under Section 4(2) of the Securities Act of 1933, as amended.

Item 6. Selected Financial Data

The following table presents selected historical consolidated financial data for Alion for each of the last five fiscal years through September 30, 2012. This information should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes in this annual report. We derived our consolidated operating data for the years ended September 30, 2012, 2011 and 2010 and our September 2012 and 2011 consolidated balance sheet data from our audited consolidated financial statements included in this annual report. We derived our consolidated operating data for the years ended September 30, 2009 and 2008 and our September 2010, 2009 and 2008 consolidated balance sheet data from our consolidated financial statements not included in this annual report. Our historical consolidated financial information may not be indicative of our future performance.

 

25


Table of Contents
     Alion Science and Technology Corporation  
     Selected Unaudited Financial Data  
     For Years Ended September 30,  
     2012     2011     2010     2009     2008  
     (In thousands, except share and per share data)  

Consolidated Operating Data:

          

Contract revenue

   $ 817,204      $ 787,314      $ 833,988      $ 802,225      $ 739,482   

Direct contract expenses

     632,831        603,481        638,000        615,700        566,408   

Operating expenses

     143,935        148,340        157,068        148,960        152,117   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     40,438        35,493        38,920        37,565        20,957   

Interest expense (a)

     (74,934     (73,919     (67,613     (55,154     (47,382

Net loss

   $ (41,447   $ (44,384   $ (15,232   $ (17,041   $ (25,334

Basic and diluted loss per share

   $ (6.74   $ (7.83   $ (2.81   $ (3.25   $ (5.01

Basic and diluted weighted-average common shares outstanding

     6,148,438        5,671,977        5,427,979        5,246,227        5,057,337   

Consolidated Balance Sheet Data at End of Period:

          

Net accounts receivable

   $ 175,293      $ 180,364      $ 174,032      $ 180,157      $ 168,451   

Total assets

     635,296        644,488        646,302        647,498        655,946   

Working capital

     51,594        46,596        59,796        27,833        33,275   

Current portion of long-term debt and interest(b)

     17,658        17,392        17,217        14,428        11,932   

Long-term debt, excluding current portion(b)

     549,425        533,067        521,957        535,822        528,774   

Redeemable common stock warrants

     —          —          —          32,717        39,996   

Redeemable common stock

     110,740        126,560        150,792        187,137        200,561   

Common stock warrants

     20,785        20,785        20,785        —          —     

Accumulated deficit

     (272,433     (258,125     (246,270     (274,559     (276,876

Other Data:

          

Depreciation and amortization

   $ 11,741      $ 11,409      $ 16,777      $ 18,959      $ 20,715   

Cash flows provided by (used in):

          

Operating activities

   $ 12,681      $ 5,721      $ 2,396      $ 8,995      $ 29,320   

Investing activities

     (2,731     (6,291     (2,147     (2,347     (12,152

Financing activities

     (3,541     (5,307     15,261        (11,750     (12,565

 

(a) Interest expense includes interest payable in cash, non-cash expenses for amortizing original issue discount and debt issue costs, and changes in the fair value of redeemable stock warrants.
(b) Debt, current and long-term, includes senior and subordinated debt and accrued PIK interest and is net of unamortized debt issue costs and original issue discount.

We divested our HFA subsidiary in September 2010. In July 2010 and September 2011, we sold some contracts with the Office of Naval Research. Operating results include divestitures through their sale date.

 

26


Table of Contents

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis is intended to assist the reader understand Alion’s business, financial condition, results of operations and liquidity and capital resources. You should read the following discussion in conjunction with the consolidated financial statements and related notes included in this annual report. This discussion contains forward-looking statements about our business and operations that involve risks and uncertainties. Future results may differ materially from those we currently anticipate because of the “Risk Factors” described beginning on page 11 and elsewhere in this annual report.

About This Management’s Discussion and Analysis

Our discussion provides an overview of our business and critical accounting policies, explains year-over-year changes in operating results, describes our liquidity, capital resources and certain other obligations, and discloses certain market and other risks that could affect us.

Overview

We are a leading provider of scientific, engineering, and information technology expertise. Alion employees apply this expertise to research and develop technological solutions for complex problems relating to national defense, homeland security, and energy and the environment. We principally serve U.S. government departments and agencies and, to a much lesser extent, commercial and international customers. Alion has a 75 year history of providing our customers a talented employee base of more than 2,800 industry thought leaders, blending together industry expertise, domain experience and functional knowledge to solve critical client needs.

Despite a very challenging defense market environment the Company performed very well in 2012. Our fiscal 2012 revenues increased 3.8% over fiscal 2011 and operating income growth exceeded revenue growth by increasing 13.9%. Revenue increases were attributed expanding our existing base of customers such as the U.S. Navy and U.S. Air Force and expanding into to new, growing markets including Special Operations Command. Our profitability gains were a result of Company initiatives to drive efficiencies throughout the business, which resulted in reduced operating expenses as well as general and administrative costs. Risks related to the Budget Control Act of 2011, sequestration, the “fiscal cliff” and other market factors, which were described earlier in this report, could impact the favorable revenue and operating income results Alion has enjoyed in fiscal 2012. The table below presents summary operating results for the past three fiscal years.

 

     For the Years Ended September 30,  
     2012     2011     2010  
     (In thousands)  

Revenue

   $ 817,204      $ 787,314      $ 833,988   
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (41,447   $ (44,384   $ (15,232
  

 

 

   

 

 

   

 

 

 

Alion contracts primarily with the U.S. federal government. We expect that we will continue to derive most of our revenue from contracts with the U.S. Department of Defense and other federal agencies. We believe we will continue to have some level of commercial, state, local and international revenues. The table below shows the percentage of revenue we derived from each major customer category for each of the past three fiscal years.

 

     September 30,  
     2012     2011     2010  
     (In thousands)  

U.S. Air Force

   $ 215,859         26.4   $ 216,835         27.5   $ 208,298         25.0

U.S. Army

     105,495         12.9     103,529         13.1     122,858         14.7

U.S. Navy

     402,330         49.2     382,000         48.5     406,166         48.7

Other Department of Defense Customers

     24,733         3.0     23,466         3.0     37,484         4.5
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

All Department of Defense Customers

   $ 748,418         91.6   $ 725,830         92.2   $ 774,807         92.9

Federal Civilian Departments and Agencies

     46,535         5.7     46,359         5.9     40,306         4.8
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

All U.S. Government Customers

     794,952         97.3     772,189         98.1     815,113         97.7

Commercial and International

     22,251         2.7     15,125         1.9     18,875         2.3
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 817,204         100.0   $ 787,314         100.0   $ 833,988         100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

 

27


Table of Contents

We intend to broaden our existing base of U.S. federal government business and further expand our scientific, engineering and information technology expertise offerings in the commercial and international markets. However, any expansion in the commercial and international markets will be relatively modest. In fiscal 2012, our international revenue was generated primarily from naval architecture and marine engineering services and engineering and technical analysis.

We earn our revenue by providing highly skilled employee and subcontractor services to our customers. The key to generating revenue is hiring new employees to meet customer requirements; retaining existing employees; and deploying our staff on revenue-generating contracts. We closely monitor hiring success, attrition trends, and direct labor utilization. Hiring enough technically skilled employees with appropriate security clearances is a key challenge in maintaining and growing our business. We strive to optimize Alion employee labor content on our contracts as we can earn higher profits from our employee services than from subcontractor services or from other goods or materials we purchase for re-sale, or on behalf of our customers. We plan to grow revenue organically by capitalizing on our skilled work force and our solutions competencies.

Our mix of contract types (i.e., cost-reimbursement, fixed-price, and time-and-material) affects our revenue and operating margins. A significant portion of our revenue is generated from services performed on cost-reimbursement contracts under which customers pay us for approved costs, plus a fee (profit) on the work we perform. We recognize revenue on cost-reimbursement contracts based on our actual costs plus a pro-rata share of fees earned. We also have a number of fixed-price government and commercial contracts for which we use the percentage-of-completion method to recognize revenue. Fixed price contracts involve higher financial risks, and in some cases higher margins, because we must deliver specified services at a predetermined price regardless of our actual costs. Failure to anticipate technical problems, estimate costs accurately or control performance costs on a fixed-price contract may reduce the contract’s overall profit or cause a loss. On time-and-material contracts, customers pay us for labor at negotiated, fixed hourly rates and related material costs on a pre-determined mark-up. We recognize time-and-material contract revenue at contractually billable rates as we deliver labor hours and incur direct expenses.

Despite the President’s stated goal of reducing government’s use of cost-reimbursable contracts, Alion’s cost-reimbursable revenue increased this year as it has for the past several years. Because the scientific and engineering services we deliver are not by nature inherently governmental functions, management believes any federal government policies and changes aimed solely at reducing overall reliance on government contractors will not materially or adversely affect operations. However, Alion faces the same risks our competitors face that overall government spending will decline because of budgetary constraints or possible sequestration. Notwithstanding this overarching business risk, if the government were to ultimately shift contracting activity away from the cost-reimbursement arena to fixed-price contracting, we believe we would likely benefit. All other factors being equal, our fixed price type contracts traditionally generate higher profit margins than our cost-reimbursable contracts do.

The table below summarizes revenue by contract type for each of the past three fiscal years.

 

     Revenue by Fiscal Year  

Contract Type

   2012     2011     2010  
     (In thousands)  

Cost-reimbursement

   $ 676,744         82.8   $ 649,754         82.5   $ 644,756         77.3

Fixed-price

     63,190         7.7     50,148         6.4     80,719         9.7

Time and material

     77,270         9.5     87,412         11.1     108,513         13.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 817,204         100.0   $ 787,314         100.0   $ 833,988         100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Annual revenue for the contract types described above may differ slightly for fiscal years 2011 and 2010 from amounts previously reported as individual contracts, task orders and programs are further defined by our customers and management team.

Results of Operations

There were no acquisitions affecting reported results in any of the past three fiscal years. In 2010, we divested Human Factors Applications Inc. (HFA) and several Office of Naval Research (ONR) contracts. We sold several ONR contracts on July 9, 2010 and our HFA subsidiary on September 30, 2010. Consolidated results include HFA and ONR contract results through their respective sale dates.

 

28


Table of Contents

Year ended September 30, 2012 Compared to Year ended September 30, 2011

The table below presents selected comparative financial information for fiscal years ended September 30, 2012 and 2011. Our discussion and analysis refers to financial information in this table and to Alion’s consolidated financial statements in this annual report on Form 10-K.

 

      Year Ended September 30,  
     2012     2011  

Selected Financial Information

          %
Revenue
           %
Revenue
 
     (In thousands)  

Total revenue

   $ 817,204         $ 787,314      

Total direct contract costs

     632,831         77.4     603,481         76.7

Direct labor costs

     254,949         31.2     255,441         32.4

Material and subcontract costs

     361,367         44.2     330,448         42.0

Other direct costs

     16,515         2.0     17,592         2.2

Gross profit

     184,373         22.6     183,833         23.3

Total operating expense

     143,935         17.6     148,340         18.8

Major components of operating expense:

          

Overhead and G&A expense

     101,133         12.4     105,524         13.4

Rental and occupancy expense

     31,086         3.8     31,311         4.0

Depreciation and amortization

     11,716         1.4     11,357         1.4

Operating income

   $ 40,438         4.9   $ 35,493         4.5

Contract Revenue. Alion’s revenues from federal government customers and work as a prime contractor increased year over year and represented 97% of overall revenue. Prime contracts with federal customers now account for 85.6% of our revenue. Revenue in 2012 was $29.9 million (3.8%) greater than 2011 revenue. Growth came from both government and commercial and international customers with commercial and international revenues up by $7.1 million (47%) over last year.

Cost-reimbursable contract revenue continued a trend of increasing as an overall percentage of our revenues. Almost 83% of our revenue is derived from cost-reimbursable contracts. Fiscal 2012 realized a $27 million increase in cost-reimbursable contract revenues as revenues on our Weapons Systems Information Analysis Center and Seaport-E Multiple Award contracts increased. Fixed price contract revenue reversed its trend and increased as a percentage of Alion revenue. Fixed price revenues increased more than $13 million, up 26% from last year. Fixed price contracts now represent more than 7.0% of Alion’s revenue. However, time-and-material contracts were down this year, in both absolute dollars ($10.1 million) and as a percentage of Alion revenue (9.5% in 2012 compared to 11.1% in 2011).

Two of our core business areas saw significant growth this year. Naval Architecture and Marine Engineering recovered from 2011 program delays and was further buoyed by new contract awards, including the Amphibious Warfare Program Office Support Services (PMS 377) and the Integrated Warfare Systems Surface Ship Weapons (IWS 3.0) contracts. This led 2012 Naval Architecture and Marine Engineering revenue to exceed $361 million and increase more than $29 million over 2011. On a combined basis, our three other core business revenues totaled approximately $456 million in fiscal 2012, which accounted for a modest increase of approximately $800 thousand. Our Technology Design and Other Services revenue grew this year, up by more than $77 million as Alion provided rapid weapon systems prototyping analysis, weapon systems integration as well as logistical analysis support functions. Defense Operations revenue declined by almost $27.5 million and Modeling and Simulation revenue was down almost $49.1 million as some work migrated to our Technology Design and Other Services and Defense Operation offerings. In addition, we faced significant procurement and award delays hampered our growth expectations. ID/IQ contracts continued prior year trends of representing more than 60% of our total revenue. This year, our ID/IQ contracts generated more than $499 million revenue, an $8.5 million increase (1.7%) over last year.

Direct Contract Expenses and Gross Profit. Direct contract costs increased by $29.4 million (4.9%) in 2012 compared to 2011. This was in line with our higher fiscal 2012 revenues. Direct labor costs were stable year over year while third-party costs for materials and subcontracts climbed 9.4% an increase of $31 million compared to last year. The increase in material and subcontractor costs are the result of Alion winning larger, more complex contracts as a prime contractor, which requires us to manage the work of other contractors. Other direct costs decreased by $1.1 million. Gross profit was up by $540 thousand this year, but declined as a percentage of overall revenue. Our contract fee rates averaged 6.3 % of costs compared to 6.7% of costs last year. This reflects, in part, our increasing level of lower margin cost-reimbursable work with the attendant limitations on contractor profit as well as the increase in materials and subcontractor costs.

 

29


Table of Contents

Operating Expenses. Operating expenses declined by $4.2 million in 2012 (down 2.9%) to 17.6% of revenue. The decrease in operating expenses were driven by a $12.9M (19.7%) reduction in general and administrative costs, which were due, in part, to previously announced headcount reductions and cost containment efforts. Specifically, executive compensation expense (stock-based compensation, bonuses, severance and incentive compensation) was reduced by $900 thousand, costs for administration and accounting and finance decreased approximately $1.2 million, and the cost for legal and compliance costs we lower by $1.4 million. Rent and related facilities costs also decreased by $225 thousand in fiscal 2012. Depreciation and amortization expense increased modestly ($360 thousand) as amortization of recently deployed intangibles offset declines in amortization charges for prior years’ acquired contracts. In addition, we also saw an increase in our spending on information technology and software support (approximately $800 thousand) and our costs for our expanded proposal and marketing efforts.

Operating Income. Although 2012 gross margin was only up modestly, lower operating expenses helped generate $40.3 million in operating income. This was a $4.8 million (13.5%) improvement over last year’s $35.5 million in operating income. In 2011, operating income as a percentage of revenue was 4.5% of revenue. This year operating income rose to 4.9% of revenue due to the cost reductions noted in the Operating Expenses.

Other Expense. Interest income, interest expense and other aggregate non-operating expenses for 2012 increased $2.0 million compared to 2011; interest accounted for half the increase and the absence of a debt extinguishment gain accounted for the other half. Secured Note interest was higher in 2012 because more interest-bearing PIK notes were outstanding. Unsecured Note interest was slightly lower because our outstanding principal was lower. Our revolver interest costs were a little higher as we used the revolver slightly more frequently in 2012 and we had a higher balance of outstanding letters of credit. PIK interest and debt issue cost amortization was also higher in 2012 than it was last year.

 

     Interest Expense  
     Year Ended September 30,  
     2012      2011  
     (In millions)  

Cash Pay Interest

     

Revolver

   $ 793       $ 574   

Secured Notes

     32,116         31,483   

Unsecured Notes

     25,112         25,349   

Other cash pay interest and fees

     69         70   
  

 

 

    

 

 

 

Sub-total cash pay interest

     58,090         57,476   

Deferred and Non- cash Interest

     

Secured Notes PIK interest

     6,423         6,300   

Debt issue costs and other non-cash items

     10,421         10,143   
  

 

 

    

 

 

 

Sub-total non-cash interest

     16,844         16,443   
  

 

 

    

 

 

 

Total interest expense

   $ 74,934       $ 73,919   
  

 

 

    

 

 

 

Debt Extinguishment. In 2012, we did not repurchase any outstanding debt. In 2011 we retired $5 million in Unsecured Note principal and recognized an aggregate debt extinguishment gain of $939 thousand.

Income Tax Expense. We recognized $7.0 million in income tax expense both this year and last year. In 2012, our deferred tax assets increased by $20.7 million and in 2011 they increased by $21.1 million. Changes in deferred tax assets which reduce income tax expense were entirely offset by corresponding increases in valuation allowances. Our 2012 and 2011 income tax expense came solely from recognizing changes in our deferred tax liability arising from amortizing tax-deductible goodwill.

Net Loss. Although our net loss in 2012 was smaller than 2011, we still incurred a net loss of $41.4 million this year. Revenue, gross margin and operating income were all higher this year and operating expenses were lower. However, higher interest expense and the absence of a debt extinguishment gain partially offset these improvements and adversely affected this year’s bottom line.

 

30


Table of Contents

Year ended September 30, 2011 Compared to Year ended September 30, 2010

The table below presents selected comparative financial information for fiscal years ended September 30, 2011 and 2010. Our discussion and analysis refers to financial information in this table and to Alion’s consolidated financial statements in this annual report on Form 10-K.

 

      Year Ended September 30,  
     2011     2010  

Selected Financial Information

          %
Revenue
           %
Revenue
 
     (In thousands)  

Total revenue

   $ 787,314         $ 833,988      

Total direct contract costs

     603,481         76.7     638,000         76.5

Direct labor costs

     255,441         32.4     272,015         32.6

Material and subcontract costs

     330,448         42.0     348,437         41.8

Other direct costs

     17,592         2.2     17,548         2.1

Gross profit

     183,833         23.3     195,988         23.5

Total operating expense

     148,340         18.8     157,068         18.8

Major components of operating expense:

          

Overhead and G&A expense

     105,524         13.4     75,726         9.1

Rental and occupancy expense

     31,311         4.0     31,204         3.7

Depreciation and amortization

     11,357         1.4     16,732         2.0

Operating income

   $ 35,493         4.5   $ 38,920         4.7

Contract Revenue. Alion’s revenues from our U.S. federal government customers, including work as a prime contractor and as a subcontractor, continued to increase as a percentage of overall revenue. U.S. federal government customers accounted for over 98% of our revenue with 83.5% of revenue from government prime contracts. However, 2011 revenue was $46.7 million (5.6%) less than 2010. The residual impact of the Congressional continuing resolutions, fear of a government shutdown and the debt ceiling crisis of 2011 caused our customers to reduce or delay funding of critical contracts and programs. These award delays as well as a number of contract protests accounted for $33.1 million (4.0%) of 2011’s decline. Revenues were also down by an additional $12.4 million in 2011 because of prior year divestitures. In 2010, we sold several contracts we had with the Office of Naval Research and divested our HFA subsidiary due to organizational conflicts of interests, or shedding of non-core business activities.

Cost-reimbursable contract revenue continued a trend of increasing as an overall percentage of our revenues. More than 82% of our 2011 revenues were attributed to cost-reimbursable contracts. This occurred even though 2011 cost-reimbursable contract revenue increased by less than $5.0 million. Fixed price contract revenue also continued its trend as a declining percentage of Alion revenue. Fixed price revenues were down $30.6 million, off almost 38% from 2010 and represented 6.4% of Alion’s revenue. Time-and-material contracts were down in 2011 as well, in both absolute dollars ($21.1 million) and as a percentage of Alion revenue (11.1% in 2011 compared to 13.0% in 2010).

The residual impact of the Congressional continuing resolutions, fear of a government shutdown and the debt ceiling crisis of 2011 affected our core business areas. In 2011, Defense Operations revenues were $203.1 million, down $13.1 million from $216.2 million in 2010. Defense Operations revenue as a percentage of revenue in 2011 was stable compared to 2010. Although Naval Architecture and Marine Engineering revenues suffered from program delays and contract protests, 2011 revenue came in at $332 million. This was down $6.6 million from 2010 revenue of $338.6 million. Naval Architecture and Marine Engineering revenues increased to 42.2% of revenue from 40.6% in 2010. Modeling and Simulation revenue for 2011 were down $24.8 million (15.1%) to $139.3 million compared to 2010 revenue of $164.1 million, declining to less than 18% of total revenue. Revenue from Technology Design and Other Services were down 1.9% to $112.8 million in 2011 compared to $115.0 million in 2010.

Consistent with 2011’s year over year revenue decline, federal government contract revenues were off $42.9 million (5.3%) compared to 2010. Department of Defense contract revenues were down $49 million compared to 2010. This was partly mitigated by a modest $6.1 million increase in 2011 revenues from federal civilian agencies and departments (up 15% over 2010). Revenues from commercial and international customers were also down $3.8 million (19.9%) in 2011.

 

31


Table of Contents

Direct Contract Expenses and Gross Profit. Direct contract costs declined $34.5 million (5.4%) in 2011 compared to 2010 in line with our 2011 revenue decline. Direct labor costs were down $16.6 million (6.1%); third-party costs for material and subcontracts fell 5.2% and were down $17.9 million compared to 2010. Other direct costs increased to 2.2% of revenue. Our significant subcontractor costs are the result of Alion’s role as a prime contractor overseeing the work of other contractors. Gross profit was down $12.2 million (6.2%) in 2011 compared to 2010, but remained stable as a percentage of overall revenue.

In 2010, we recognized additional cost-plus revenue related to prior years’ indirect rate variances. In 2011, we recognized revenue on cost-reimbursable contracts for current year rate variances but we did not recognize any additional revenue for prior year indirect rate variances. Our contract fee rates averaged 6.7% of costs in 2011. In both 2011 and 2010, our aggregate contract fee rate declined. This reflects, in part, our increasing level of lower margin cost-reimbursable work with the attendant limitations on contractor profit, as well as the increasing proportion of subcontractor costs, as we typically earn lower fee rates on work performed by our subcontractors.

Operating Expenses. Operating expenses declined by $8.7 million for 2011 but continued to represent 18.8% of revenue. Indirect contract expenses increased approximately $300 thousand over last year despite reduced headcount and revenue volume. Rent and related costs were stable. Depreciation and amortization expense declined by $5.4 million as charges for prior years’ acquired contracts continued to tail off.

In 2011 Alion recognized $1.4 million less in executive compensation expense than we did in 2010. Excluding executive compensation expense (stock-based compensation, bonuses, severance and incentive compensation), general and administrative expenses in 2011 decreased $4.8 million (7.2%) compared to 2010. In 2011, we did not have re-financing expenses. Our 2011 charges for bid protests and contract protests declined compared to 2010. We spent $3.6 million less this year for internal and external legal, accounting and related costs compared to 2010 when we were engaged in re-financing our debt. We also spent less in 2011 on information technology and management projects as a result of having deployed significant system improvements last year.

In 2010, our WCGS subsidiary sold several contracts with the Office of Naval Research for $5.0 million and recognized a gain on the transaction. In September 2010, we sold HFA for $275 thousand and recognized a $2.4 million loss. There were no comparable transactions in 2011. We included our 2010 divestitures in operating income as the underlying activities of HFA and the ONR contracts were and remain part of Alion’s ongoing business operations. In 2011, we continued to perform work for the U.S. Navy and provide environmental services.

Operating Income. Although 2011 revenue were down compared to 2010, lower direct costs and decreased operating expenses produced $35.5 million in operating income. After allowing for $2.6 million in prior-year one-time divestiture related gains, operating income year over year was essentially unchanged ($36.3 million and 4.3% of revenue in 2010). In 2010, divestitures improved operating income by partially offsetting higher operating expenses. In 2010 revenue from prior years’ indirect rate variances improved operating margins by an additional $3.2 million and operating income was 4.7% of revenue. Without comparable transactions, 2011 operating income as a percentage of revenue was slightly lower at 4.5% of revenue.

Other Expense. Interest income, interest expense and other aggregate non-operating expenses for 2011 increased $6.4 million compared to 2010; interest alone was up by $6.3 million. We paid $15.2 million more in interest on our Secured Notes this year because they were outstanding for the entire year compared to only six months in 2010. We also had $3.0 million more in Secured Note PIK interest expense. However, in 2010 we paid $11.0 million in Term B interest expense and $4.0 million in penalties and consent and waiver fees. Transaction costs from our 2010 re-financing increased our 2011 debt issue cost amortization charges by $3.1 million.

 

32


Table of Contents
     Interest Expense  
     Year Ended September 30,  
     2011      2010  
     (In millions)  

Cash pay interest expense

     

Revolver

   $ 574       $ 320   

Senior Term Loan

     —           11,047   

Secured Notes

     31,483         16,303   

Unsecured Notes

     25,349         25,625   

Other cash pay interest and fees

     70         4,023   
  

 

 

    

 

 

 

Sub-total cash pay interest

     57,476         57,318   

Deferred and Non- cash Interest

     

Secured Note PIK interest

     6,300         3,263   

Debt issue costs and other non-cash items

     10,143         7,192   

Subordinated Note warrants

     —           (160
  

 

 

    

 

 

 

Sub-total deferred and non-cash interest

     16,443         10,295   
  

 

 

    

 

 

 

Total interest expense

   $ 73,919       $ 67,613   
  

 

 

    

 

 

 

Debt Extinguishment. In 2011 we were able to retire $5 million of our Unsecured Notes. We re-purchased $2 million of our debt in November 2010 and another $3 million in June 2011. Each purchase was an open market transaction and occurred at a discount to face value and carrying value. We recognized an aggregate debt extinguishment gain of $939 thousand from our two repurchases. This contrasts dramatically with the almost $51 million gain we recognized in 2010 from refinancing our debt.

On March 22, 2010, Alion used proceeds from issuing $310 million of Secured Notes to retire the then-outstanding Term B Credit Facility loans, the Subordinated Note and related warrants, and to pay debt issue costs. We paid approximately $240 million to retire Term B debt at par plus accrued interest. We recognized a $6.7 million loss on extinguishing this debt by writing off the balance of unamortized Term B-related debt issue costs.

In 2010, Alion paid $25 million to retire the Subordinated Note and related warrants at a steep discount to both carrying and estimated fair values. We recognized a $67.7 million gain on extinguishing these liabilities in 2010. This was offset in part by writing off $10.3 million in unamortized debt issue and debt modification costs. In 2010, we recognized a one-time $50.7 million net benefit from re-financing and debt extinguishment transactions.

Income Tax Expense. We recognized $7.0 million in income tax expense in 2011. Deferred tax assets increased by $21.1 million in 2011 which was offset by a corresponding increase in valuation allowances. Continuing losses make it unlikely Alion will reasonably be able to realize the full value of its deferred tax assets. In 2010, because of our debt re-financing, income tax expense was significantly higher; we recognized a $33.8 million liability on changing from a pass-through to a taxable entity. Our 2011 income tax expense came entirely from our deferred tax liability related to amortizing tax-deductible goodwill.

Until March 22, 2010, we had no material income tax expense. Alion and its subsidiaries were a consolidated pass-through entity whose income was attributable to our sole shareholder, the tax-exempt ESOP Trust. Some states did not recognize Alion’s S-corporation status and required the Company and its subsidiaries to file separate state tax returns. Alion’s Canadian subsidiary has always been a taxable entity required to accrue a Canadian tax liability as necessary. In 2010 our Canadian subsidiary recognized a $40 thousand tax benefit for Canadian research and development tax credits refunded.

In March 2010, we issued 310,000 Senior Secured notes. Each Unit included a Secured Note with a $1,000 face value and a warrant to purchase 1.9439 shares of Alion common stock. The warrants were considered to be a second class of stock under the IRC. By issuing the Secured Note warrants, our S-corporation status automatically terminated; we were no longer a tax-sheltered pass-through entity exempt from federal and most state income taxes.

Net Loss. We had a $44.4 million net loss in 2011. Revenue and operating income were lower than in 2010, and interest expense was higher. In 2010 we had the benefit of a $50.7 million debt extinguishment gain, and a gain from our divestitures, but we also had to recognize $37.2 million in income tax expense. Material changes in debt extinguishment, tax expense, interest expense and divestitures contributed to the significant difference in our performance between 2011 and 2010.

 

33


Table of Contents

Liquidity and Capital Resources

Alion requires liquidity to timely pay its vendors and debt obligations, to fund operations while awaiting payment from customers and to invest in capital projects. Delays in customer contract funding will increase our accounts receivable balances as we are unable to invoice our customers until such time as the contract funding actions have been executed. As accounts receivable increase, cash from other sources is required to fund Alion activities to support our customers, and as such, is a use of cash. We fund our current business with cash from operating activities and cash from financing activities. Management plans to fund future operations in a similar fashion.

Alion also has access to a $35 million revolving credit facility which we can use for short term borrowing needs and letters of credit. At year end, we had $4.0 million in letters of credit outstanding which reduced our borrowing capacity under the revolving credit facility. Except for current and potential future letters of credit, management does not currently estimate Alion will need to use its revolving credit facility to any significant extent. At year end, we had $27 million in available cash; no outstanding balance on our revolver; and $31 million in available revolving credit borrowing capacity.

Cash Flows.

We continue to sustain losses. Our net loss was $41.6 million after taxes in 2012, a $2.8 million improvement over our $44.4 million loss last year. This year we generated approximately $12.7 million in cash from operations — a $7.0 million improvement over our 2011 results. In 2012, operating cash flows were unaffected by one-time asset sales or debt extinguishments. Improved operating cash flows were the result of increased revenue, decreased expenses and more efficient deployment of working capital. In 2012, management took a variety of actions intended to improve Alion’s overall cash flow, reduce days’ sales outstanding (DSO) overall, and reduce unbilled receivables in particular. Management and operational focus along with improved reporting and visibility, mandatory cash flow training, and increased collaboration with our customers have helped resolve contract funding issues and enabled the Company to bill customers sooner and to collect cash for receivables more quickly.

In 2012, we realized the benefit of our efforts to manage receivables and other assets which contributed $8.4 million to operating cash flow. In 2011, growing receivables and investments in other assets consumed $7.6 million in cash. This year non-cash accruals increased to $16.6 million compared to $12.4 million last year. In 2011 our outstanding payables increased and boosted cash flow by $7.9 million. In 2012, we were able to bring down payables by $7.6 million. In 2011, payables climbed by almost $7.9 million. The 2012 reduction in payables represents a change of more than $15 million year over year.

This year like most years, we had significant non-cash operating expenses: $16.8 million for debt issue costs and PIK interest; $11.7 million for depreciation and amortization; $7.0 million for income taxes. In 2012 depreciation and amortization charges increased by $300 thousand; charges for amortizing recently deployed intangibles offset expected reductions in charges for amortizing JJMA and Anteon contracts. Non-cash debt related charges were higher by $400 thousand compared to 2011 because we had more Secured Notes outstanding. Periodic income tax accruals were unchanged year over year. Non-cash charges for compensation declined to $1.4 million in 2012 compared to $2.7 million in 2011.

This year we invested $2.7 million in tangible and intangible capital assets. This year’s expenditures were more consistent with our traditional investment levels. In 2011, we invested in several internally-developed software applications and created major ship-design prototypes to support efforts to expand our presence in the domestic and international naval architecture and engineering markets. The $3.6 million reduction in expenditures contributed to our increased cash on hand at year end.

In 2012, Alion collected $829 million in receivables. Last year collections were just under $800 million. This $29 million improvement was consistent with higher revenue, increased collection efforts and improvements in the contract modification process resulting in a reduction of our unbilled receivables. Our success enabled us to return to our prior pattern of collections outpacing revenue. Our year end billed receivable balance increased by approximately $9 million as a result of increased revenues and moving unbilled receivables to billed receivables. Increased revenue and contract funding modifications allowed us to bill customers for both current and previous work, and led to higher year end balances for outstanding invoices. The actions that increased our outstanding invoice balance also helped reduced year end unbilled and at-risk receivables by more than $13 million. Unbilled receivables declined to 49% of total accounts receivable, compared to 55% of total accounts receivable last year.

Our 2012 DSO declined to 78.3 days from 83.6 days outstanding in September 2011. Higher overall revenue in 2012 caused our revenue per day to increase approximately 3.8% compared to 2011. This accounted for a 3.0 day decrease in DSO. A $5.1 million decrease in overall receivables accounted for an additional 2.3 day decrease in DSO as of September 2012. We determine DSO based on trailing twelve month revenue and net receivables. We expect DSO to track at current levels for at least the next several months.

 

34


Table of Contents

Cash management efforts held total year-to-date revolver borrowing activity to $26.0 million, $9.0 million more than 2011’s activity. In 2012 and 2011 our highest revolver balance was $10 million, although we did use our revolver to a slightly greater extent this year. Our weighted average utilized balance was $711 thousand in 2012 compared to $185 thousand in 2011. We did not use our revolver from October through mid-February and only had to access our revolver for three weeks in the third quarter of fiscal 2012.

Share redemptions from the ESOP Trust and loans to the ESOP Trust were $1.2 million lower in 2012, partly because of lower share prices for our common stock. This year we repurchased $4.8 million of common stock compared to $5.7 million in 2011 share repurchases. Although ESOP loans were lower this year than last year, they did not significantly affect our cash flow this year or last year. However, we expect to face greater diversification demands during the coming fiscal year as more plan participants become eligible to diversify their ESOP holdings into mutual fund investments. This will likely increase the funds we have to lend to the ESOP Trust.

Employee investments in Alion common stock continued to decline year over year, in part, to the reductions in Alion personnel that we discussed previously in this report. In 2012, employees invested $706 thousand less in our common stock than they did in 2011. Unlike 2011 when we received cash for both current and prior year employee investments, this year we only received cash for mid-year salary deferrals. This decreased this year’s cash inflows by $3.9 million compared to last year.

We cannot predict with any degree of accuracy the extent to which share re-purchases for distribution and diversification demands will increase in future years. However, as required by the IRC, ERISA and the terms of the Plan, this coming year a significant number of ESOP participants will become eligible to diversify their vested ESOP shares into investments other than shares of Alion common stock. During the first half of the coming fiscal year, such diversification demands are likely to increase the Company’s share redemption cash outflows beyond recent historical levels. Management also believes that potential distribution and diversification demands are likely to increase overall. Such demands could increase further with any future increase in the price of a share of Alion common stock.

While a decline in the price of a share of Alion common stock, as occurred in past three valuations (September 2012, March 2012, and September 2011), could reduce the value of each individual Plan participant’s beneficial interest, such a potential price decline could be offset by increased distribution and diversification requests and thus might not reduce the aggregate value of future demands on the Company’s cash. Management attempts to monitor future potential impacts through reliance in part on internal and external financial models that incorporate Plan census data along with financial inputs intended to simulate changes in Alion’s share price.

Based on our existing long-term financing, our cash on hand, and our continuing cash management efforts, we believe we will have sufficient cash from operations and the revolving credit facility to meet obligations over the next twenty-one months. Alion retains the ability to restrict or defer certain types of cash payments that in the past caused the Company to fail to comply with certain prior debt covenants.

Cash flow effects and risks associated with equity-related obligations

Changes in the price of a share of Alion common stock affect cash outflows for ESOP share redemptions. Management is unable to forecast the share price the ESOP Trustee will determine in future valuations. Because future share prices may differ from the current share price, the Company is unable to forecast share redemption outflows. Current financial information includes the effects of the most recent ESOP Trust transactions.

The next regularly scheduled valuation period ends March 2013. Interest rates, market-based factors and volatility, as well as the Company’s financial results will affect the future value of a share of Alion common stock. After each semi-annual valuation period, the ESOP Plan permits former employees and beneficiaries to request distribution of their vested ESOP account balances. Consistent with the terms of the Plan, the Company intends to pay distribution requests in five annual installments and to defer initial payments as permitted. The Plan allows the Company to defer initial installment payments for five years for former employees who are not disabled, deceased or retired.

The coming fiscal year is the fifth Plan year since the Company instituted permitted redemption delays. Therefore, all other things being equal, management does not forecast that this practice will materially, favorably affect near-term ESOP-related cash outflows. In the second quarter of the upcoming fiscal year, Alion faces the probability of greater cash flow demands to fund ESOP diversification requests from employees who have met statutory age and length of service eligibility requirements.

 

35


Table of Contents

Discussion of Debt Structure

Alion’s current debt structure includes a $35 million revolving credit facility, $323.3 million in Secured Notes ($310 million in initial face value plus $13.3 million in PIK interest notes issued), and $245 million in Unsecured Notes. Our credit arrangements, including our Unsecured and Secured Note Indentures and our revolving credit facility include a number of covenants. We expect to be able to comply with our indenture covenants and our credit facility financial covenants for at least the next twenty-one months. The Company is in compliance with each of the affirmative and negative financial and non-financial covenants in its existing debt agreements. See Note 11 – Long term debt in the accompanying audited financial statements elsewhere in this report for a detailed discussion of Alion’s current debt structure and a list of relevant terms and limitations in existing long-term debt agreements including our Credit Agreement, the Secured Note Indenture and the Unsecured Note Indenture.

Credit Agreement – Covenant Compliance

Alion’s Credit Agreement defines Consolidated EBITDA and requires the Company to achieve minimum Consolidated EBITDA threshold in order to maintain access to its credit facility and avoid potential cross default on the Secured and Unsecured Notes. Neither EBITDA nor Consolidated EBITDA is a measure of financial performance in accordance with generally accepted accounting principles.

The Credit Agreement permits Alion to exclude certain expenses and requires it to exclude certain one-time gains when computing Consolidated EBITDA. The Credit Agreement required Alion to have a minimum $60.5 million in Consolidated EBITDA for the twelve months ended September 30, 2012. We had approximately $71.8 million in Consolidated EBITDA for the twelve months ended September 30, 2012 and exceeded the requirement by approximately $11.3 million. The minimum Consolidated EBITDA requirement will increase to $63.0 million beginning on October 1, 2012.

 

     September 30, 2012    September 30, 2011

TTM Consolidated EBIDTA

   $ 71.8 million    $ 63.2 million

TTM Consolidated Interest Expense

   $ 74.9 million    $ 73.9 million

Ratio

   0.96 to 1.0    0.86 to 1.0

Secured Note Indenture and Unsecured Note Indenture

There are no financial covenants in either the Secured Note Indenture or the Unsecured Note Indenture. Certain provisions in the Secured Note Indenture and the Unsecured Note Indenture limit our ability to incur additional debt or pay dividends if our ratio of trailing twelve month Adjusted EBITDA to trailing twelve-month Consolidated Interest Expense is not greater than 2.0 to 1.0. The Secured and Unsecured Note Indentures define Adjusted EBITDA and Consolidated Interest Expense. Adjusted EBITDA under the Secured Note Indenture and the Unsecured Note Indenture differs from Consolidated EBITDA as defined in our Credit Agreement. Adjusted EBITDA is less than Consolidated EBITDA because it does not include employee investments in Alion common stock. Set out below are our actual ratios as of September 30, 2012 and 2011.

 

     September 30, 2012    September 30, 2011

TTM Adjusted EBIDTA

   $ 69.3 million    $ 60.1 million

TTM Consolidated Interest Expense

   $ 74.9 million    $ 73.9 million

Ratio

   0.93 to 1.0    0. 81 to 1.0

During the next three fiscal years the Company expects that at a minimum, it will have to make the estimated interest and principal payments set forth in the table below. Management believes that Alion will need to refinance its existing secured indebtedness prior to maturity. Management predicts that the Company will be unable to generate sufficient cash flow from operations to retire its debt at it comes due. There can be no assurance that we will be able to obtain future financings on acceptable terms, if at all.

 

36


Table of Contents
     3-Fiscal Year Period  
     ($ In thousands)  
     2013      2014      2015  

Credit Agreement

        

- Interest ( 1)

   $ 966       $ 863       $ —     

Secured Notes (2)

        

- Interest

     32,491         33,144         16,821   

- Principal

     —           —           339,788   

Unsecured Notes (3)

        

- Interest

     25,113         25,113         12,556   

- Principal

     —           —           245,000   
  

 

 

    

 

 

    

 

 

 

Total cash – pay interest

     58,570         59,120         29,377   

Total cash – pay principal

     —           —           584,788   
  

 

 

    

 

 

    

 

 

 

Total

   $ 58,570       $ 59,120       $ 614,165   
  

 

 

    

 

 

    

 

 

 

 

(1) We expect we will occasionally use our $35.0 million revolving credit facility to meet working capital needs through 2014. Management expects the average utilized revolver balance will be immaterial and that interest expense will consist of commitment fees for unused balances and outstanding letters of credit. The current facility expires August 22, 2014.
(2) The Secured Notes bear interest at 10% in cash and 2% in PIK. Outstanding principal will increase over time for the 2% compounding PIK interest added to the initial $310 million in principal. The Secured Notes, including $29.8 million in PIK interest, mature November 1, 2014.
(3) The Unsecured Notes bear interest at 10.25% and mature February 1, 2015.

Contingent Obligations

Other Contingent obligations which will impact the Company’s cash flow

Management forecasts that continuing net operating losses for income tax purposes will permit Alion to avoid significant cash outflows for income taxes. Other contingent obligations which will impact our cash flow include:

 

   

ESOP share repurchase and diversification obligations; and

 

   

Long-term incentive compensation plan obligations.

As of September 30, 2012, Alion had spent a cumulative total of $91.5 million to repurchase shares of its common stock to satisfy ESOP distribution and diversification requests from former employees and Plan beneficiaries. In 2008, we changed our prior practice of immediately paying out all distribution requests in full. In March 2008, we began paying ESOP beneficiaries over the five-year distribution period permitted by ERISA and the terms of the Plan. Alion intends to continue this practice for the foreseeable future in part to offset the cash flow effects of annual employee diversification requests that began in fiscal 2008 and which are expected to continue for the foreseeable future. Our debt agreements limit our ability to fund certain discretionary ESOP diversification demands on our cash flow. The table below lists current and prior year share re-purchases.

 

37


Table of Contents

Date

   Number of
Shares
Repurchased
     Share
Price
     Total Value
Purchased
 
                   (In thousands)  

Last two years of repurchases

        

December 2010

     119,945       $ 26.65       $ 3,196   

February 2011

     322       $ 26.65       $ 8   

March 2011

     136       $ 26.65       $ 4   

April 2011

     166       $ 27.15       $ 5   

May 2011

     3,677       $ 27.15       $ 100   

June 2011

     87,319       $ 27.15       $ 2,371   

July 2011

     2,300       $ 27.15       $ 62   

August 2011

     292       $ 27.15       $ 8   

September 2011

     289       $ 27.15       $ 8   

November 2011

     1,481       $ 20.95       $ 31   

December 2011

     106,385       $ 20.95       $ 2,231   

January 2012

     22,782       $ 20.95       $ 477   

May 2012

     3,104       $ 18.00       $ 56   

June 2012

     113,342       $ 18.00       $ 2,040   

August 2012

     418       $ 18.00       $ 8   
  

 

 

       

 

 

 

Total

     461,957          $ 10,605   
  

 

 

       

 

 

 

Management believes cash flow from operations and cash available under Alion’s current revolving credit facilities should provide sufficient capital to fulfill current business plans and fund working capital needs for at least the next twenty-one months. Over the past year, Alion has been able to manage its obligations without having had to significantly access its revolving credit facility for any material period of time. Management believes that over the next twenty-one months Alion will be able to continue to manage future cash flows in a similar manner without having to utilize the revolving credit facility for material periods of time or significant amounts. Therefore, management also believes that despite the increasing EBITDA threshold in the Credit Agreement, Alion will likely be able to maintain access to its revolving credit facility as and when necessary.

Although the financial covenants in Alion’s Credit Agreement are less restrictive than similar covenants in the Term B Senior Credit Agreement were, the Company must generate higher levels of EBITDA in the coming fiscal year and thereafter in order to be able to continue accessing its revolving credit facility over the remaining life of the Credit Agreement. Management believes Alion will be able to meet this and other financial covenants and thereby maintain access to its short-term borrowing capability.

Management intends to continue to focus on organic growth, margin improvement and process improvement. We plan to achieve incremental cash flow and operating performance improvements through more efficient, less costly business processes, reduced operating expenses and further organizational streamlining. However, even if operating cash flows were to improve beyond management’s current forecast, Alion must generate significantly more revenue than it currently does and must earn net income to be able to meet its obligations. Absent these events, Alion will be unable to repay principal and interest on the Secured Notes and Unsecured Notes, and may be unable to meet ESOP repurchase and diversification obligations.

The Secured Note Indenture, the Unsecured Note Indenture and the Credit Agreement allow Alion to make certain permitted acquisitions. If the Company were to have the available resources and were to identify a suitable candidate, it might use available financing to make a permitted acquisition. We will need to refinance some if not all our senior debt prior to maturity in November 2014 and February 2015 when we will have to pay out more than $600 million over a three-month period. We are uncertain if we will be able to refinance these obligations or if refinancing terms will be favorable. We will also have to extend or replace our Credit Agreement which expires in August 2014.

If we cannot refinance our senior debt, we will not have sufficient cash from operations to satisfy all our obligations. If plans or assumptions change, if assumptions prove inaccurate, if we make additional or larger investments than we currently plan, if we invest in or acquire other companies to a greater extent than we currently plan, if we experience unexpected costs or competitive pressures, or if existing cash and projected cash flow from operations prove insufficient, we may need to obtain additional financing sooner than we expect. We intend only to enter into new financing or refinancing we believe to be advantageous. However, given the extent of our existing debt and the most-recent further downgrade of our credit rating, and the uncertain state of the government services marketplace and federal budget constraints, we cannot be certain sources of financing will be available to us in the future, or, if available, that financing terms would be favorable.

 

38


Table of Contents

The following table summarizes the contractual and other long-term debt obligations Alion is legally obligated to pay. The table does not include income tax obligations as we do not expect to have to pay taxes for at least the next five years.

 

     Payments Due by Fiscal Year (In thousands)  
     Total      2013      2014      2015      2016      Thereafter  

Contractual Obligations:

                 

Long-term debt including principal and interest

   $ 731,855       $ 58,570       $ 59,120       $ 614,165       $ —         $ —     

Lease Obligations

     147,838         25,974         25,425         24,925         20,701         50,813   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total contractual obligations

   $ 879,693       $ 84,544       $ 84,545       $ 639,090       $ 20,701       $ 50,813   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Off-Balance Sheet Financing Arrangements

Alion accounts for operating leases entered into in the routine course of business in accordance with ASC 840 Leases. Our only off-balance sheet financing arrangements are operating leases and letters of credit under our revolving credit agreement. Alion has no relationship with any unconsolidated or special purpose entity and has not issued any guarantees.

Summary of Critical Accounting Policies

Revenue Recognition

Alion derives its revenue from delivering technology services under three types of contracts. Some contracts provide for reimbursement of costs plus fees; others are fixed-price or time-and-material type contracts. We recognize revenue when a contract has been executed, the contract price is fixed or determinable, delivery of services or products has occurred and our ability to collect the contract price is considered reasonably assured. Alion applies the percentage of completion method in Accounting Standards Codification (ASC) Topic 605 – Revenue Recognition to recognize revenue.

Alion recognizes revenue on cost-reimbursement contracts as it incurs costs and includes estimated fees earned. The Company recognizes time-and-material contract revenue at negotiated, fixed, contractually billable rates as it delivers labor hours and incurs other direct expenses. We use various performance measures under the percentage of completion method to recognize revenue for fixed-price contracts. Estimating contract costs at completion and recognizing revenue appropriately involve significant management estimates. Actual costs may differ from estimated costs and affect estimated profitability and revenue recognition timing. From time to time, facts develop that require us to revise estimated total costs or expected revenue. We record the cumulative effect of revised estimates in the period when the facts requiring revised estimates become known. We recognize the full amount of anticipated losses on any contract in the period a loss becomes known. For each of the periods presented, the cumulative effects of revised estimates were immaterial to the Company’s financial performance.

U.S. federal government contracts are subject to periodic funding by our contracting agency customers. A customer may fund a contract at inception or incrementally throughout the period of performance as services are provided. If we determine contract funding is not probable, we defer revenue recognition until realization is probable. The federal government can audit Alion’s contract costs and adjust amounts through negotiation. The federal government considers Alion a major contractor and maintains an office on site. DCAA is currently auditing our 2006 and 2007 claimed indirect costs. We are negotiating our 2005 indirect rates and have settled our rates through 2004. We timely submitted our indirect cost proposals for all open fiscal years. We have recorded revenue on federal government contracts in amounts we expect to realize.

Alion recognizes revenue on unpriced change orders as it incurs expenses and only to the extent it is probable it will recover such costs. The Company recognizes revenue in excess of costs on unpriced change orders only when management can also estimate beyond a reasonable doubt the amount of excess and experience provides a sufficient basis for recognition. Alion recognizes revenue on claims as expenses are incurred and only to the extent it is probable that it will recover such costs and can reliably estimate the amount it will recover.

 

39


Table of Contents

Income Taxes

Alion accounts for income taxes by applying the provisions in currently enacted tax laws. The Company determines deferred income taxes based on the estimated future tax effects of differences between the financial statement and tax bases of its assets and liabilities. Deferred income tax provisions and benefits change as assets or liabilities change from year to year. In providing for deferred taxes, Alion considers the tax regulations of the jurisdictions where it operates; estimates of future taxable income; and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies change, the carrying value of deferred tax assets and liabilities may require adjustment.

Alion has a history of operating losses for both tax and financial statement purposes. The Company has recorded valuation allowances equal to deferred tax assets based on the likelihood that it may not be able to realize the value of these assets. Alion recognizes the benefit of a tax position only after determining that the relevant tax authority would “more likely than not” sustain the Company’s position following an audit. For tax positions meeting the “more likely than not” threshold, the Company recognizes the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

Going Concern Assumption

Each year management assesses Alion’s financial capabilities, forecast cash flows and liquidity to determine whether it is appropriate for the Company to report its financial position on a going concern basis. Management believes that in the coming fiscal year Alion will generate sufficient revenue and cash flow to meet debt service requirements, fund operations and comply with the minimum Consolidated EBITDA covenant in Alion’s revolving credit agreement. Management’s going concern determination is based on current forecasts for which future results could differ materially as a result of general economic uncertainties and risks associated with federal government spending and contracting levels for the coming calendar year. Based on management’s going concern determination, Alion’s consolidated financial statements do not include any adjustments to reflect the possible effects on the recoverability of assets or the amounts of liabilities that may result from the resolution of the uncertainty about the Company’s ability to continue as a going concern.

Alion depends heavily on federal government prime contracts and subcontracts which account for nearly all the Company’s revenue. Interruptions in the government funding process, whether from federal budget delays, debt ceiling limitations, sequestration or Department of Defense spending cuts, could materially and adversely affect the Company’s revenue and cash flows in the coming year. This could cause Alion to be unable to fund operations, meet debt service requirements or comply with the revolving credit agreement Consolidated EBITDA covenant.

If Alion were unable to meet the revolving credit agreement Consolidated EBITDA covenant, the Company would be unable to borrow funds and could be required to immediately repay any amount then outstanding under the revolving credit agreement. The Company could seek a covenant waiver or an amendment to the revolving credit agreement in order to preserve its ability to borrow funds as and when needed. Management can provide no assurance that Alion would be able to obtain an amendment or waiver, or if one were available, that the terms would be favorable. If the Company was unable to obtain a requested waiver or amendment, it might be unable to pay its debts as they became due.

In each of the past three fiscal years, Alion generated sufficient cash flow from operations to fulfill its financial commitments. Nevertheless, management does not expect current operations to generate sufficient cash flow for Alion to be able to repay its outstanding debt when it becomes due in fiscal 2015. The Company will need to identify additional sources of financing to retire its existing debt. Management can provide no assurance such additional sources of financing will be available, and if available, that terms would be favorable.

Cash and Cash Equivalents

The Company considers cash in banks, and deposits with financial institutions with maturities of three months or less at time of purchase which it can liquidate without prior notice or penalty, to be cash and cash equivalents.

Accounts Receivable and Billings in Excess of Revenue Earned

Accounts receivable include billed accounts receivable, amounts currently billable and revenue in excess of billings on uncompleted contracts (accumulated project expenses and fees which were not billed or are not currently billable as of the date of the consolidated balance sheet). Revenue in excess of billings on uncompleted contracts is stated at estimated realizable value. Unbilled accounts receivable include revenue recognized for customer-requested work Alion performed on new and existing contracts for which the Company had not received contracts or contract modifications. The allowance for doubtful accounts is Alion’s best estimate of the amount of probable losses in the Company’s existing billed and unbilled accounts receivable. The Company determines the allowance using specific identification and historical write-off experience based on receivable age. Billings in excess of revenue and advance collections from customers represent amounts received from or billed to customers in excess of project revenue recognized to date.

 

40


Table of Contents

Property, Plant and Equipment

Leasehold improvements, software and equipment are recorded at cost. Maintenance and repairs that do not add significant value or significantly lengthen an asset’s useful life are charged to current operations. Software and equipment are depreciated on the straight-line method over their estimated useful lives (typically 3 years for software and 5 years for equipment). Leasehold improvements are amortized on the straight-line method over the shorter of the asset’s estimated useful life or the life of the lease. Upon sale or retirement of an asset, costs and related accumulated depreciation are deducted from the accounts, and any gain or loss is recognized in the consolidated statements of operations.

Goodwill

Management determined that, on an enterprise value basis, Alion’s reporting units have positive carrying value. In reviewing its discounted cash flow analysis prepared for testing goodwill for potential impairment, management considered macroeconomic and other conditions such as:

 

  the deterioration in general economic conditions arising from federal budget deficits;

 

  Defense and aerospace industry and market concerns about the effects of sequestration and federal budget deficits on future Department of Defense procurement actions;

 

  Alion’s credit rating and its potential for limiting future access to capital;

 

  An increase in market risks

 

  A lower discount rate for valuing estimated future cash flows;

 

  A decline in market-dependent multiples and metrics in both absolute terms and for Alion relative to its peers;

 

  Alion’s current year sales increase compared to last year; and

 

  Alion’s success in obtaining $833 million of additional customer contract funding and new contracts in the past six months.

Alion completed its most recent goodwill impairment analysis in the fourth quarter of fiscal year 2012 and concluded no goodwill impairment existed as of September 30, 2012. Management determined the totality of events and circumstances would not have supported a decision to roll forward its prior year goodwill impairment analysis and avoid performing a step one goodwill impairment analysis. Management chose to perform a step one analysis which supported a lower enterprise value for Alion as of September 2012 compared to September 2011. September 2012 estimated discounted future cash flows declined 11% compared to September 2011. The estimated fair value of Alion’s outstanding debt increased approximately seven percent from September 2011 to September 2012. As a result of changes in Alion’s estimated enterprise fair value, the estimated fair value of Alion’s outstanding redeemable common stock declined approximately 21% from September 2011 to September 2012.

As of September 30, 2012, the estimated fair value of each reporting unit substantially exceeded its carrying value. Consistent with prior years’ disclosures, the decline in discounted cash flows for 2012 compared to 2011 did not result in an impairment to goodwill. The results of Alion’s step one impairment testing make it unlikely that a reasonably probable change in assumptions would have triggered an impairment. A hypothetical 10% decrease in fair value would not have resulted in impairment to goodwill for any reporting unit or triggered the need to perform additional step two analyses for any reporting unit.

The tables below set out for each reporting unit as of September 30, 2012 and 2011: the goodwill assigned to each reporting unit; reporting unit carrying value; reporting unit estimated fair value; and the excess of estimated fair value over carrying value for each reporting unit. Management used the reporting unit estimated fair values presented below in testing goodwill for impairment in the fourth quarter of fiscal year 2012 and 2011.

 

41


Table of Contents
     Goodwill      Carrying
Value
     Estimated
Fair Value
     Excess of
Estimated Fair

Value over
Carrying Value
 
     at September 30, 2012  

Sector

   (In millions, except percentages)  

TEOSS

   $ 201.9       $ 197.7       $ 258.4       $ 60.7         31

EISS

     197.0         193.2         227.6         34.4         18
  

 

 

    

 

 

    

 

 

    

 

 

    

Total

   $ 398.9       $ 390.9       $ 486.0       $ 95.1         24
  

 

 

    

 

 

    

 

 

    

 

 

    
     Goodwill      Carrying
Value
     Estimated
Fair Value
     Excess of
Estimated Fair

Value over
Carrying Value
 
     at September 30, 2011  

Sector

   (In millions, except percentages)  

TEOSS

   $ 201.9       $ 212.8       $ 295.6       $ 82.8         39

EISS

     197.0         205.9         242.8         36.9         18
  

 

 

    

 

 

    

 

 

    

 

 

    

Total

   $ 398.9       $ 418.7       $ 538.4       $ 119.7         29
  

 

 

    

 

 

    

 

 

    

 

 

    

Intangible Assets

Alion amortizes intangible assets as it consumes economic benefits over estimated useful lives. As of September 30, 2012, the Company had approximately $5.2 million in net intangible assets, including contracts purchased in the JJMA and Anteon contract acquisitions and internally-developed software and engineering designs. Alion’s intangible assets have the following estimated useful lives:

 

Purchased contracts

     1 – 6 years   

Internal use software and engineering designs

     1 – 5 years   

Redeemable Common Stock

There is no public market for Alion’s redeemable common stock and therefore no observable price for its equity, individually or in the aggregate. The ESOP Trust holds all the Company’s outstanding common stock. Under certain circumstances, ESOP beneficiaries can require the ESOP Trust to distribute the value of their beneficial interests. The Internal Revenue Code (IRC) and the Employee Retirement Income Security Act (ERISA) require the Company to offer ESOP participants who receive Alion common stock a liquidity put right. The put right requires the Company to purchase distributed shares at their then-current fair market value at any time during two put option periods. Common stock distributed by the ESOP Trust is subject to a right of first refusal. Prior to any subsequent transfer, the shares must first be offered to the Company and then to the ESOP Trust. Eventual redemption of shares of Alion common stock as a result of distributions is outside the Company’s control. Therefore, Alion classifies its outstanding shares of redeemable common stock as other than permanent equity.

At each reporting date, Alion is required to increase or decrease the reported value of its outstanding common stock to reflect its estimated redemption value. Management estimates the value of Alion’s obligation to repurchase its outstanding shares of redeemable common stock by considering, in part, the most recent price at which the Company was able to sell shares to the ESOP Trust. The reported value of outstanding redeemable common stock equals the current share price multiplied by total shares issued and outstanding.

In its fiduciary capacity the ESOP Trustee is independent of the Company and its management. Consistent with its fiduciary responsibilities, the ESOP Trustee retains an independent third party valuation firm to assist it in determining the fair market value (share price) at which the ESOP Trustee may acquire or dispose of investments in Alion common stock. The Audit and Finance Committee of Alion’s Board of Directors reviews the reasonableness of the amount management has determined Alion should recognize for the Company’s obligation to repurchase shares of its outstanding redeemable common stock. The Audit and Finance Committee considers various factors in its review, including, in part, the most recent valuation report and the share price selected by the ESOP Trustee.

 

42


Table of Contents

Alion records changes in the reported value of its outstanding common stock through an offsetting charge or credit to accumulated deficit. The Company recognizes changes in the fair value of its redeemable common stock on March 31 and September 30 each year. The accumulated deficit at September 30, 2012 included a $10.6 million cumulative benefit for changes in share price which reduced the Company’s aggregate share redemption obligation. Outstanding redeemable common stock had an aggregate fair value of approximately $110.8 million as of September 30, 2012.

Concentration of Credit Risk

Alion is subject to credit risk for its cash equivalents and accounts receivable. The Company believes the high credit quality of its cash equivalent investments limits its credit risk with respect to such investments. Alion believes its concentration of credit risk with respect to accounts receivable is limited as the receivables are principally due from the federal government.

Fair Value of Financial Instruments

Alion is required to disclose the fair value of its financial instruments, but is not required to record its senior long term debt at fair value. See Note 11 for a discussion of Alion’s long term debt and Note 12 for the related fair value disclosures. The fair value of cash, cash equivalents, accounts payable and accounts receivable is not materially different from carrying value because of the short maturity of those instruments.

Off-Balance Sheet Financing Arrangements

Alion accounts for operating leases entered into in the routine course of business in accordance with ASC 840 Leases. We have no off-balance sheet financing arrangements other than operating leases and letters of credit under our revolving credit facility. Alion has no relationship with any unconsolidated or special purpose entity and has not issued any guarantees.

Recently Issued Accounting Pronouncements

In December 2010, FASB issued Accounting Standards Update 2010-28 (ASU 2010-28) Goodwill and Other Intangibles — When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts. ASU 2010-28 updates ASC 350 – Intangibles – Goodwill and Other (ASC 350). ASU 2010-28 modifies goodwill impairment testing for reporting units with zero or negative carrying amounts.

ASU 2010-28 requires an entity to perform a step two goodwill impairment analysis for reporting units with zero or negative carrying value as part of an annual goodwill impairment analysis; whenever an event occurs or circumstances indicate that a reporting unit’s fair value is more likely than not below its carrying amount; whenever an event occurs or circumstances indicate that a goodwill impairment exists; and upon adoption of the standard.

ASU 2010-28 is effective for fiscal years beginning on or after December 15, 2010, and can only be applied prospectively. Any goodwill impairment recognized on adopting ASU 2010-28 is to be recorded as a cumulative effect adjustment to retained earnings in the period of adoption. Any goodwill impairments occurring subsequent to adoption are to be recognized in current earnings as required by ASC 350. The Company adopted ASU 2010-28 in the first quarter this year with no effect on Alion’s consolidated financial position or operating results.

In September 2011, the FASB issued Accounting Standards Update 2011-08 (ASU 2011-08), Intangibles—Goodwill and Other (Topic 350) – Testing Goodwill for Impairment. ASU 2011-08 permits an entity to first assess qualitative factors including the totality of events and circumstances to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value and therefore whether to test goodwill for impairment. Under ASU 2011-08 an entity may bypass qualitative assessment for any reporting unit in any period and perform a Step One analysis and may resume using qualitative assessment in any subsequent period.

ASU 2011-08 removes the requirement that an entity calculate the fair value of a reporting unit unless the entity determines it is more likely than not that the reporting unit’s fair value is less than its carrying value. Where an entity is required to test goodwill for impairment, ASU 2011-08 does not change existing guidance on how to test goodwill for impairment. The update improves the examples an entity should consider in determining whether to measure an impairment loss for a reporting unit with negative carrying value. ASU 2011-08 is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted. The Company adopted ASU 2011-08 in the first quarter this year.

 

43


Table of Contents

In May 2011, the FASB issued Accounting Standards Update 2011-04 (ASU 2011-04) Fair Value Measurement (Topic 820) – Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs. ASU 2011-04 provides guidance on how to measure fair value; expands fair value disclosure requirements; and offers guidance on what disclosures to make about fair value measurements. ASU 2011-04 was effective for all public companies for interim and annual periods beginning after December 15, 2011.

In June 2011, the FASB issued Accounting Standards Update 2011-05 (ASU 2011-05) Comprehensive Income (Topic 220) – Presentation of Comprehensive Income. ASU 2011-05 requires entities to present all non-owner changes in stockholder’s equity either in a continuous, single statement of comprehensive income or in two separate, but consecutive, statements. An entity that presents two statements must present total net income and its components in the first statement followed by a second statement that presents total other comprehensive income and its components, along with total comprehensive income.

ASU 2011-05 does not change how an entity calculates earnings per share; the items to be reported in other comprehensive income; or when items must be reclassified to net income. An entity is still permitted to present components of other comprehensive income net of tax effects or before tax effects with tax effects for all items of other comprehensive income presented in the aggregate. An entity must disclose the tax effects of each item of other comprehensive income in the notes to its financial statements. Alion’s only item of other comprehensive income is amortization of actuarial gains and losses for the Company’s post-retirement medical benefit plan which has no effect on Alion’s provision for income taxes.

ASU 2011-05 is effective for public companies for fiscal years, and interim periods within those years, beginning after December 15, 2011. ASU 2011-05 is to be applied retrospectively; early adoption is permitted. The Company adopted ASU 2011-05 in the first quarter this year with no effect on Alion’s consolidated financial position, operating results, or cash flows.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

Interest rate risk

We face interest rate risk for periodic borrowings on our $35.0 million senior revolving credit facility. Outstanding balances, if any, bear interest at a variable rate based on Credit Suisse’s prime rate plus a maximum spread of 600 basis points. Variable rates increase the risk that interest charges could increase materially if both market interest rates and outstanding balances were to increase. We estimate that a 100 basis point change in interest rates under the revolving credit facility would not have a material effect on the company’s operating results. The Secured Notes and the Unsecured Notes are fixed-rate obligations. Other than the current revolving credit facility, Alion currently has no variable rate debt. We do not use derivatives for trading purposes. We invest excess cash in short-term, investment grade, and interest-bearing securities.

Foreign currency risk

International contract expenses and revenues are U.S. dollar-denominated. Alion does not believe operations are subject to material risks from currency fluctuations.

Risk associated with value of Alion common stock

Changes in the fair market value of Alion’s stock affect our estimated KSOP share repurchase obligations and, to a lesser extent, our stock appreciation right obligations. The number of employees who seek to redeem shares of Alion stock following termination of employment and the number of shares they seek to redeem affect the timing and amount of our repurchase obligations. The number of employees who exercise stock appreciation rights during any particular time period can affect the timing and amount of our stock appreciation right obligations.

 

44


Table of Contents

Item 8. Financial Statements and Supplementary Data

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Consolidated Financial Statements of Alion Science and Technology Corporation

 

Report of Independent Registered Public Accounting Firm

     46   

Consolidated Financial Statements:

  

Consolidated Balance Sheets as of September 30, 2012 and 2011

     47   

Consolidated Statements of Comprehensive Loss for the years ended September 30, 2012, 2011, and 2010

     48   

Consolidated Statements of Redeemable Common Stock, Common Stock Warrants, and Accumulated Deficit for the years ended September 30, 2012, 2011, and 2010

     49   

Consolidated Statements of Cash Flows for the years ended September 30, 2012, 2011, and 2010

     50   

Notes to Consolidated Financial Statements

     51   

 

Consolidated Financial Statement Schedule

  

Schedule II — Valuation and Qualifying Accounts

     111   

 

45


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors

Alion Science and Technology Corporation

McLean, Virginia

We have audited the accompanying consolidated balance sheets of Alion Science and Technology Corporation and subsidiaries (the “Company”) as of September 30, 2012 and 2011, and the related consolidated statements of comprehensive loss, redeemable common stock, common stock warrants and accumulated deficit, and cash flows for each of the three years in the period ended September 30, 2012. Our audits also included the financial statement schedule listed in the Index at Item 15. These financial statements and financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on the financial statements and financial statement schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all material respects the financial position of Alion Science and Technology Corporation and subsidiaries as of September 30, 2012 and 2011, and the results of their operations and their cash flows for each of the three years in the period ended September 30, 2012, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects the information set forth therein.

/s/ DELOITTE & TOUCHE LLP

McLean, Virginia

December 17, 2012

 

46


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

CONSOLIDATED BALANCE SHEETS

 

     September 30,  
     2012     2011  
     (In thousands, except
share and per share
information)
 

Current assets:

    

Cash and cash equivalents

   $ 27,227      $ 20,818   

Accounts receivable, net

     175,293        180,364   

Receivable due from ESOP Trust

     1,129        —     

Prepaid expenses and other current assets

     5,448        6,086   
  

 

 

   

 

 

 

Total current assets

     209,097        207,268   

Property, plant and equipment, net

     10,605        10,367   

Intangible assets, net

     5,242        11,734   

Goodwill

     398,921        398,921   

Other assets

     11,431        16,198   
  

 

 

   

 

 

 

Total assets

   $ 635,296      $ 644,488   
  

 

 

   

 

 

 

Current liabilities:

    

Interest payable

   $ 17,658      $ 17,392   

Trade accounts payable

     44,793        52,355   

Accrued liabilities

     52,460        48,435   

Accrued payroll and related liabilities

     39,926        39,738   

Billings in excess of revenue earned

     2,666        2,752   
  

 

 

   

 

 

 

Total current liabilities

     157,503        160,672   

Secured Notes

     306,502        291,003   

Unsecured Notes

     242,923        242,064   

Accrued compensation and benefits, excluding current portion

     5,905        5,729   

Non-current portion of lease obligations

     12,364        10,762   

Deferred income taxes

     51,156        44,181   

Commitments and contingencies

    

Other liabilities

     —          980   

Redeemable common stock, $0.01 par value, 8,000,000 shares authorized, 6,731,889 and 6,041,029 shares issued and outstanding at September 30, 2012 and September 30, 2011

     110,740        126,560   

Common stock warrants

     20,785        20,785   

Accumulated other comprehensive loss

     (149     (123

Accumulated deficit

     (272,433     (258,125
  

 

 

   

 

 

 

Total liabilities, redeemable common stock, warrants and accumulated deficit

   $ 635,296      $ 644,488   
  

 

 

   

 

 

 

See accompanying notes to consolidated financial statements.

 

47


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 

     Year Ended September 30,  
     2012     2011     2010  
     (In thousands, except share and per share
information)
 

Contract revenue

   $ 817,204      $ 787,314      $ 833,988   

Direct contract expense

     632,831        603,481        638,000   
  

 

 

   

 

 

   

 

 

 

Gross profit

     184,373        183,833        195,988   
  

 

 

   

 

 

   

 

 

 

Operating expenses

     91,494        83,035        87,970   

General and administrative

     52,441        65,305        69,098   
  

 

 

   

 

 

   

 

 

 

Operating income

     40,438        35,493        38,920   

Other income (expense):

      

Interest income

     78        45        119   

Interest expense

     (74,934     (73,919     (67,613

Other

     (55     32        (242

Gain on debt extinguishment

     —          939        50,749   
  

 

 

   

 

 

   

 

 

 

Total other income (expenses)

     (74,911     (72,903     (16,987

Income (loss) before income taxes

     (34,473     (37,410     21,933   

Income tax expense

     (6,974     (6,974     (37,165
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (41,447   $ (44,384   $ (15,232
  

 

 

   

 

 

   

 

 

 

Basic and diluted loss per share

   $ (6.74   $ (7.83   $ (2.81
  

 

 

   

 

 

   

 

 

 

Basic and diluted weighted average common shares outstanding

     6,148,438        5,671,977        5,427,979   
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (41,447   $ (44,384   $ (15,232

Other comprehensive income:

      

Postretirement actuarial gains

     26        55        61   
  

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (41,421   $ (44,329   $ (15,171
  

 

 

   

 

 

   

 

 

 

See accompanying notes to consolidated financial statements.

 

48


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

CONSOLIDATED STATEMENTS OF REDEEMABLE COMMON STOCK,

COMMON STOCK WARRANTS AND ACCUMULATED DEFICIT

FOR THE YEARS ENDED SEPTEMBER 30, 2012, 2011, AND 2010

 

     Redeemable Common Stock     Common
Stock
Warrants
     Comprehensive
Loss
    Accumulated
Deficit
 
     Shares     Amount         
     (In thousands, except share and per share information)  

Balances at September 30, 2009

     5,424,274      $ 187,137      $ —         $ —        $ (274,559

Redeemable common stock issued

     516,590        14,124        —           —          —     

Redeemable common stock retired

     (282,630     (9,338     —           —          —     

Common stock warrants issued

     —          —          20,785         —          —     

Change in common stock redemption value

     —          (41,131     —           —          41,131   

Postretirement medical plan actuarial benefit

     —          —          —           61        —     

Loss on sale of subsidiary

     —          —          —           —          2,390   

Net loss for year ended September 30, 2010

     —          —          —           (15,232     (15,232
         

 

 

   

Comprehensive loss for year ended September 30, 2010

     —          —          —         $ (15,171     —     
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Balances at September 30, 2010

     5,658,234      $ 150,792      $ 20,785           (246,270
  

 

 

   

 

 

   

 

 

      

 

 

 

Redeemable common stock issued

     597,240        14,059        —           —          —     

Redeemable common stock retired

     (214,445     (5,762     —           —          —     

Change in common stock redemption value

     —          (32,529     —           —          32,529   

Postretirement medical plan actuarial benefit

     —          —          —           55        —     

Net loss for year ended September 30, 2011

     —          —          —           (44,384     (44,384
         

 

 

   

Comprehensive loss for year ended September 30, 2010

     —          —          —         $ (44,329     —     
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Balances at September 30, 2011

     6,041,029      $ 126,560      $ 20,785         $ (258,125
  

 

 

   

 

 

   

 

 

      

 

 

 

Redeemable common stock issued

     938,492        16,162        —           —          —     

Redeemable common stock retired

     (247,632     (4,843     —           —          —     

Change in common stock redemption value

     —          (27,139     —           —          27,139   

Postretirement medical plan actuarial benefit

     —          —          —           26        —     

Net loss for year ended September 30, 2011

     —          —          —           (41,447     (41,447
         

 

 

   

Comprehensive loss for year ended September 30, 2010

     —          —          —         $ (41,421     —     
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Balances at September 30, 2012

     6,731,889      $ 110,740      $ 20,785         $ (272,433
  

 

 

   

 

 

   

 

 

      

 

 

 

See accompanying notes to consolidated financial statements.

 

49


Table of Contents

ALION SCIENCE AND TECHNOLOGY

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

     Year Ended September 30,  
     2012     2011     2010  
     (In thousands)  

Cash flows from operating activities:

      

Net loss

   $ (41,447   $ (44,384   $ (15,232

Adjustments to reconcile net loss to net cash used in operating activities:

      

Depreciation and amortization

     11,741        11,409        16,777   

Paid in kind interest

     6,423        6,300        3,263   

Bad debt expense

     802        —          —     

Amortization of debt issuance costs

     10,421        10,143        7,199   

Change in fair value of redeemable common stock warrants

     —          —          (160

Incentive and stock-based compensation

     1,310        2,655        3,171   

Gain on debt extinguishment

     —          (939     (50,749

Deferred income taxes

     6,974        6,974        37,207   

Loss on sale of subsidiary

     —          —          2,589   

Gain on sale of contracts

     —          —          (514

Other gains and losses

     (95     29        (59

Changes in assets and liabilities:

      

Accounts receivable, net

     4,269        (6,332     6,624   

Other assets

     4,122        (1,277     (1,287

Trade accounts payable

     (7,562     7,869        (16,102

Accrued liabilities

     16,513        12,370        1,595   

Interest payable

     266        175        8,178   

Other liabilities

     (1,056     729        (104
  

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     12,681        5,721        2,396   

Cash flows from investing activities:

      

Cash paid for acquisitions-related obligations

     —          —          (50

Capital expenditures

     (2,731     (6,305     (2,207

Asset sales proceeds

     —          14        110   
  

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (2,731     (6,291     (2,147

Cash flows from financing activities:

      

Sale of Secured Notes

     —          —          281,465   

Sale of Common Stock Warrants

     —          —          20,785   

Payment of debt issue costs

     —          (710     (18,183

Repurchase Senior Unsecured Notes

     —          (3,993     —     

Repayment of Term B Loan

     —          —          (236,596

Repurchase of Subordinated Note and related warrants

     —          —          (25,000

Revolver borrowings

     26,000        17,000        84,200   

Revolver repayments

     (26,000     (17,000     (84,200

Loan to ESOP Trust

     (477     (776     (5,323

ESOP loan repayment

     477        776        5,323   

Redeemable common stock purchased from ESOP Trust

     (4,843     (5,762     (9,338

Redeemable common stock sold to ESOP Trust

     1,302        5,158        2,128   
  

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     (3,541     (5,307     15,261   

Net increase (decrease) in cash and cash equivalents

     6,409        (5,877     15,510   

Cash and cash equivalents at beginning of period

     20,818        26,695        11,185   
  

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 27,227      $ 20,818      $ 26,695   
  

 

 

   

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

      

Cash paid for interest

   $ 57,755      $ 57,301      $ 49,161   

Cash paid (received) for taxes

     —          —          (41

Non-cash investing and financing activities:

      

Common stock issued to ESOP Trust in satisfaction of employer contribution liability

   $ 13,732      $ 10,797      $ 10,099   

Landlord funded leasehold improvements

   $ 1,841      $ 2,823      $ 1,197   

See accompanying notes to consolidated financial statements.

 

50


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(1) Description and Formation of the Business

Alion Science and Technology Corporation and its subsidiaries (collectively, the Company or Alion) provide scientific, engineering and information technology expertise to research and develop technological solutions for problems relating to national defense, homeland security, and energy and environmental analysis. Alion serves federal government departments and agencies, and to a lesser extent, commercial and international customers.

Alion was formed as a for-profit S-corporation in October 2001, to purchase substantially all assets and certain liabilities of IIT Research Institute (IITRI), a not-for-profit corporation controlled by Illinois Institute of Technology (IIT). In December 2002, Alion acquired substantially all of IITRI’s assets and liabilities except for its Life Sciences Operation, for approximately $127.3 million. Prior to that time, the Company’s activities were organizational in nature. In 2010, the Company became a C-corporation when it ceased to qualify as an S corporation.

(2) Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

The accompanying audited consolidated financial statements include the accounts of Alion Science and Technology Corporation (a Delaware corporation) and its wholly-owned subsidiaries and have been prepared in accordance with U.S. generally accepted accounting principles on the accrual basis of accounting. The statements include the accounts of Alion and its wholly-owned subsidiaries from date of formation or acquisition. All inter-company accounts have been eliminated in consolidation. The wholly-owned subsidiaries are:

 

   

Innovative Technology Solution Corporation (ITSC) – acquired October 2003

 

   

Alion - IPS Corporation (IPS) – acquired February 2004

 

   

Alion - METI Corporation (METI) – acquired February 2005

 

   

Alion - CATI Corporation (CATI) – acquired February 2005

 

   

Alion International Corporation (Alion International) – established February 2005

 

   

Alion Science and Technology (Canada) Corporation – established February 2005

 

   

Alion - JJMA Corporation (JJMA) – acquired April 2005

 

   

Alion - BMH Corporation (BMH) – acquired February 2006

 

   

Washington Consulting, Inc. (WCI) – acquired February 2006

 

   

Alion - MA&D Corporation (MA&D) – acquired May 2006

 

   

Alion Offshore Services, Inc. (Alion Offshore) (Delaware) – established May 2006

 

   

Washington Consulting Government Services, Inc. (WCGS) – established July 2007

 

   

Alion India Corporation (Alion India) (Delaware) – established May 2012

Fiscal, Quarter and Interim Periods

Alion’s fiscal year ends on September 30. The Company operates based on a three-month quarter, four-quarter fiscal year with quarters ending December 31, March 31, June 30, and September 30.

Use of Estimates

Preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect amounts reported for assets and liabilities, disclosures of contingent assets and liabilities as of financial statement dates and amounts reported for operating results for each period presented. Actual results are likely to differ from those estimates, but management does not believe such differences will materially affect Alion’s financial position, results of operations, or cash flows.

Reclassifications

Certain items in the consolidated financial statements have been reclassified to conform to the current presentation. The Company has aggregated indirect contract expense, rental and occupancy expense, depreciation and amortization as operating expenses. These amounts were formerly presented separately on the face of the statement of comprehensive loss.

 

51


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Summary of Critical Accounting Policies

Revenue Recognition

Alion derives its revenue from delivering technology services under three types of contracts. Some contracts provide for reimbursement of costs plus fees; others are fixed-price or time-and-material type contracts. We recognize revenue when a contract has been executed, the contract price is fixed or determinable, delivery of services or products has occurred and our ability to collect the contract price is considered reasonably assured. Alion applies the percentage of completion method in Accounting Standards Codification (ASC) Topic 605 – Revenue Recognition to recognize revenue.

Alion recognizes revenue on cost-reimbursement contracts as it incurs costs and includes estimated fees earned. The Company recognizes time-and-material contract revenue at negotiated, fixed, contractually billable rates as it delivers labor hours and incurs other direct expenses. We use various performance measures under the percentage of completion method to recognize revenue for fixed-price contracts. Estimating contract costs at completion and recognizing revenue appropriately involve significant management estimates. Actual costs may differ from estimated costs and affect estimated profitability and revenue recognition timing. From time to time, facts develop that require us to revise estimated total costs or expected revenue. We record the cumulative effect of revised estimates in the period when the facts requiring revised estimates become known. We recognize the full amount of anticipated losses on any contract in the period a loss becomes known. For each of the periods presented, the cumulative effects of revised estimates were immaterial to the Company’s financial performance.

U.S. federal government contracts are subject to periodic funding by our contracting agency customers. A customer may fund a contract at inception or incrementally throughout the period of performance as services are provided. If we determine contract funding is not probable, we defer revenue recognition until realization is probable. The federal government can audit Alion’s contract costs and adjust amounts through negotiation. The federal government considers Alion a major contractor and maintains an office on site. DCAA is currently auditing our 2006 and 2007 claimed indirect costs. We are negotiating our 2005 indirect rates and have settled our rates through 2004. We timely submitted our indirect cost proposals for all open fiscal years. We have recorded revenue on federal government contracts in amounts we expect to realize.

Alion recognizes revenue on unpriced change orders as it incurs expenses and only to the extent it is probable it will recover such costs. The Company recognizes revenue in excess of costs on unpriced change orders only when management can also estimate beyond a reasonable doubt the amount of excess and experience provides a sufficient basis for recognition. Alion recognizes revenue on claims as expenses are incurred and only to the extent it is probable that it will recover such costs and can reliably estimate the amount it will recover.

Income Taxes

Alion accounts for income taxes by applying the provisions in currently enacted tax laws. The Company determines deferred income taxes based on the estimated future tax effects of differences between the financial statement and tax bases of its assets and liabilities. Deferred income tax provisions and benefits change as assets or liabilities change from year to year. In providing for deferred taxes, Alion considers the tax regulations of the jurisdictions where it operates; estimates of future taxable income; and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies change, the carrying value of deferred tax assets and liabilities may require adjustment.

Alion has a history of operating losses for both tax and financial statement purposes. The Company has recorded valuation allowances equal to deferred tax assets based on the likelihood that it may not be able to realize the value of these assets. Alion recognizes the benefit of a tax position only after determining that the relevant tax authority would “more likely than not” sustain the Company’s position following an audit. For tax positions meeting the “more likely than not” threshold, the Company recognizes the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

Going Concern Assumption

Each year management assesses Alion’s financial capabilities, forecast cash flows and liquidity to determine whether it is appropriate for the Company to report its financial position on a going concern basis. Management believes that in the coming fiscal year Alion will generate sufficient revenue and cash flow to meet debt service requirements, fund operations and comply with the minimum Consolidated EBITDA covenant in Alion’s revolving credit agreement. Management’s going concern determination is based on current forecasts for which future results could differ materially as a result of general economic uncertainties and risks associated with federal government spending and contracting levels for the coming calendar year. Based on management’s going concern determination, Alion’s consolidated financial statements do not include any adjustments to reflect the possible effects on the recoverability of assets or the amounts of liabilities that may result from the resolution of the uncertainty about the Company’s ability to continue as a going concern.

 

52


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Alion depends heavily on federal government prime contracts and subcontracts which account for nearly all the Company’s revenue. Interruptions in the government funding process, whether from federal budget delays, debt ceiling limitations, sequestration or Department of Defense spending cuts, could materially, adversely affect the Company’s revenue and cash flows in the coming year. This could cause Alion to be unable to fund operations, meet debt service requirements or comply with the revolving credit agreement Consolidated EBITDA covenant.

If Alion were unable to meet the revolving credit agreement Consolidated EBITDA covenant, the Company would be unable to borrow funds and could be required to immediately repay any amount then outstanding under the revolving credit agreement. The Company could seek a covenant waiver or an amendment to the revolving credit agreement in order to preserve its ability to borrow funds as and when needed. Management can provide no assurance that Alion would be able to obtain an amendment or waiver, or if one were available, that the terms would be favorable. If the Company was unable to obtain a requested waiver or amendment, it might be unable to pay its debts as they became due.

In each of the past three fiscal years, Alion generated sufficient cash flow from operations to fulfill its financial commitments. Nevertheless, management does not expect current operations to generate sufficient cash flow for Alion to be able to repay its outstanding debt when it becomes due in fiscal 2015. The Company will need to identify additional sources of financing to retire its existing debt. Management can provide no assurance such additional sources of financing will be available, and if available, that terms would be favorable.

Cash and Cash Equivalents

The Company considers cash in banks, and deposits with financial institutions with maturities of three months or less at time of purchase which it can liquidate without prior notice or penalty, to be cash and cash equivalents.

Accounts Receivable and Billings in Excess of Revenue Earned

Accounts receivable include billed accounts receivable, amounts currently billable and revenue in excess of billings on uncompleted contracts (accumulated project expenses and fees which were not billed or are not currently billable as of the date of the consolidated balance sheet). Revenue in excess of billings on uncompleted contracts is stated at estimated realizable value. Unbilled accounts receivable include revenue recognized for customer-requested work Alion performed on new and existing contracts for which the Company had not received contracts or contract modifications. The allowance for doubtful accounts is Alion’s best estimate of the amount of probable losses in the Company’s existing billed and unbilled accounts receivable. The Company determines the allowance using specific identification and historical write-off experience based on receivable age. Billings in excess of revenue and advance collections from customers represent amounts received from or billed to customers in excess of project revenue recognized to date.

Property, Plant and Equipment

Leasehold improvements, software and equipment are recorded at cost. Maintenance and repairs that do not add significant value or significantly lengthen an asset’s useful life are charged to current operations. Software and equipment are depreciated on the straight-line method over their estimated useful lives (typically 3 years for software and 5 years for equipment). Leasehold improvements are amortized on the straight-line method over the shorter of the asset’s estimated useful life or the life of the lease. Upon sale or retirement of an asset, costs and related accumulated depreciation are deducted from the accounts, and any gain or loss is recognized in the consolidated statements of operations.

Goodwill

Alion assigns the purchase price paid to acquire the stock or assets of a business to the net assets acquired based on the estimated fair value of assets acquired. Goodwill is the purchase price in excess of the estimated fair value of the tangible net assets and separately identified intangible assets acquired. There were no changes to goodwill carrying value this year.

 

53


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company accounts for goodwill and other intangible assets in accordance with the provisions of ASC 350, Intangibles, Goodwill and Other. Alion operates in one segment and tests goodwill at the reporting unit level. There are two reporting units. We review goodwill for impairment in the fourth quarter each year, and whenever events or circumstances indicate goodwill might be impaired. Alion is required to recognize an impairment loss to the extent that goodwill carrying amount exceeds fair value. Evaluating goodwill involves significant management estimates. To date, our annual reviews have resulted in no goodwill impairment adjustments. See Note 9 for a detailed discussion of the Company’s goodwill impairment testing process.

Intangible Assets

Alion amortizes intangible assets as it consumes economic benefits over estimated useful lives. As of September 30, 2012, the Company had approximately $5.2 million in net intangible assets, including contracts purchased in the JJMA and Anteon contract acquisitions and internally-developed software and engineering designs. Alion’s intangible assets have the following estimated useful lives:

 

Purchased contracts

     1 – 6 years   

Internal use software and engineering designs

     1 – 5 years   

Redeemable Common Stock

There is no public market for Alion’s redeemable common stock and therefore no observable price for its equity, individually or in the aggregate. The ESOP Trust holds all the Company’s outstanding common stock. Under certain circumstances, ESOP beneficiaries can require the ESOP Trust to distribute the value of their beneficial interests. The Internal Revenue Code (IRC) and the Employee Retirement Income Security Act (ERISA) require the Company to offer ESOP participants who receive Alion common stock a liquidity put right. The put right requires the Company to purchase distributed shares at their then-current fair market value at any time during two put option periods. Common stock distributed by the ESOP Trust is subject to a right of first refusal. Prior to any subsequent transfer, the shares must first be offered to the Company and then to the ESOP Trust. Eventual redemption of shares of Alion common stock as a result of distributions is outside the Company’s control. Therefore, Alion classifies its outstanding shares of redeemable common stock as other than permanent equity.

At each reporting date, Alion is required to increase or decrease the reported value of its outstanding common stock to reflect its estimated redemption value. Management estimates the value of Alion’s obligation to repurchase its outstanding shares of redeemable common stock by considering, in part, the most recent price at which the Company was able to sell shares to the ESOP Trust. The reported value of outstanding redeemable common stock equals the current share price multiplied by total shares issued and outstanding.

In its fiduciary capacity the ESOP Trustee is independent of the Company and its management. Consistent with its fiduciary responsibilities, the ESOP Trustee retains an independent third party valuation firm to assist it in determining the fair market value (share price) at which the ESOP Trustee may acquire or dispose of investments in Alion common stock. The Audit and Finance Committee of Alion’s Board of Directors reviews the reasonableness of the amount management has determined Alion should recognize for the Company’s obligation to repurchase shares of its outstanding redeemable common stock. The Audit and Finance Committee considers various factors in its review, including, in part, the most recent valuation report and the share price selected by the ESOP Trustee.

Alion records changes in the reported value of its outstanding common stock through an offsetting charge or credit to accumulated deficit. The Company recognizes changes in the fair value of its redeemable common stock on March 31 and September 30 each year. The accumulated deficit at September 30, 2012 included a $10.6 million cumulative benefit for changes in share price which reduced the Company’s aggregate share redemption obligation. Outstanding redeemable common stock had an aggregate fair value of approximately $110.8 million as of September 30, 2012.

Concentration of Credit Risk

Alion is subject to credit risk for its cash equivalents and accounts receivable. The Company believes the high credit quality of its cash equivalent investments limits its credit risk with respect to such investments. Alion believes its concentration of credit risk with respect to accounts receivable is limited as the receivables are principally due from the federal government.

 

54


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Fair Value of Financial Instruments

Alion is required to disclose the fair value of its financial instruments, but is not required to record its senior long term debt at fair value. See Note 11 for a discussion of Alion’s long term debt and Note 12 for the related fair value disclosures. The fair value of cash, cash equivalents, accounts payable and accounts receivable is not materially different from carrying value because of the short maturity of those instruments.

Off-Balance Sheet Financing Arrangements

Alion accounts for operating leases entered into in the routine course of business in accordance with ASC 840 Leases. We have no off-balance sheet financing arrangements other than operating leases and letters of credit under our revolving credit facility. Alion has no relationship with any unconsolidated or special purpose entity and has not issued any associated guarantees.

Recently Issued Accounting Pronouncements

In December 2010, FASB issued Accounting Standards Update 2010-28 (ASU 2010-28) Goodwill and Other Intangibles — When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts. ASU 2010-28 updates ASC 350 – Intangibles – Goodwill and Other (ASC 350). ASU 2010-28 modifies goodwill impairment testing for reporting units with zero or negative carrying amounts.

ASU 2010-28 requires an entity to perform a step two goodwill impairment analysis for reporting units with zero or negative carrying value as part of an annual goodwill impairment analysis; whenever an event occurs or circumstances indicate that a reporting unit’s fair value is more likely than not below its carrying amount; whenever an event occurs or circumstances indicate that a goodwill impairment exists; and upon adoption of the standard.

ASU 2010-28 is effective for fiscal years beginning on or after December 15, 2010, and can only be applied prospectively. Any goodwill impairment recognized on adopting ASU 2010-28 is to be recorded as a cumulative effect adjustment to retained earnings in the period of adoption. Any goodwill impairments occurring subsequent to adoption are to be recognized in current earnings as required by ASC 350. The Company adopted ASU 2010-28 in the first quarter this year with no effect on Alion’s consolidated financial position or operating results.

In September 2011, the FASB issued Accounting Standards Update 2011-08 (ASU 2011-08), Intangibles—Goodwill and Other (Topic 350) – Testing Goodwill for Impairment. ASU 2011-08 permits an entity to first assess qualitative factors including the totality of events and circumstances to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value and therefore whether to test goodwill for impairment. Under ASU 2011-08 an entity may bypass qualitative assessment for any reporting unit in any period and perform a Step One analysis and may resume using qualitative assessment in any subsequent period.

ASU 2011-08 removes the requirement that an entity calculate the fair value of a reporting unit unless the entity determines it is more likely than not that the reporting unit’s fair value is less than its carrying value. Where an entity is required to test goodwill for impairment, ASU 2011-08 does not change existing guidance on how to test goodwill for impairment. The update improves the examples an entity should consider in determining whether to measure an impairment loss for a reporting unit with negative carrying value. ASU 2011-08 is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. Early adoption is permitted. The Company adopted ASU 2011-08 in the first quarter this year.

In May 2011, the FASB issued Accounting Standards Update 2011-04 (ASU 2011-04) Fair Value Measurement (Topic 820) – Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs. ASU 2011-04 provides guidance on how to measure fair value; expands fair value disclosure requirements; and offers guidance on what disclosures to make about fair value measurements. ASU 2011-04 was effective for all public companies for interim and annual periods beginning after December 15, 2011.

In June 2011, the FASB issued Accounting Standards Update 2011-05 (ASU 2011-05) Comprehensive Income (Topic 220) – Presentation of Comprehensive Income. ASU 2011-05 requires entities to present all non-owner changes in stockholder’s equity either in a continuous, single statement of comprehensive income or in two separate, but consecutive, statements. An entity that presents two statements must present total net income and its components in the first statement followed by a second statement that presents total other comprehensive income and its components, along with total comprehensive income.

 

55


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

ASU 2011-05 does not change how an entity calculates earnings per share; the items to be reported in other comprehensive income; or when items must be reclassified to net income. An entity is still permitted to present components of other comprehensive income net of tax effects or before tax effects with tax effects for all items of other comprehensive income presented in the aggregate. An entity must disclose the tax effects of each item of other comprehensive income in the notes to its financial statements. Alion’s only item of other comprehensive income is amortization of actuarial gains and losses for the Company’s post-retirement medical benefit plan which has no effect on Alion’s provision for income taxes.

ASU 2011-05 is effective for public companies for fiscal years, and interim periods within those years, beginning after December 15, 2011. ASU 2011-05 is to be applied retrospectively; early adoption is permitted. The Company adopted ASU 2011-05 in the first quarter this year with no effect on Alion’s consolidated financial position, operating results, or cash flows.

(3) Business Dispositions

Dispositions

On September 30, 2010, Alion sold its former HFA subsidiary for $275 thousand. The Company recognized a $2.4 million loss on the sale.

On July 9, 2010, Alion’s WCGS subsidiary sold several U.S. Navy contracts and certain related assets and liabilities for $5.0 million and recognized a $5.1 million gain on the sale. WCGS continued to provide professional engineering services to the U.S. Navy under several existing contracts through September 30, 2011. Alion provides professional engineering services to the U.S. Navy under a variety of existing contracts.

Neither the sale of Alion’s HFA subsidiary nor the WCGS contract sale was material or significant; therefore no pro forma disclosures are presented in these consolidated financial statements.

(4) Employee Stock Ownership Plan (ESOP) and ESOP Trust

In December 2001, the Company adopted the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan (the Plan) and the ESOP Trust. The Plan, a tax qualified retirement plan, includes an ESOP and a 401(k) component. In April 2010, the Internal Revenue Service (IRS) issued a determination letter that the ESOP Trust and the Plan, as amended and restated as of October 1, 2006, including Plan amendments executed in June 2009 and May 2010; qualify under Sections 401(a) and 501(a) of the IRC.

In August 2008, Alion amended the Trust Agreement between the Company and the ESOP Trust. In June 2011, the Company amended the Plan to eliminate the one year service requirement for employer 401(k) matching contributions; to automatically enroll new hires in the Plan’s 401(k) component; and to designate all future profit sharing contributions solely in Alion common stock. Alion believes that the Plan and the ESOP Trust have been designed and are being operated in compliance with applicable IRC requirements.

(5) Loss Per Share

Basic and diluted loss per share is computed by dividing net loss by the weighted average number of common shares outstanding excluding the impact of warrants. Because of Alion’s losses, warrants are anti-dilutive for all periods presented, even after including required adjustments to the earnings per share numerator. The Company’s 1,630,437 Subordinated Note warrants were outstanding through March 22, 2010 when they were extinguished. Also on March 22, 2010, Alion issued 310,000 Units that included the Secured Notes and warrants to purchase 602,614 shares of Alion common stock The Secured Note warrants have a penny per share exercise price, are currently exercisable and expire March 15, 2017. The Secured Note warrants are not redeemable and do not have price protection; they are classified as permanent equity.

(6) Redeemable common stock

The ESOP Trust owns all of Alion’s issued and outstanding common stock, for the benefit of current and former employee participants in the Alion KSOP. Participants and beneficiaries are entitled to a distribution of the fair value of their vested ESOP account balance upon death, disability, retirement or termination of employment. The Plan permits distributions to be paid over a five year period commencing the year after a participant’s retirement at age 65, death or disability. Alion can delay distributions to other terminating participants for five years before commencing payment over a subsequent five year period.

 

56


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Terminating ESOP participants can hold or immediately sell their distributed shares to the Company. If a participant elects to hold distributed shares, the IRC and ERISA require Alion to offer a put option to allow the recipient to sell stock to Alion at the estimated fair value share price based on the most recent price at which the Company was able to sell shares to the ESOP Trust ($16.45 at September 30, 2012 and $18.00 at March 31, 2012). The put right requires Alion to purchase distributed shares during two put option periods at then-current fair market value. Consistent with its duty of independence from Alion management and its fiduciary responsibilities, the ESOP Trustee retains an independent third party valuation firm to assist it in determining the fair market value (share price) at which the Trustee may acquire or dispose of investments in Alion common stock.

Alion management determines and the Board of Directors’ Audit and Finance Committee reviews the reasonableness of Alion’s recorded redeemable common stock liability. The Audit and Finance Committee considers various factors in its review, including in part, the ESOP valuation report and the share price selected by the ESOP Trustee. Management considers the share price selected by the ESOP Trustee along with other factors, in estimating Alion’s aggregate liability for outstanding redeemable common stock. A limited number of participants who beneficially acquired shares of Alion common stock on December 20, 2002, can sell such shares distributed from their accounts at the greater of $10.00 or the current estimated fair value share price.

Although the Company and the ESOP retain the right to delay distributions consistent with the terms of the Plan, and to control the circumstances of future distributions, eventual redemption of shares of Alion common stock is deemed to be outside the Company’s control.

(7) Accounts Receivable

Accounts receivable at September 30 consisted of the following:

 

     September 30,  
     2012     2011  
     (In thousands)  

Billed receivables and amounts billable as of the balance sheet date

   $ 94,028      $ 85,242   

Unbilled receivables:

    

Amounts billable after the balance sheet date

     48,730        40,621   

Revenues recorded in excess of milestone billings on fixed price contracts

     2,666        2,737   

Revenues recorded in excess of estimated contract value or funding

     18,998        30,759   

Retainages and other amounts billable upon contract completion

     15,016        24,416   

Allowance for doubtful accounts

     (4,145     (3,411
  

 

 

   

 

 

 

Total Accounts Receivable

   $ 175,293      $ 180,364   
  

 

 

   

 

 

 

Billed accounts receivable include invoices issued to customers for services performed as of the balance sheet date. Unbilled accounts receivable represent revenue recognized as of the balance sheet date for which Alion has yet to issue invoices to customers. Amounts that are currently billable are expected to be invoiced to customers within the next twelve months. Fixed-price contract revenue in excess of milestone billings is not yet contractually billable. Revenue in excess of contract value or funding is billable when Alion receives contractual amendments or modifications. Approximately $138.9 million (77%) and $124.2 million (68%) of contract receivables at September 30, 2012 and September 30, 2011 were from federal government prime contracts.

Alion recognized $85.4 million in revenue in excess of billings on uncompleted contracts as of September 30, 2012, including approximately $19 million for customer-requested work for which the Company had not received contracts or contract modifications. At September 30, 2011, Alion had recognized $98.5 million in revenue in excess of billings on uncompleted contracts including approximately $30.7 million for customer-requested work for which the Company had not received contracts or contract modifications.

 

57


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(8) Property, Plant and Equipment

 

     September 30,  
     2012     2011  
     (In thousands)  

Leasehold improvements

   $ 12,168      $ 11,281   

Equipment and software

     35,562        33,373   
  

 

 

   

 

 

 

Total cost

     47,730        44,654   

Less: accumulated depreciation and amortization

     (37,125     (34,287
  

 

 

   

 

 

 

Net Property, Plant and Equipment

   $ 10,605      $ 10,367   
  

 

 

   

 

 

 

Depreciation and leasehold amortization expense for fixed assets was approximately $4.3 million, $4.4 million and $5.7 million for the years ended September 30, 2012, 2011 and 2012.

(9) Goodwill

The Company accounts for goodwill and other intangible assets according to ASC 350 Intangibles – Goodwill and Other (ASC 350) which requires that Alion review goodwill at least annually for impairment or more frequently if events or circumstances indicate goodwill might be impaired. The Company performs this review at the end of each fiscal year. As of September 30, 2012, Alion had approximately $398.9 million in goodwill. There were no changes to the goodwill carrying amount for the years ended September 30, 2011 and 2010, nor were there any significant events this quarter that indicated a potential impairment to goodwill as of September 30, 2012.

Alion operates in one segment and tests goodwill at the reporting unit level. Each of Alion’s two reporting units delivers a similar set of professional engineering, scientific and technical services to a wide array of federal government customers, principally within the Department of Defense. Each reporting unit provides the full range of services Alion offers to customers overall.

Alion’s management has organized reporting units based on managerial responsibility and administrative structure, contract portfolios, and the availability of discrete financial information. Management evaluates reporting unit financial performance based on contract revenue and non-GAAP operating income. Alion does not maintain reporting unit balance sheets and does not track cash flows by reporting unit.

Management identifies reporting units as “sectors” which in turn include lower level business units identified as “groups” consisting of still lower level “operations.” For each business combination, management assigned the goodwill arising from acquisitions to the reporting unit or units expected to benefit from the synergies of each business combination. Coincident with its goodwill determination and purchase price allocation, management assigned assets acquired to reporting units based on the unit or units anticipated to utilize such assets. Management did not allocate to reporting units the liabilities arising from business combinations. Alion’s reporting units are the Engineering and Integration Solutions Sector (EISS) and the Technology, Engineering and Operational Solutions Sector (TEOSS). Management assigned $197.0 million in goodwill to EISS and $201.9 million in goodwill to TEOSS.

In 2012, TEOSS had $435 million in contract revenue EISS had $386 million in contract revenue. In 2011, TEOSS had $437 million in contract revenue and EISS had $357 million in contract revenue. Total contract revenue for all reporting units exceeds Alion’s total reported revenue because reporting unit contract revenue does not include the effects of inter-company eliminations, discounts and GSA industrial funding fees that the Company does not track by reporting unit. These amounts were $3.9 million for fiscal 2012 and $6.8 million for 2011.

Management applied the guidance in ASC 350 and the related guidance in ASC Topic 280 Segment Reporting to analyze Alion’s reporting units to determine the appropriate level at which to test goodwill for potential impairment. The Company employs a reasonable, supportable and consistent method to assign goodwill to reporting units expected to benefit from the synergies arising from acquisitions. Alion determined reporting unit goodwill in a manner similar to the way it determines goodwill in a purchase allocation by using fair value to determine reporting unit purchase price, assets, liabilities and goodwill. Reporting unit residual fair value after this allocation is the implied fair value of reporting unit goodwill. The Company allocates the goodwill related to acquisitions on a specific identification basis consistent with reporting unit structure.

 

58


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company performs its own independent analysis to determine whether goodwill is potentially impaired. Management performs a discounted cash flow analysis and uses market-multiple-based analyses to estimate the enterprise fair value of Alion and its reporting units and the fair value of reporting unit goodwill in order to test goodwill for potential impairment. Management independently determines the rates and assumptions it uses to: perform its goodwill impairment analysis; assess the probability of future contracts and revenue; and evaluate the recoverability of goodwill. At September 2012, executed contract backlog was approximately 2.9 times trailing twelve month revenue. Executed backlog at September 2011 was 3.3 times trailing twelve month revenue based on lower volume last year.

Alion’s cash flow analysis depends on several significant management inputs and assumptions. Management uses observable inputs, rates and assumptions generally consistent with those used by the independent third party to prepare the valuation report for the ESOP Trustee. However, management’s sensitivity analyses also incorporated a more conservative range of growth assumptions in addition to assumptions generally consistent with those used by the independent third party to prepare the valuation report for the ESOP Trust. Management’s cash flow analysis includes the following significant inputs and assumptions: estimated future revenue and revenue growth; estimated future operating margins and EBITDA; observable market multiples for comparable companies; and a discount rate consistent with a market-based weighted average cost of capital. Management includes EBITDA in its analysis in order to use publicly available valuation data.

In Alion’s most recent impairment testing in 2012, market multiples for trailing twelve month EBITDA for comparable companies (publicly traded professional services government contractors) ranged from a low of 5.6 to a high of 18.2, with a median value of 12.8. Market multiples for trailing twelve month revenue ranged from a low of 0.3 to a high of 3.02, with a median value of 1.32. Management based its goodwill impairment testing valuation on discounted cash flows, and revenue and EBITDA multiples. Management discounted median market multiples by 14%-40% to reflect Alion’s recent financial performance compared to its peers and the significant uncertainties in the professional services government contracting marketplace likely to adversely affect future financial performance. Management used a weighted average cost of capital rate of 12.5% derived from market-based inputs, the tax-effected interest cost of Alion’s outstanding debt and a hypothetical market participant capital structure. Management estimates future years’ EBITDA based on Alion’s historical adjusted EBITDA as a percentage of revenue. To the extent that management’s analysis included forecasts of future revenue growth, management based such estimates on existing contract backlog, recent contract wins, current year performance and new business opportunities. Management analyzed goodwill for impairment using a range of near-term growth values of 0-1% and a range of 0-2% for longer-term out year forecasts.

Prior year market multiples for trailing twelve month EBITDA for comparable professional services government contractors ranged from a low of 10.9 to a high of 20.8 with a median value of 14.1. Prior year market multiples for trailing twelve month revenue ranged from a low of 1.02 to a high of 2.30, with a median value of 1.36. The prior year weighted average cost of capital rate was 13.0% derived from market-based inputs, the tax-effected interest cost of Alion’s outstanding debt and a hypothetical market participant capital structure. Last year management discounted median market multiples by up to 22% to reflect Alion’s lower EBITDA margins compared to its peer group. Last year, management analyzed goodwill for impairment using a range of near-term growth values of 5-8% and a range of 0-3% for longer-term out year forecasts. The Company does not allocate general corporate debt obligation to reporting units.

There were no changes to the methods used to evaluate goodwill in prior periods. Changes in one or more inputs could materially alter the calculation of Alion’s enterprise fair value and thus the Company’s determination of whether its goodwill is potentially impaired. A hypothetical 10% increase or decrease in the weighted average cost of capital rate at September 30, 2012, would have produced a corresponding approximate 5% decrease or increase in estimated enterprise value. Alion’s enterprise value based on EBITDA multiples from mergers and acquisitions in the government services market place was approximately 34% higher than discounted cash flow enterprise value at September 30, 2012.

Management reviews the Company’s internally-computed enterprise fair value to confirm the reasonableness of the internal analysis and compares the results of its independent analysis with the results of the independent third party valuation report prepared for the ESOP Trustee. Management compares each reporting unit’s carrying amount to its estimated fair value. If a reporting unit’s carrying value exceeds its estimated fair value, the Company compares the reporting unit’s goodwill carrying amount with the corresponding implied fair value of its goodwill. If the carrying amount of reporting unit goodwill exceeds its fair value, the Company recognizes an impairment loss to the extent that the carrying amount of goodwill exceeds implied fair value. Alion performs impairment testing on an enterprise value basis as there is no public market for the Company’s common stock.

 

59


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Management determined that, on an enterprise value basis, Alion’s reporting units have positive carrying value. In reviewing its discounted cash flow analysis prepared for testing goodwill for potential impairment, management considered macroeconomic and other conditions such as:

 

   

the deterioration in general economic conditions arising from federal budget deficits;

 

   

Defense and aerospace industry and market concerns about the effects of sequestration and federal budget deficits on future Department of Defense procurement actions;

 

   

Alion’s credit rating and its potential for limiting future access to capital;

 

   

An increase in market risks

 

   

A lower discount rate for valuing estimated future cash flows;

 

   

A decline in market-dependent multiples and metrics in both absolute terms and for Alion relative to its peers;

 

   

Alion’s current year sales increase compared to last year; and

 

   

Alion’s success in obtaining $833 million of additional customer contract funding and new contracts in the past six months.

Alion completed its most recent goodwill impairment analysis in the fourth quarter of fiscal year 2012 and concluded no goodwill impairment existed as of September 30, 2012. Management determined the totality of events and circumstances would not have supported a decision to roll forward its prior year goodwill impairment analysis and avoid performing a step one goodwill impairment analysis. Management chose to perform a step one analysis which supported a lower enterprise value for Alion as of September 2012 compared to September 2011. September 2012 estimated discounted future cash flows declined 11% compared to September 2011. The estimated fair value of Alion’s outstanding debt increased approximately seven percent from September 2011 to September 2012. As a result of changes in Alion’s estimated enterprise fair value, the estimated fair value of Alion’s outstanding redeemable common stock declined approximately 21% from September 2011 to September 2012.

As of September 30, 2012, the estimated fair value of each reporting unit substantially exceeded its carrying value. Consistent with prior years’ disclosures, the decline in discounted cash flows for 2012 compared to 2011 did not result in an impairment to goodwill. The results of Alion’s step one impairment testing make it unlikely that a reasonably probable change in assumptions would have triggered an impairment. A hypothetical 10% decrease in fair value would not have resulted in impairment to goodwill for any reporting unit or triggered the need to perform additional step two analyses for any reporting unit.

(10) Intangible Assets

The Company accounts for intangible assets according to ASC 350 Intangibles – Goodwill and Other. Intangible assets include contracts acquired through the Anteon and JJMA transactions and internally-developed software and engineering designs. The table below shows the components of intangible assets as of September 30, 2012 and 2011.

 

     September 30, 2012      September 30, 2011  
            Accumulated                   Accumulated        
     Gross      Amortization     Net      Gross      Amortization     Net  

Purchased contracts

   $ 111,635       $ (106,935   $ 4,700       $ 111,635       $ (100,864   $ 10,771   

Internal use software and engineering designs

     3,182         (2,640     542         3,182         (2,219     963   
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total

   $ 114,817       $ (109,575   $ 5,242       $ 114,817       $ (103,083   $ 11,734   
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

The weighted-average remaining amortization period of intangible assets was approximately three years at September 30, 2012. Amortization expense was approximately $6.5 million, $7.0 million and $11.0 million for the years ended September 30, 2012, 2011 and 2010. Estimated aggregate amortization expense for the next five years and thereafter is as follows.

 

60


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Fiscal year ending

September 30,

   (In thousands)  

2013

   $ 3,202   

2014

     1,079   

2015

     736   

2016

     141   

2017

     51   

Thereafter

     33   
  

 

 

 
   $ 5,242   
  

 

 

 

(11) Long-Term Debt

Alion’s current debt structure includes a $35 million revolving credit facility, $323.3 million in Secured Notes ($310 million in initial face value plus $13.3 million in PIK interest notes issued) and $245 million of Unsecured Notes. The Company is in compliance with each of the affirmative and negative financial and non-financial covenants in its existing debt agreements.

Credit Agreement

In March 2010, Alion entered into an agreement for a $25.0 million senior revolving credit facility that matures August 2014 (Credit Agreement). In March 2011, Alion and its lenders amended the Credit Agreement increasing the credit limit to $35 million. In August 2011, Alion and its lenders amended the Credit Agreement to revise the definition of Consolidated EBITDA and increase the Minimum Consolidated EBITDA covenant. In December 2012, Alion and its lenders amended the Credit Agreement to increase the maximum fees the Company is permitted to pay outside directors and to retroactively waive non-compliance with the former limitation in the Credit Agreement. The Company can use its credit facility for working capital, permitted acquisitions and general corporate purposes, including up to $35.0 million in letters of credit and up to $5.0 million in short-term swing line loans. As of September 30, 2012, the Company had $4.0 million in outstanding letters of credit and no balance actually drawn.

Security. The Credit Agreement is secured by a first priority security interest in all current and future tangible and intangible property of Alion and its guarantor subsidiaries, IPS, CATI, METI, JJMA, BMH, WCI, WCGS, MA&D and Alion International Corporation. In March 2010 Alion and the subsidiary guarantors entered into an Intercreditor Agreement with Wilmington Trust Company and Credit Suisse AG, Cayman Islands Branch to grant Credit Agreement lenders a super priority right of payment with respect to the underlying collateral. Credit Agreement lenders’ rights are superior to Secured Note holders’ rights.

Guarantees. Alion’s Credit Agreement obligations are guaranteed by its subsidiaries, IPS, CATI, METI, JJMA, BMH, WCI, WCGS, MA&D and Alion International Corporation. These subsidiaries also guarantee all the Company’s Secured Note and Unsecured Note obligations (described below).

Interest and Fees. Alion can choose whether the Credit Agreement loans bear interest at one of two floating rates using either a Eurodollar rate or an alternative base rate. The minimum interest rate is 8.5%. The minimum Eurodollar interest rate is 2.5% plus 600 basis points. The minimum alternate base rate is 3.5% plus 500 basis points.

Other Fees and Expenses. Each quarter Alion pays a commitment fee of 175 basis points per year on the prior quarter’s daily unused Credit Agreement balance. The Company paid approximately $559 thousand and $532 thousand in commitment fees for the years ended September 30, 2012 and 2011.

Alion pays letter-of-credit issuance and administrative fees, and up to a 25 basis point fronting fee and interest in arrears each quarter on all outstanding letters of credit. The interest rate is based on the Eurodollar loan rate which was 6.0% as of September 30, 2012. The Company also pays an annual agent’s fee.

Covenants. The Credit Agreement requires Alion to achieve minimum trailing twelve month Consolidated EBITDA levels which increase over the life of the agreement. The table below sets out the required minimum for the remaining life of the Credit Agreement.

 

61


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Period

   Minimum Consolidated EBITDA  

October 1, 2011 through September 30, 2012

   $ 60.5 million   

October 1, 2012 through September 30, 2013

   $ 63.0 million   

October 1, 2013 through August 22, 2014

   $ 65.5 million   

The Credit Agreement defines Consolidated EBITDA as net income or loss in accordance with GAAP, plus the following items, without duplication, to the extent deducted from or included in net income or loss:

 

   

consolidated interest expense;

 

   

provision for income taxes;

 

   

depreciation and amortization;

 

   

cash contributed to the ESOP in respect of Alion’s repurchase liability;

 

   

non-cash stock-based and incentive compensation expense;

 

   

non-cash ESOP contributions;

 

   

employee compensation expense payments invested in Alion common stock;

 

   

any extraordinary losses; and

 

   

nonrecurring charges and adjustments included in ESOP valuation reports as prepared by an independent third party.

To the extent included in net income or loss, the following items, without duplication, are deducted in determining Consolidated EBITDA:

 

   

all cash payments on account of reserves, restructuring charges or other cash and non-cash charges added to net income pursuant to the list above in a previous period;

 

   

any extraordinary gains; and

 

   

all non-cash items of income.

The Credit Agreement restricts us from doing any of the following without the prior consent of syndicate lenders that extended more than 50 percent of the aggregate amount of all Credit Agreement loans then outstanding:

 

   

incur additional debt other than permitted additional debt;

 

   

grant certain liens and security interests;

 

   

enter into sale and leaseback transactions;

 

   

make certain loans and investments including acquisitions of businesses, other than permitted acquisitions;

 

   

consolidate, merge or sell all or substantially all our assets;

 

   

pay dividends or distributions other than distributions required by the ESOP Plan or by certain legal requirements;

 

   

make certain payments for subordinated indebtedness;

 

   

enter into certain transactions with our shareholders and affiliates;

 

   

enter into agreements which restrict our ability to incur liens or which restrict the ability of our subsidiaries to pay dividends

 

   

change lines of business;

 

   

repay subordinated debt before it is due;

 

   

redeem or repurchase certain equity;

 

   

enter into certain transactions not permitted under ERISA;

 

   

change the terms of our other indebtedness or our KSOP in a way materially disadvantageous to us;

 

   

make more than $8 million in capital expenditures in any fiscal year;

 

   

pay certain earn-outs in connection with permitted acquisitions; or

 

   

change our fiscal year.

The Credit Agreement contains customary events of default including, without limitation:

 

62


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

   

breach of representations and warranties;

 

   

payment default;

 

   

uncured covenant breaches;

 

   

default under certain other debt exceeding an agreed amount;

 

   

bankruptcy and certain insolvency events;

 

   

incurrence of a civil or criminal liability in excess of $5 million of Alion or any subsidiary arising from a government investigation;

 

   

unstayed judgments in excess of an agreed amount;

 

   

failure of any Credit Agreement guarantee to be in effect;

 

   

failure of the security interests to be valid, perfected, first priority security interests in the collateral;

 

   

notice of debarment, suspension or termination under a material government contract;

 

   

actual termination of a material contract due to alleged fraud, willful misconduct, negligence, default or any other wrongdoing;

 

   

certain uncured defaults under our material contracts;

 

   

certain ERISA violations;

 

   

imposition on the ESOP Trust of certain taxes in excess of an agreed amount;

 

   

final determination the ESOP is not a qualified plan;

 

   

so long as any Secured Notes remain outstanding, the Intercreditor Agreement shall fail to be effective;

 

   

a borrowing which would cause us to exceed a certain cash balance limit;

 

   

Failure to provide within 90 days of fiscal year-end, consolidated, comparative financial statements audited by an independent public accountant of recognized national standing with an opinion of such accountant that shall not include a “going concern” explanatory note or similar limitation, or

 

   

a change of control (as defined below).

Under the Credit Agreement a change of control generally occurs when, before Alion lists its common stock to trade on a national securities exchange and obtains at least $35 million in net proceeds from an underwritten public offering, the ESOP Trust fails to own at least 51 percent of Alion’s outstanding equity interests, or, after such a qualified public offering, any person or group other than the ESOP Trust owns more than 37.5 percent of Alion’s outstanding equity interests. A change of control may also occur if a majority of the seats (other than vacant seats) on Alion’s Board of Directors shall at any time be occupied by persons who were neither nominated by the board nor were appointed by directors so nominated. A change of control may also occur if a change of control occurs under any of Alion’s material debt including the Secured and Unsecured Note Indentures.

Alion depends heavily on federal government contracts; delays in the federal budget process, reduced federal spending, budget cuts, sequestration and fiscal and political uncertainties could adversely affect Alion’s revenue for the coming fiscal year. Despite uncertainties in the government contracting professional services marketplace, particularly the prospect of sequestration and/or Department of Defense programmatic and budgetary cuts, management believes Alion will be able to generate sufficient revenue and EBITDA in the coming twelve months and the Company will be able to comply with financial and non-financial covenants in the Credit Agreement.

If Alion were unable to meet a Credit Agreement covenant because of a revenue shortfall or for any other reason, the Company could seek a covenant waiver or seek to negotiate a Credit Agreement amendment. Management can provide no assurance that Alion would be able to obtain a requested covenant waiver or amend the Credit Agreement on favorable terms.

Secured Notes

In March 2010, Alion issued and sold $310 million of its private units (Units) to Credit Suisse, which informed the Company it had resold most of the Units to qualified institutional buyers. Each of the 310,000 Units consisted of $1,000 in face value of Alion’s private 12% senior secured notes (Secured Notes) and a warrant to purchase 1.9439 shares of Alion common stock. On September 2, 2010, Alion exchanged the private Secured Notes for publicly tradable Secured Notes with the same terms.

Security. The Secured Notes are secured by a first priority security interest in all current and future tangible and intangible property of Alion and its guarantor subsidiaries, IPS, CATI, METI, JJMA, BMH, WCI, WCGS, MA&D and Alion International Corporation. The Secured Notes are senior obligations of Alion and rank pari passu in right of payment with existing and future senior debt, including the Credit Agreement, except to the extent that the Intercreditor Agreement provides Credit Agreement lenders with a super priority right of payment with respect to the underlying collateral.

 

63


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Guarantees. The Company’s obligations under the Secured Notes are guaranteed by the Company’s subsidiaries, IPS, CATI, METI, JJMA, BMH, WCI, WCGS, MA&D and Alion International Corporation.

Interest and Fees. The Secured Notes bear interest at 12% per year; 10% is payable in cash and 2% increases the Secured Note principal (PIK Interest). Interest is payable semi-annually in arrears on May 1 and November 1. Alion pays interest to holders of record as of the immediately preceding April 15 and October 15. The Company must pay interest on overdue principal or interest at 13% per annum to the extent lawful. The Secured Notes mature November 1, 2014.

Covenants. As of September 30, 2012, Alion was in compliance with the covenants set forth in the Indenture governing its 12% Secured Notes (Secured Note Indenture). The Secured Note Indenture does not contain any financial covenants.

A Secured Note Indenture covenant restricts our ability to incur additional debt. Defined terms in the Secured Note Indenture include: Net Available Cash, Total Assets, Restricted Subsidiaries, Indebtedness, Adjusted EBITDA and Consolidated Interest Expense. Alion and its Restricted Subsidiaries may not issue, incur, assume, guarantee, or otherwise become liable for any debt unless our Adjusted EBITDA to Consolidated Interest Expense ratio is greater than 2.0 to 1.0. Adjusted EBITDA under the Secured Note Indenture differs from Consolidated EBITDA as defined in our Credit Agreement. Adjusted EBITDA is less than Consolidated EBITDA because it does not include employee investments in Alion common stock. Our ratio of Adjusted EBITDA ($69.3 million) to Consolidated Interest Expense ($74.9 million) was 0.93 to 1.0 as of September 30, 2012 and 0.81 to 1.0 as of September 30, 2011 ($60.1 million in Adjusted EBITDA to $73.9 million in Consolidated Interest Expense). Even if Adjusted EBITDA is not at least two times Consolidated Interest Expense, we may incur other permitted debt including:

 

   

debt pursuant to certain agreements up to $25 million;

 

   

permitted inter-company debt;

 

   

the Secured Notes and any public notes exchanged for those notes;

 

   

debt pre-dating the Secured Notes;

 

   

permitted debt of acquired subsidiaries;

 

   

permitted refinancing debt;

 

   

hedging agreement debt;

 

   

performance, bid, appeal and surety bonds and completion guarantees;

 

   

ordinary course insufficient funds coverage;

 

   

permitted refinancing debt guarantees;

 

   

working capital debt of non-U.S. subsidiaries;

 

   

debt for capital expenditures, and capital and synthetic leases up to $25 million in the aggregate and 2.5% of Alion’s Total Assets;

 

   

permitted subordinated debt of Alion or any Restricted Subsidiary to finance a permitted acquisition, certain permitted ESOP transactions and refinancing debt of acquired non-U.S. subsidiaries up to $35 million in the aggregate;

 

   

letter of credit reimbursement obligations;

 

   

certain agreements in connection with a business disposition provided liabilities incurred in connection therewith do not exceed the cash and non-cash proceeds received and are not reflected on the Company’s balance sheet;

 

   

certain deferred compensation agreements; and

 

   

certain other debt up to $20 million.

The Secured Note Indenture has a covenant that restricts our ability to declare and pay any cash dividend or other distribution related to any equity interest in Alion, repurchase or redeem any equity interest of Alion, repurchase or redeem the Unsecured Notes or other subordinated debt, or make certain investments. However, within certain limits we may make such payments in limited amounts if Adjusted EBITDA is at least two times Consolidated Interest Expense. Even if Adjusted EBITDA to Consolidated Interest Expense is not greater than 2.0 to 1.0, we may make or pay:

 

   

such payments out of substantially concurrent contributions of equity and substantially concurrent incurrences of permitted debt;

 

64


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

   

certain limited and permitted dividends;

 

   

certain repurchases of the Company’s equity securities deemed to occur upon exercise of stock options or warrants;

 

   

cash payments in lieu of the issuance of fractional shares in connection with the exercise of warrants, options or other securities convertible into or exchangeable for our equity securities;

 

   

the required Secured Note premium payable on a change of control;

 

   

certain permitted inter-company subordinated obligations;

 

   

certain repurchases and redemptions of subordination obligations of the Company or a Subsidiary Guarantor from Net Available Cash (as defined in the Secured Note Indenture);

 

   

repurchases of subordinated obligations in connection with an asset sale to the extent required by the Secured Note Indenture;

 

   

certain permitted ESOP transactions;

 

   

long-term incentive plan payments to our directors, officers and employees, subject to a $3 million annual cap that may increase annually;

 

   

any purchase, repurchase, redemption, defeasance or other acquisition or retirement for value of the Unsecured Notes, up to an aggregate amount of $10 million; and

 

   

certain other payments not exceeding $10 million in the aggregate.

The Secured Note Indenture restricts our ability to engage in other transactions including restricting our subsidiaries from making distributions and paying dividends to parents, merging or selling all or substantially all our assets, issuing certain subsidiary equity securities, engaging in certain transactions with affiliates, incurring liens, entering into sale lease-back transactions and engaging in business unrelated to our business when we issued the Secured Notes.

Events of Default. The Secured Note Indenture contains customary events of default, including:

 

   

payment default on interest obligations when due;

 

   

payment default on principal at maturity;

 

   

uncured covenant breaches;

 

   

default under an acceleration of certain other debt exceeding $30 million;

 

   

bankruptcy and certain insolvency events;

 

   

judgment for payment in excess of $30 million entered against the Company or any material subsidiary that remains outstanding for a period of 60 days and is not discharged, waived or stayed;

 

   

failure of any Secured Note guarantee to be in effect or any subsidiary guarantor’s denial or disaffirmation of its guaranty obligations; and

 

   

failure of any Secured Note security interest to constitute a valid and perfected lien with its applicable priority after a permitted cure period.

Change of Control. Upon a change in control, each Secured Note holder has the right to require Alion repurchase its notes in cash for 101% of principal plus accrued and unpaid interest. Any of the following events constitutes a change in control:

 

   

subject to certain exceptions, a person, other than the ESOP Trust, is or becomes the beneficial owner, directly or indirectly, of more than 35% of the total voting power or voting stock of Alion;

 

   

individuals who constituted Alion’s board of directors on March 22, 2010, (or individuals who were elected or nominated by them, or directors subsequently nominated or elected by them) cease for any reason to constitute a majority of the Company’s board of directors;

 

   

the adoption of a plan relating to Alion’s liquidation or dissolution; and

 

   

subject to certain exceptions, the merger or consolidation of the Company with or into another person or the merger of another person with or into the Company, or the sale of all or substantially all the assets of Alion to another person.

Optional Redemption. Prior to April 1, 2013, not more than once in any twelve month period, we may redeem up to $31 million of Secured Notes at a redemption price of 103% of the principal amount of the Secured Notes redeemed, plus accrued and unpaid interest to the redemption date. Prior to April 1, 2013, the Company may redeem all, but not less than all, of the Secured Notes at a redemption price equal to 100% of the principal amount of the Secured Notes plus accrued and unpaid interest to the redemption date plus an applicable make-whole premium as of the redemption date.

 

65


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

In addition, any time prior to April 1, 2013, subject to certain conditions, the Company may use the proceeds of a qualified equity offering to redeem Unsecured Notes in an aggregate principal amount not to exceed $108.5 million at a redemption price equal to the sum of 112% of the aggregate principal amount of the notes actually redeemed, plus accrued and unpaid interest to the redemption date.

On or after April 1, 2013, the Company may redeem all or a portion of the Secured Notes at the redemption prices set forth below (expressed in percentages of principal amount on the redemption date), plus accrued and unpaid interest to the redemption date, if redeemed during the periods set forth below:

 

Period

   Redemption Price  

April 1, 2013 to September 30, 2013

     105.0

October 1, 2013 to March 31, 2014

     103.0

April 1, 2014 and thereafter

     100.0

Unsecured Notes

In February 2007, Alion issued and sold $250.0 million of its private 10.25% senior unsecured notes due February 1, 2015 (Unsecured Notes) to Credit Suisse, which informed the Company it had resold most of the notes to qualified institutional buyers. In June 2007, Alion exchanged the private Unsecured Notes for publicly tradable Unsecured Notes with the same terms. IPS, CATI, METI, JJMA, BMH, WCI, WCGS, MA&D and Alion International Corporation guarantee the Unsecured Notes. In November 2010, Alion repurchased $2 million of the Unsecured Notes. In June 2011, Alion repurchased another $3 million of Unsecured Notes.

Interest and Fees. The Unsecured Notes bear interest at 10.25% per year, payable semi-annually in arrears on February 1 and August 1. Alion pays interest to holders of record as of the immediately preceding January 15 and July 15. The Company must pay interest on overdue principal or interest at 11.25% per annum to the extent lawful.

Covenants. There are no financial covenants in the Unsecured Note Indenture. As of September 30, 2012, we were in compliance with Unsecured Note Indenture non-financial covenants.

A covenant in the Unsecured Note Indenture restricts our ability to incur additional debt. Defined terms in the Unsecured Note Indenture include: Net Available Cash, Total Assets, Restricted Subsidiaries, Indebtedness, Adjusted EBITDA and Consolidated Interest Expense. Alion and its Restricted Subsidiaries may not issue, incur, assume, guarantee, or otherwise become liable for any indebtedness unless our Adjusted EBITDA to Consolidated Interest Expense ratio is greater than 2.0 to 1.0. Adjusted EBITDA under the Unsecured Note Indenture differs from Consolidated EBITDA as defined in our Credit Agreement. Adjusted EBITDA is less than Consolidated EBITDA because it does not include employee investments in Alion common stock. Our ratio of Adjusted EBITDA ($69.3 million) to Consolidated Interest Expense ($74.9 million) was 0.93 to 1.0 as of September 30, 2012 and 0.81 to 1.0 as of September 30, 2011 ($60.1 million in Adjusted EBITDA to $73.9 million in Consolidated Interest Expense). Even if Adjusted EBITDA is not at least two times Consolidated Interest Expense, we may incur other permitted debt including:

 

   

debt pursuant to our now terminated Term B Credit Facility and certain other contracts up to $360 million less principal repayments made under that indebtedness;

 

   

permitted inter-company debt;

 

   

the Unsecured Notes;

 

   

debt pre-dating the Unsecured Notes;

 

   

permitted debt of acquired subsidiaries;

 

   

permitted refinancing debt;

 

   

hedging agreement debt;

 

   

performance, bid, appeal and surety bonds and completion guarantees;

 

   

ordinary course insufficient funds coverage;

 

   

permitted refinancing debt guarantees;

 

   

working capital debt of non-U.S. subsidiaries;

 

   

debt for capital expenditures, capital and synthetic leases up to $25 million in the aggregate and 2.5% of Alion’s Total Assets;

 

66


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

   

permitted subordinated debt of Alion or any Restricted Subsidiary to finance a permitted acquisition, certain permitted ESOP transactions and refinancing debt of acquired non-U.S. subsidiaries up to $35 million in the aggregate;

 

   

letters of credit reimbursement obligations;

 

   

certain agreements in connection with the disposition of a business provided liabilities incurred in connection therewith do not exceed the cash and non-cash proceeds received and are not reflected on the Company’s balance sheet;

 

   

certain deferred compensation agreements; and

 

   

certain other debt up to $35 million.

The Unsecured Note Indenture has a covenant that restricts our ability to declare and pay any cash dividend or other distribution with regard to any equity interest in the Company, make any repurchase or redemption of any equity interest in Alion, repurchase or redeem subordinated debt, and make certain investments. However, within certain limits we may make such payments in limited amounts if Adjusted EBITDA is at least two times Consolidated Interest Expense. Even if Adjusted EBITDA to Consolidated Interest Expense is not greater than 2.0 to 1.0, we may make or pay:

 

   

such payments out of substantially concurrent contributions of equity and substantially concurrent incurrences of permitted debt;

 

   

certain limited and permitted dividends;

 

   

certain repurchases of the Company’s equity securities deemed to occur upon exercise of stock options or warrants;

 

   

cash payments in lieu of the issuance of fractional shares for the exercise of warrants, options or other securities convertible into or exchangeable for our equity securities;

 

   

the required Unsecured Note premium payable on a change of control;

 

   

certain permitted inter-company subordinated obligations;

 

   

certain repurchases and redemptions of subordination obligations of the Company or a Subsidiary Guarantor from Net Available Cash;

 

   

repurchases of subordinated obligations in connection with an asset sale to the extent required by the Indenture;

 

   

repurchase of common stock from former Alion Joint Spectrum Center employees;

 

   

certain permitted transactions with the ESOP not exceeding $25 million in the aggregate; and

 

   

certain other payments not exceeding $30 million in the aggregate.

The Unsecured Note Indenture restricts the Company’s ability to engage in other transactions including restricting our subsidiaries from making distributions and paying dividends to parents, merging or selling all or substantially all our assets, issuing certain subsidiary equity securities, engaging in certain transactions with affiliates, incurring liens, entering into sale lease-back transactions and engaging in business unrelated to our business when we issued the Unsecured Notes.

Events of Default. The Unsecured Note Indenture contains customary events of default, including:

 

   

payment default on interest obligations when due;

 

   

payment default on principal at maturity;

 

   

uncured covenant breaches;

 

   

default under an acceleration of certain other debt exceeding $30 million;

 

   

certain bankruptcy and insolvency events;

 

   

judgment for payment in excess of $30 million entered against the Company or any material subsidiary that remains outstanding for a period of 60 days and is not discharged, waived or stayed; and

 

   

failure of any Unsecured Note guarantee or any subsidiary guarantor’s denial or disaffirmation of its guaranty obligations.

Change of Control. Upon a change in control, each Unsecured Note holder has the right to require Alion repurchase its notes in cash for 101% of principal plus accrued and unpaid interest. Any of the following events constitutes a change in control:

 

   

subject to certain exceptions, a person, other than the ESOP Trust, is or becomes the beneficial owner, directly or indirectly, of more than 35% of the total voting power or voting stock of Alion;

 

67


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

   

individuals who constituted Alion’s board of directors on February 8, 2007, (or individuals who were elected or nominated by them, or individuals who were elected or nominated by them) cease for any reason to constitute a majority of the Company’s board of directors;

 

   

adoption of a plan relating to Alion’s liquidation or dissolution; and

 

   

subject to certain exceptions, Alion’s merger or consolidation with or into another person or the merger of another person with or into Alion, or the sale of all or substantially all our assets to another person.

Optional Redemption. We may redeem all or a portion of the Unsecured Notes at the redemption prices set forth below (expressed in percentages of principal amount on the redemption date), plus accrued and unpaid interest to the redemption date, if redeemed during the 12-month period commencing on February 1 of the years set forth below:

 

68


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Period

   Redemption Price  

2012

     102.563

2013 and thereafter

     100.000

Interest Payable

As of September 30, 2012 and 2011 interest payable consisted of the following amounts.

 

     September 30,  
     2012      2011  
     (In thousands)  

Unsecured Notes

   $ 4,188       $ 4,187   

Secured Notes

     13,470         13,205   
  

 

 

    

 

 

 

Total

   $ 17,658       $ 17,392   
  

 

 

    

 

 

 

Retired Term B Senior Credit Agreement

In August 2004, Alion entered into the Term B Senior Credit Agreement with a syndicate of financial institutions. The Company borrowed and re-paid various sums over the life of the loan. As of March 22, 2010, the Term B Senior Credit Agreement consisted of a $236.0 million senior term loan, a $25.0 million senior revolving credit facility with no balance actually drawn, and approximately $4.0 million in accrued interest payable. On March 22, 2010, the Company used proceeds from issuing the Secured Notes to redeem and retire all amounts outstanding under the Term B Senior Credit Agreement including all accrued and unpaid interest. Alion recognized a $6.9 million loss on extinguishing the Term B loans.

As a cost of the consents and waivers the Company obtained from its lenders in September and December 2009, the annual interest rate on the outstanding Term B loan balances increased by 100 basis points on February 1, 2010 and the Company paid the Term B lenders a 100 basis point penalty on March 1, 2010.

Retired Subordinated Note

In December 2002, Alion issued a $39.9 million Subordinated Note to IITRI as part of the purchase price for substantially all of IITRI’s assets. In July 2004, IIT acquired the Subordinated Note and related warrant agreement from IITRI. Over the life of the Subordinated Note, IIT and Alion amended its terms to adjust interest accrual rates, timing and payments and to revise the loan amortization schedule.

Through December 2008, Subordinated Note interest was payable quarterly in arrears by issuing paid-in-kind (PIK) notes maturing at the same time as the Subordinated Note. Beginning December 2008, interest was payable at 10% for PIK notes and 6% in cash with all notes due August 2013. On December 21, 2009, IIT agreed to sell Alion the Subordinated Note and warrants for $25 million and to defer Alion’s January 2010 interest payment to April 2010.

On March 22, 2010, the Company used $25 million of proceeds from issuing the Secured Notes to redeem the Subordinated Note and related warrants recognizing a $57.6 million debt extinguishment gain. The Subordinated Note had an aggregate carrying value of $50.0 million ($60.1 million of principal, PIK and accrued interest net of $10.1 million in unamortized debt issue and loan modification costs). The warrants had an estimated fair value of $32.6 million. Alion was not required to make the deferred January interest payment and de-recognized the related interest expense.

 

69


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

As of September 30, 2012, Alion must make the following principal repayments (at face amount before debt discount) for its outstanding debt.

 

     2013      2014      2015      Total  
     (In thousands)  

Secured Notes and PIK Interest (1)

   $ —         $ —         $ 339,788       $ 339,788   

Unsecured Notes (2)

        —           245,000         245,000   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Principal Payments

   $ —         $ —         $ 584,788       $ 584,788   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

1. The Secured Notes due November 2014 include $310 million of debt issued in March 2010 and an estimated $29.8 million in PIK interest added to principal over the life of the notes. As of September 30, 2012, the $306.5 million carrying value on the face of the balance sheet included $310 million in principal, $13.3 million in PIK notes issued; $2.7 million in accrued PIK interest and is net of $19.5 million in aggregate unamortized debt issue costs. Initial debt issue costs consist of $7.7 million in original issue discount, $13.5 million in third-party costs and $20.8 million for the Secured Note warrants’ initial fair value.
2. The Unsecured Notes on the face of the balance sheet include $245 million in principal and $2.1 million in unamortized debt issue costs as of September 30, 2012 (initially $7.1 million).

(12) Fair Value Measurement

Alion applies ASC 820 – Fair Value Measurements and Disclosures in determining the fair value to be disclosed for financial and nonfinancial assets and liabilities on a recurring or nonrecurring basis. The Company has no assets or liabilities, other than its redeemable common stock, which it is required to report at fair value. Valuation techniques utilized in the fair value measurement of assets and liabilities for each period presented were unchanged from previous practice.

ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. It establishes a fair value hierarchy and a framework which requires categorizing assets and liabilities into one of three levels based on the assumptions (inputs) used in valuing the asset or liability. Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. Level 1inputs are unadjusted, quoted market prices in active markets for identical assets or liabilities. Level 2 inputs are observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets. Level 3 inputs include unobservable inputs that are supported by little, infrequent, or no market activity and reflect management’s own assumptions about inputs used in pricing the asset or liability. The Company uses the following valuation techniques to measure fair value.

Level 1 primarily consists of financial instruments, such as overnight bank re-purchase agreements or money market mutual funds whose value is based on quoted market prices published by a financial institution, an exchange fund, exchange-traded instruments and listed equities.

Level 2 assets include U.S. Government and agency securities whose valuations are based on market prices from a variety of industry-standard data providers or pricing that considers various assumptions, including time value, yield curve, volatility factors, credit spreads, default rates, loss severity, current market and contractual prices for the underlying instruments, and broker and dealer quotes. All are observable in the market or can be derived principally from or corroborated by observable market data for which the Company can obtain independent external valuation information.

Level 3 consists of unobservable inputs. The Company’s former Subordinated Note warrants were classified as Level 3 liabilities. Assets and liabilities are considered Level 3 when their fair value inputs are unobservable or not available, including situations involving limited market activity, where determination of fair value requires significant judgment or estimation. Alion froze the estimated fair value of its Subordinated Note Warrants at their December 2009 reported value when the Company arranged to re-purchase the Subordinated Note and Warrants. In March 2010, the Company re-purchased the Subordinated Note and Warrants and de-recognized its December 2009 Subordinated Note Warrant liability.

 

70


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

In March 2010, Alion measured the fair value of the Secured Note warrants at issuance based on the $34.50 underlying estimated fair value of a share of Alion common stock as of September 2009, the then most-recent valuation selected by the ESOP Trustee and presented to the Board of Directors; a 3.39% risk-free U.S. Treasury interest rate for a comparable seven-year investment period and a 36% equity volatility factor based on the historical volatility of the common stock of publicly-traded companies considered to be comparable to Alion. The Secured Note warrants are classified as permanent equity and are carried at the historical date-of-issue fair value. As permanent equity, the value of the Secured Note warrants is not re-measured at future reporting dates.

The table below sets out the face value, net carrying value and fair value of Alion’s Secured and Unsecured Notes. The fair values disclosed below are based on quoted market prices for Alion’s outstanding notes.

 

     September 30, 2012     September 30, 2011  
     (In thousands)  
     Secured
Notes
    Unsecured
Notes
    Senior
Secured
Notes
    Senior
Unsecured
Notes
 

Face value of original notes outstanding

   $ 310,000      $ 245,000      $ 310,000      $ 245,000   

PIK interest notes issued

     13,293        —          6,920        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Face value of outstanding notes

   $ 323,293      $ 245,000      $ 316,920      $ 245,000   

PIK interest notes to be issued

     2,692        —          2,643        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Face value of notes outstanding and notes to be issued

   $ 325,985      $ 245,000      $ 319,563      $ 245,000   

Less: unamortized debt issue costs

     (19,483     (2,077     (28,560     (2,936
  

 

 

   

 

 

   

 

 

   

 

 

 

Carrying value

   $ 306,502      $ 242,923      $ 291,003      $ 242,064   
  

 

 

   

 

 

     

Fair value of outstanding notes

   $ 303,598      $ 141,605      $ 278,727      $ 140,982   
  

 

 

   

 

 

   

 

 

   

 

 

 

(13) Redeemable Common Stock Warrants

In December 2002, Alion issued 1,080,437 detachable, redeemable common stock warrants at an exercise price of $10.00 per share in connection with its now-extinguished $39.9 million Subordinated Note. The Company recognized approximately $7.1 million for the initial fair value of the warrants as original issue discount. Subordinated Note warrants were originally exercisable until December 2010.

In August 2008, Alion issued an additional 550,000 redeemable common stock warrants at an exercise price of $36.95 per share in connection with amending the Subordinated Note. The Company recognized approximately $10.3 million in debt issue costs for the fair value of the August 2008 warrants and amending the December 2002 warrants. Both sets of warrants were exercisable at the current fair value per share of Alion common stock, less their exercise price. On March 22, 2010, the Company retired the Subordinated Note and the related warrants for $25 million in total and recognized a net gain of $57.6 million.

In accordance with ASC 815 – Derivatives, Alion classified the Subordinated Note warrants as debt instruments indexed to and potentially settled in the Company’s own stock, not as equity. Alion used an option pricing model to estimate the fair value of its now-retired redeemable common stock warrants. Management considered the share price selected by the ESOP Trustee along with other factors, to assist in estimating the Company’s aggregate redeemable warrant liability. The Board of Directors’ Audit and Finance Committee reviewed the reasonableness of the warrant liability determined by management. The Audit and Finance Committee considered various factors in its review, including risk free interest rates, volatility of the common stock of comparable publicly-traded companies, and in part, the valuation report prepared for and the share price selected by the ESOP Trustee.

(14) Secured Note Common Stock Warrants

On March 22, 2010, Alion issued 310,000 Units. Each Unit consists of $1,000 of Secured Note face value and a warrant to purchase 1.9439 shares of Alion common stock. The Secured Note warrants entitle holders to purchase a total of 602,614 shares of Alion common stock. Each Secured Note warrant has an exercise price of a penny per share; the Secured Note warrants are not redeemable for cash.

 

71


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company registered the Secured Notes, but is not required to register the warrants. The Units separated into Secured Notes and warrants on June 22, 2010. Each warrant became exercisable on March 22, 2011 and expires on March 15, 2017.

The Secured Note warrants had an initial fair value of approximately $20.8 million based on Alion’s former share price of $34.50. Alion recognized the value of the warrants as part of the debt issue costs for the Secured Notes and recorded a corresponding credit to equity. The Company accounts for the Secured Note warrants as equity and reassesses this classification each reporting period. The Company identified no required changes in accounting treatment as of September 30, 2012.

(15) Leases

Future minimum lease payments under non-cancelable operating leases for buildings, equipment and automobiles at September 30, 2012 are set out below. Alion subleases some excess capacity under its operating leases to subtenants under non-cancelable operating leases.

 

Lease Payments for Fiscal Years Ending

   (In thousands)  

2013

   $ 25,974   

2014

     25,425   

2015

     24,925   

2016

     20,701   

2017

     17,253   

And thereafter

     33,560   
  

 

 

 

Gross lease payments

   $ 147,838   

Less: non-cancelable subtenant receipts

     (2,125
  

 

 

 

Net lease payments

   $ 145,713   
  

 

 

 

Composition of Total Rent Expense

 

     September 30,  
     2012     2011     2010  
     (In thousands)  

Minimum rentals

   $ 20,639      $ 21,992      $ 22,100   

Less: Sublease rental income

     (156     (1,610     (1,829
  

 

 

   

 

 

   

 

 

 

Total rent expense, net

   $ 20,483      $ 20,382      $ 20,271   
  

 

 

   

 

 

   

 

 

 

(16) Postretirement Benefits

Alion sponsors a postretirement plan providing medical, dental, and vision coverage to eligible former employees. The Company is self-insured with a stop-loss limit under an insurance agreement. The plan was closed to new participants in fiscal 2008. It provides benefits until age 65 for employees who met certain age and service requirements. Alion requires most participants to pay the full expected cost of benefits. A limited number of participants, eligible for coverage after age 65, contribute a lesser amount. As of September 30, 2012, the Company had recognized a $647 thousand unfunded plan liability. Alion paid $59 thousand, $48 thousand and $59 thousand in plan benefits for the years ended September 30, 2012, 2011, and 2010. Participants contributed $12 thousand, $18 thousand and $20 thousand for the years ended September 30, 2012, 2011, and 2010.

(17) ESOP Expense

Alion makes 401(k) matching contributions in shares of its redeemable common stock. The Company matches the first 3% and one-half of the next 2% of eligible employee salary deferrals by contributing shares of Alion common stock to the ESOP Trust on March 31 and September 30 each year. The Company also makes profit sharing contributions of Alion common stock to the ESOP Trust on the same dates. Through June 2011, Alion contributed 1% of eligible employee compensation in common stock to the ESOP Trust and 1.5% of eligible employee compensation in cash to the 401(k) component. As of July 2011, profit sharing contributions of 2.5% of eligible employee compensation are entirely in shares of Alion common stock.

 

72


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Alion recognized $13.7 million, $13.2 million and $13.4 million in expense for the Plan for the years ended September 30, 2012, 2011 and 2010. In 2011, Plan expense included approximately $1.2 million in cash and approximately $11.0 million in common stock. In 2010, Plan expense included approximately $3.2 million in cash and $10.2 million in common stock. The non-cash component of ESOP expense appears in the statement of cash flows supplemental disclosures as “common stock issued in satisfaction of employer contribution liability” and is included in operating cash flows within the changes in our accrued liabilities balance.

(18) Stock-based Compensation

Stock Appreciation Rights (SAR) Plan

Alion’s SAR Plan adopted in 2004 expires in 2014. The chief executive officer may award SARs as he deems appropriate. Awards vest ratably over four years with payment following the grant date fifth anniversary. Grants with no intrinsic value expire on their year-five payment date. The Plan permits accelerated vesting in the event of death, disability or a change in control of the Company. Approximately 762 thousand SARs were outstanding at September 30, 2012, at a weighted average grant date fair value of $32.77 per share. No outstanding grant has any intrinsic value. In 2012, 2011 and 2010, Alion recognized credits to SAR-related compensation expense of $90 thousand, $146 thousand and $932 thousand.

Phantom Stock Plans

Alion formerly maintained Executive and Director Phantom Stock Plans. In 2011, Alion paid out the final vested Director Plan grant and recognized compensation expense of $4 thousand. In 2010 Alion recognized a $218 thousand credit to compensation expense.

The Company uses a Black-Scholes-Merton option pricing model based on the fair market value of a share of its common stock to recognize share-based compensation expense. There is no established public trading market for Alion’s common stock. The ESOP Trust is the only holder of our common stock. Alion does not expect to pay any dividends on its common stock and intends to retain future earnings, if any, to use in operating its business.

(19) Long Term Incentive Plan

Alion adopted a long-term cash incentive compensation plan for certain executives in December 2008. Individual grants contain specific financial and performance goals and vest over varying periods. Some grants are for a fixed amount; others provide a range of values from a minimum of 50% to a maximum of 150% of initial grant value. The Company periodically evaluates the probability that individuals will achieve stated financial and performance goals.

Alion recognizes long term incentive compensation expense based on outstanding grants’ stated values, estimated probability of achieving stated goals and estimated probable future values of existing grants. In 2012, 2011 and 2010, the Company recognized $1.4 million, $2.8 million and $4.3 million in incentive compensation expense.

(20) Income Taxes

In March 2010, Alion automatically ceased to qualify as an S-corporation and became a C-corporation subject to income taxation at the federal and state level. The Company’s subsidiaries also terminated their qualified Subchapter S status and became subject to separate taxation in states that do not follow IRC consolidated tax return guidelines. When it issued the Secured Notes, Alion also issued deep-in-the-money warrants considered to constitute a second class of stock in contravention of IRC requirements that an S-corporation have only a single class of stock.

Alion’s C-corporation status should allow it to use anticipated net operating loss (NOL) carryforwards to offset taxes that may become due in the future if the Company is able to generate future taxable income. The Company’s ability to utilize NOL tax benefits will depend upon the amount of its future taxable income and could be limited under certain circumstances. All of the Company’s prior S-corporation income tax gains and losses were allocated to its sole shareholder, the tax-exempt ESOP Trust.

 

73


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

When Alion’s tax status changed, the Company recorded a deferred tax liability of $33.8 million, a deferred tax asset of $35.4 million and an offsetting valuation allowance of $35.4 million. The net effect of this was to recognize a $33.8 million charge to current earnings for deferred tax expense in 2010. The Company’s history of losses gives rise to a presumption that it might not be able to realize the full benefit of any deferred tax assets it is required to recognize. Therefore, the Company established a valuation allowance equal to the deferred tax assets it was required to recognize on becoming a C-corporation.

Alion is subject to income taxes in the U.S., various states and Canada. Tax statutes and regulations within each jurisdiction are subject to interpretation requiring management to apply significant judgment. The Company continued to recognize income tax expense in 2011 for the difference between the book and tax basis of its tax-deductible goodwill and continued to fully offset deferred tax assets with a valuation allowance. Alion recorded $7.0 million in deferred tax expense and liabilities related to tax-basis goodwill amortization in both 2012 and 2011. The Company does not include interest and penalties related to income taxes in income tax expense. It records tax-related interest as interest expense and records penalties as other expense.

Even though Alion recorded a full valuation allowance for all deferred tax assets, the Company does not expect to pay any income taxes for the foreseeable future. Alion’s ability to utilize NOL tax benefits will depend upon how much future taxable income it has and may be limited under certain circumstances. Alion does not have any NOL tax benefits it can carry back to prior years

IRC Section 108(i) allows the Company to elect to defer recognizing until fiscal year 2015, the gain on extinguishing its Subordinated Note. The gain on extinguishing the related warrants was not subject to income taxes. Management determined that an election to defer the extinguishment gain for tax purposes was not beneficial to the Company. Although the Company offers post-retirement prescription drug coverage to a limited number of retirees and beneficiaries, Alion has not claimed any federal tax credit in prior years. The Affordable Care Act has reduced the value of the federal subsidy for retiree drug coverage. Alion’s tax provision is unaffected by this legislative change. Management will decide whether to seek a subsidy in the future based on its anticipated value and the cost associated with seeking the subsidy.

Tax Uncertainties

FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes” now codified as ASC Topic 740 Income Taxes prescribes a recognition threshold and a measurement attribute for financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. The Company may recognize a benefit for that amount which it has a more than 50% chance of realizing. If the Company’s position involves uncertainty, then in order to recognize a benefit, a given tax position must be “more-likely-than-not” to be sustained upon examination by taxing authorities.

Based on the latest available information, Alion periodically assesses its liabilities and contingencies for all periods open to examination by tax authorities. Where management believes there is more than a 50 percent chance the Company’s tax position will not be sustained, Alion records its best estimate of the resulting tax liability, including interest. Interest or penalties related to income taxes are reported separately from income tax expense. The Company has recorded liabilities for tax uncertainties for all years that remain open to review. . The Company also has unrecorded tax benefits related to goodwill deductions. If Alion is able to utilize these benefits to reduce taxes payable in the future, the Company will recognize a reduction in its income tax liability and a corresponding reduction in goodwill carrying value.

Alion may become subject to federal or state income tax examination for tax years ended September 2009 and forward. Alion’s former status as a pass-through entity owned by a tax-exempt trust makes an examination unlikely and the possibility of an adverse determination remote. The Company does not expect resolution of tax matters for any open years to materially affect operating results, financial condition, cash flows or its effective tax rate.

As of September 30, 2012 deferred tax assets and related valuation allowances were $78.4 million and deferred tax liabilities were $51.2 million. Alion’s effective tax rate for 2012 was -20.2%. As of September 30, 2012 and September 30, 2011 our net deferred tax liability was:

 

74


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

     September 30,  
     2012     2011  
     (in thousands)  

Current deferred tax assets

   $ 11,207      $ 10,543   

Noncurrent deferred tax assets

     67,207        47,721   

Valuation allowances

     (78,414     (58,264

Noncurrent deferred tax liability

     (51,156     (44,181
  

 

 

   

 

 

 

Net deferred tax liability

   $ (51,156   $ (44,181
  

 

 

   

 

 

 

The provision for income taxes for the years ended September 30, 2012, 2011 and 2010 was:

 

     September 30,  
     2012      2011      2010  
     (In thousands)  

Current:

        

State

     —           —           (2

Foreign

     —           —           (40
  

 

 

    

 

 

    

 

 

 

Total current provision

   $ —         $ —         $ (42
  

 

 

    

 

 

    

 

 

 

Deferred:

        

Federal

   $ 5,740       $ 5,740       $ 30,622   

State

     1,234         1,234         6,585   
  

 

 

    

 

 

    

 

 

 

Total deferred provision

   $ 6,974       $ 6,974       $ 37,207   
  

 

 

    

 

 

    

 

 

 

Total provision for income taxes

   $ 6,974       $ 6,974       $ 37,165   
  

 

 

    

 

 

    

 

 

 

Alion’s income tax provisions at September 30, 2012, 2011 and 2010 include the effects of state income taxes, debt extinguishment and changes in valuation allowances. The provision for income taxes for the years ended September 30, 2012, 2011 and 2010 differ from the amounts computed by applying the statutory U.S. federal income tax rate to income before taxes as a result of the following:

 

     For the Year Ended September 30,  
     2012     2011     2010  
     (Dollars in thousands)  

Expected federal income tax (benefit)

     35.0   $ (12,066     35.0   $ (13,093     35.0   $ 7,677   

State income taxes (net of federal benefit)

     4.5     (1,539     4.5     (1,666     0.8     201   

Nondeductible expenses

     (0.4 %)      146        (0.6 %)      232        1.2     260   

Provision to return true-ups

     (0.8 %)      283        (0.4 %)      166        0.0     (2

Tax credits

     0.0     —          0.0     —          (0.2 %)      (40

Changes in valuation allowance

     (58.5 %)      20,150        (57.0 %)      21,335        168.4     36,929   

Deferred tax assets at conversion

     0.0     —          0.0     —          (161.2 %)      (35,359

Deferred tax liability at conversion

     0.0     —          0.0     —          154.2     33,818   

S-corporation share of net income

     0.0     —          0.0     —          (16.6 %)      (3,638

Non-taxable debt extinguishment gain

     0.0     —          0.0     —          (12.2 %)      (2,681
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income tax expense (benefit)

     (20.2 %)    $ 6,974        (18.6 %)    $ 6,974        169.4   $ 37,165   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

75


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

At September 30, 2012 and 2011, the components of deferred tax assets and deferred tax liabilities were:

 

     September 30,  
     2012     2011  
     (In thousands)  

Deferred tax assets:

  

Accrued expenses and reserves

   $ 11,207      $ 10,567   

Intangible amortization

     14,305        14,122   

Deferred rent

     3,398        2,956   

Deferred wages

     3,954        4,070   

Depreciation and leases

     3,226        3,915   

Carryforwards and tax credits

     42,299        22,612   

Other

     25        22   
  

 

 

   

 

 

 

Gross deferred tax assets

   $ 78,414      $ 58,264   
  

 

 

   

 

 

 

Less Valuation

   $ (78,414   $ (58,264
  

 

 

   

 

 

 

Deferred tax liabilities:

    

Goodwill

     (51,156     (44,181
  

 

 

   

 

 

 

Net deferred tax asset/(liability)

   $ (51,156   $ (44,181
  

 

 

   

 

 

 

(21) Segment Information and Customer Concentration

Alion operates in a single segment, delivering a broad array of scientific and engineering expertise to research and develop technological solutions for problems relating to national defense, public health and safety, and nuclear safety and analysis under contracts with the federal government, state and local governments, and commercial customers. Federal government customers typically exercise independent contracting authority. Federal agency and department offices or divisions may use Alion’s services as a separate customer directly, or through a prime contractor, as long as they have independent decision-making and contracting authority in their organization. Over 80% of Alion’s revenue comes from government prime contracts. The following six prime contracts represented over 50% of our revenue for the past three years.

 

          September 30,  

Government Agency

  

Contract

   2012     2011     2010  

DoD—U.S. Navy

   Seaport-E Multiple Award Contract for the Naval Sea Systems Command      19.1     13.5     9.2

DoD—Defense Information Systems Agency

   Weapons System Information Analysis Center for the Defense Information Systems Agency      17.1     8.2     6.0

DoD—U.S. Air Force

   Technical and Analytical Support for the U.S. Air Force      9.9     11.1     10.3

DoD—Defense Information Systems Agency

   Modeling and Simulation Information Analysis Center for the Defense Information Systems Agency      8.1     14.1     13.0

DoD—U.S. Navy

   Naval Sea Systems Command Surface Ships Life Cycle Program Management and Engineering Support      5.8     N/A        N/A   

DoD—U.S. Navy

   Naval Sea Systems Command Multiple Award Contract      2.7     10.8     12.7

 

76


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(22) Guarantor/Non-guarantor Condensed Consolidated Financial Information

Alion’s Secured Notes and Unsecured Notes are general obligations of the Company. Certain of Alion’s 100% owned domestic subsidiaries have jointly, severally, fully and unconditionally guaranteed the Secured Notes and Unsecured Notes. The following information presents condensed consolidating balance sheets as of September 30, 2012 and September 30, 2011; and condensed consolidating statements of comprehensive loss and cash flows for the years ended September 30, 2012, 2011 and 2010 of the parent company issuer, the guarantor subsidiaries and the non-guarantor subsidiaries. Investments include investments in subsidiaries held by the parent company issuer and have been presented using the equity method of accounting. As disclosed in Note 3, Alion sold its HFA guarantor subsidiary in September 2010. The results of HFA’s operations and cash flows are included in the condensed consolidating statements for 2010 only.

 

77


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Condensed Consolidating Balance Sheet Information at September 30, 2012

 

     Parent     Guarantor
Companies
    Non-Guarantor
Companies
    Eliminations     Consolidated  
     (In thousands)  

Current assets:

          

Cash and cash equivalents

   $ 27,271      $ (44   $ —        $ —        $ 27,227   

Accounts receivable, net

     172,365        2,783        145        —          175,293   

Receivable due from ESOP Trust

     1,129        —          —          —          1,129   

Prepaid expenses and other current assets

     5,378        70        —          —          5,448   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current assets

     206,143        2,809        145        —          209,097   

Property, plant and equipment, net

     10,064        529        12        —          10,605   

Intangible assets, net

     5,242        —          —          —          5,242   

Goodwill

     398,921        —          —          —          398,921   

Investment in subsidiaries

     27,994        —          —          (27,994     —     

Intercompany receivables

     1,438        27,475        —          (28,913     —     

Other assets

     11,427        —          4        —          11,431   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

   $ 661,229      $ 30,813      $ 161      $ (56,907   $ 635,296   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Current liabilities:

          

Interest payable

   $ 17,658      $ —        $ —        $ —        $ 17,658   

Trade accounts payable

     44,582        201        10        —          44,793   

Accrued liabilities

     52,265        190        5        —          52,460   

Accrued payroll and related liabilities

     39,305        589        32        —          39,926   

Billings in excess of costs revenue earned

     2,656        6        4        —          2,666   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current liabilities

     156,466        986        51        —          157,503   

Intercompany payables

     27,476        —          1,437        (28,913     —     

Secured Notes

     306,502        —          —          —          306,502   

Unsecured Notes

     242,923        —          —          —          242,923   

Accrued compensation and benefits, excluding current portion

     5,905        —          —          —          5,905   

Non-current portion of lease obligations

     11,858        506        —          —          12,364   

Deferred income taxes

     51,156        —          —          —          51,156   

Other liabilities

     —          —          —          —          —     

Redeemable common stock

     110,740        —          —          —          110,740   

Common stock of subsidiaries

     —          4,084        —          (4,084     —     

Commitments and contingencies

     —          —          —          —          —     

Common stock warrants

     20,785        —          —          —          20,785   

Accumulated other comprehensive loss

     (149     —          —          —          (149

Accumulated surplus (deficit)

     (272,433     25,237        (1,327     (23,910     (272,433
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities, redeemable common stock and accumulated deficit

   $ 661,229      $ 30,813      $ 161      $ (56,907   $ 635,296   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

78


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Condensed Consolidating Balance Sheet Information at September 30, 2011

 

     Parent     Guarantor
Companies
    Non-
Guarantor
Companies
    Eliminations     Consolidated  
     (In thousands)  

Current assets:

          

Cash and cash equivalents

   $ 20,845      $ (27   $ —        $ —        $ 20,818   

Accounts receivable, net

     177,618        2,358        388        —          180,364   

Receivable due from ESOP Trust

     —          —          —          —          —     

Prepaid expenses and other current assets

     5,991        93        2        —          6,086   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current assets

     204,454        2,424        390        —          207,268   

Property, plant and equipment, net

     9,733        614        20        —          10,367   

Intangible assets, net

     11,734        —          —          —          11,734   

Goodwill

     398,921        —          —          —          398,921   

Investment in subsidiaries

     24,566        —          —          (24,566     —     

Intercompany receivables

     1,460        24,675        —          (26,135     —     

Other assets

     16,181        12        5        —          16,198   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

   $ 667,049      $ 27,725      $ 415      $ (50,701   $ 644,488   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Current liabilities:

          

Interest payable

   $ 17,392      $ —        $ —        $ —        $ 17,392   

Trade accounts payable

     52,092        257        6        —          52,355   

Accrued liabilities

     48,087        319        29        —          48,435   

Accrued payroll and related liabilities

     38,766        915        57        —          39,738   

Billings in excess of costs revenue earned

     2,723        5        24        —          2,752   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current liabilities

     159,060        1,496        116        —          160,672   

Intercompany payables

     24,675        —          1,460        (26,135     —     

Secured Notes

     291,003        —          —          —          291,003   

Unsecured Notes

     242,064        —          —          —          242,064   

Accrued compensation and benefits, excluding current portion

     5,729        —          —          —          5,729   

Non-current portion of lease obligations

     10,260        502        —          —          10,762   

Deferred income taxes

     44,181        —          —          —          44,181   

Other liabilities

     980        —          —          —          980   

Redeemable common stock

     126,560        —          —          —          126,560   

Common stock of subsidiaries

     —          4,084        —          (4,084     —     

Commitments and contingencies

     —          —          —          —          —     

Common stock warrants

     20,785        —          —          —          20,785   

Accumulated other comprehensive loss

     (123     —          —          —          (123

Accumulated surplus (deficit)

     (258,125     21,643        (1,161     (20,482     (258,125
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities, redeemable common stock and accumulated deficit

   $ 667,049      $ 27,725      $ 415      $ (50,701   $ 644,488   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

79


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Condensed Consolidating Statement of Comprehensive Loss

 

     Year Ended September 30, 2012  
     Parent     Guarantor
Companies
     Non-
Guarantor
Companies
    Eliminations     Consolidated  
     (In thousands)  

Contract revenue

   $ 802,664      $ 14,015       $ 525      $ —        $ 817,204   

Direct contract expenses

     624,788        7,743         300        —          632,831   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Gross profit

     177,876        6,272         225        —          184,373   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Operating expenses

     88,736        2,531         227        —          91,494   

General and administrative

     52,123        156         162        —          52,441   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Operating income (loss)

     37,017        3,585         (164     —          40,438   

Other income (expense):

           

Interest income

     78        —           —          —          78   

Interest expense

     (74,934     —           —          —          (74,934

Other

     (63     9         (1     —          (55

Gain on debt extinguishment

     —          —           —          —          —     

Equity in net income of subsidiaries

     3,429        —           —          (3,429     —     
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Total other income (expense)

     (71,490     9         (1     (3,429     (74,911

Income (loss) before income taxes

     (34,473     3,594         (165     (3,429     (34,473

Income tax (expense) benefit

     (6,974     —           —          —          (6,974
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (41,447   $ 3,594       $ (165   $ (3,429   $ (41,447
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Other comprehensive income:

           

Postretirement actuarial gain

     26        —           —          —          26   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (41,421   $ 3,594       $ (165   $ (3,429   $ (41,421
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

80


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Condensed Consolidating Statement of Comprehensive Loss

 

     Year Ended September 30, 2011  
     Parent     Guarantor
Companies
     Non-
Guarantor
Companies
    Eliminations     Consolidated  
     (In thousands)  

Contract revenue

   $ 769,467      $ 17,025       $ 822      $ —        $ 787,314   

Direct contract expenses

     593,600        9,333         548        —          603,481   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Gross profit

     175,867        7,692         274        —          183,833   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Operating expenses

     79,871        3,076         88        —          83,035   

General and administrative

     64,374        620         311        —          65,305   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Operating income (loss)

     31,622        3,996         (125     —          35,493   

Other income (expense):

           

Interest income

     45        —           —          —          45   

Interest expense

     (73,919     —           —          —          (73,919

Other

     (535     568         (1     —          32   

Gain on debt extinguishment

     939        —           —          —          939   

Equity in net income of subsidiaries

     4,438        —           —          (4,438     —     
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Total other income (expense)

     (69,032     568         (1     (4,438     (72,903

Income (loss) before income taxes

     (37,410     4,564         (126     (4,438     (37,410

Income tax (expense) benefit

     (6,974     —           —          —          (6,974
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (44,384   $ 4,564       $ (126   $ (4,438   $ (44,384
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Other comprehensive income:

           

Post retirement actuarial gain

     55        —           —          —          55   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (44,329   $ 4,564       $ (126   $ (4,438   $ (44,329
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

81


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Condensed Consolidating Statement of Comprehensive Loss

 

     Year Ended September 30, 2010  
     Parent     Guarantor
Companies
     Non-
Guarantor
Companies
    Eliminations     Consolidated  
     (In thousands)  

Contract revenue

   $ 803,565      $ 30,276       $ 147      $ —        $ 833,988   

Direct contract expenses

     618,018        19,864         118        —          638,000   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Gross profit

     185,547        10,412         29        —          195,988   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Operating expenses

     83,788        4,091         91        —          87,970   

General and administrative

     64,392        4,365         341        —          69,098   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Operating income (loss)

     37,367        1,956         (403     —          38,920   

Other income (expense):

           

Interest income

     93        26         —          —          119   

Interest expense

     (67,613     —           —          —          (67,613

Other

     (559     317         —          —          (242

Gain on debt extinguishment

     50,749        —           —          —          50,749   

Equity in net income of subsidiaries

     1,938        —           —          (1,938     —     
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Total other income (expense)

     (15,392     343         —          (1,938     (16,987

Income (loss) before income taxes

     21,975        2,299         (403     (1,938     21,933   

Income tax (expense) benefit

     (37,207     2         40        —          (37,165
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (15,232   $ 2,301       $ (363   $ (1,938   $ (15,232
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Other comprehensive income:

           

Postretirement actuarial gain

     61        —           —          —          61   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (15,171   $ 2,301       $ (363   $ (1,938   $ (15,171
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

82


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Condensed Consolidating Statement of Cash Flows

Year Ended September 30, 2012

 

     Parent     Guarantors     Non-
Guarantors
     Consolidated  
     (In thousands)  

Net cash provided by (used in) operating activities

   $ 12,700      $ (19   $ —         $ 12,681   

Cash flows from investing activities:

         

Capital expenditures

     (2,733     2        —           (2,731
  

 

 

   

 

 

   

 

 

    

 

 

 

Net cash provided by (used in) investing activities

     (2,733     2        —           (2,731
  

 

 

   

 

 

   

 

 

    

 

 

 

Cash flows from financing activities:

         

Revolver borrowings

     26,000        —          —           26,000   

Revolver repayments

     (26,000     —          —           (26,000

Loan to ESOP trust

     (477     —          —           (477

ESOP loan repayment

     477        —          —           477   

Redeemable common stock purchased from ESOP trust

     (4,843     —          —           (4,843

Redeemable common stock sold to ESOP Trust

     1,302        —          —           1,302   
  

 

 

   

 

 

   

 

 

    

 

 

 

Net cash provided by (used in) financing activities

     (3,541     —          —           (3,541
  

 

 

   

 

 

   

 

 

    

 

 

 

Net increase (decrease) in cash and cash equivalents

     6,426        (17     —           6,409   

Cash and cash equivalents at beginning of period

     20,845        (27     —           20,818   
  

 

 

   

 

 

   

 

 

    

 

 

 

Cash and cash equivalents at end of period

   $ 27,271      $ (44   $ —         $ 27,227   
  

 

 

   

 

 

   

 

 

    

 

 

 

 

83


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Condensed Consolidating Statement of Cash Flows

Year Ended September 30, 2011

 

     Parent     Guarantors     Non-
Guarantors
    Consolidated  
     (In thousands)  

Net cash provided by (used in) operating activities

   $ 5,061      $ 636      $ 24      $ 5,721   

Cash flows from investing activities:

        

Capital expenditures

     (5,694     (588     (23     (6,305

Proceeds from sale of fixed assets

     14        —          —          14   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) investing activities

     (5,680     (588     (23     (6,291
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

        

Payment of debt issuance cost

     (710     —          —          (710

Repayment of unsecured notes

     (3,993     —          —          (3,993

Revolver borrowings

     17,000        —          —          17,000   

Revolver repayments

     (17,000     —          —          (17,000

Loan to ESOP trust

     (776     —          —          (776

ESOP loan repayment

     776        —          —          776   

Redeemable common stock purchased from ESOP trust

     (5,762     —          —          (5,762

Redeemable common stock sold to ESOP Trust

     5,158        —          —          5,158   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     (5,307     —          —          (5,307
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     (5,926     48        1        (5,877

Cash and cash equivalents at beginning of period

     26,770        (74     (1     26,695   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 20,844      $ (26   $ —        $ 20,818   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

84


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Condensed Consolidating Statement of Cash Flows

Year Ended September 30, 2010

 

     Parent     Guarantors     Non-
Guarantors
    Consolidated  
     (In thousands)  

Net cash provided by (used in) operating activities

   $ 2,250      $ 143      $ 3      $ 2,396   

Cash flows from investing activities:

        

Cash paid for acquisitions-related obligations

     (50     —          —          (50

Capital expenditures

     (2,205     (2     —          (2,207

Proceeds from sale of fixed assets

     110        —          —          110   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) investing activities

     (2,145     (2     —          (2,147
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

        

Sale of Secured Notes

     281,465        —          —          281,465   

Sale of Common Stock Warrants

     20,785        —          —          20,785   

Payment of debt issuance cost

     (18,183     —          —          (18,183

Repayment of Term B Loan

     (236,596     —          —          (236,596

Repurchase of Subordinated Note and related warrants

     (25,000     —          —          (25,000

Revolver borrowings

     84,200        —          —          84,200   

Revolver repayments

     (84,200     —          —          (84,200

Loan to ESOP trust

     (5,323     —          —          (5,323

ESOP loan repayment

     5,323        —          —          5,323   

Redeemable common stock purchased from ESOP trust

     (9,338     —          —          (9,338

Redeemable common stock sold to ESOP Trust

     2,128        —          —          2,128   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     15,261        —          —          15,261   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     15,366        141        3        15,510   

Cash and cash equivalents at beginning of period

     11,404        (215     (4     11,185   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 26,770      $ (74   $ (1   $ 26,695   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

85


Table of Contents

ALION SCIENCE AND TECHNOLOGY CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(23) Related Party Transactions

Up through December 31, 2010, Alion used the consulting services of One Team, a company owned by General George Joulwan, (USA Ret.), a member of Alion’s board of directors. The Company paid One Team approximately $60 thousand in fiscal 2010.

(24) Commitments and Contingencies

Government Audits

Federal government cost-reimbursement contract revenues and expenses in the consolidated financial statements are subject to DCAA audit and possible adjustment. Alion is a major contractor and DCAA maintains an office on site to perform its various audits throughout the year. The Company has settled indirect rates through 2004 based on completed DCAA audits and is currently negotiating 2005 indirect rates. Alion has recorded federal government contract revenue based on amounts it expects to realize upon final settlement.

Legal Proceedings

We are involved in routine legal proceedings occurring in the ordinary course of business. We believe these routine legal proceedings are not material to our financial condition, operating results, or cash flows.

As a government contractor, from time to time we may be subject to DCAA audits and federal government inquiries. The federal government may suspend or debar for a period of time any federal contractor it finds has violated the False Claims Act, or any contractor indicted for or convicted of violating other federal laws. This could also result in fines or penalties. Given Alion’s dependence on federal government contracts, suspension or debarment could have a material effect on our business, financial condition, operating results, cash flows and our ability to meet our financial obligations. We are not aware of any such pending federal government claims or investigations.

(25) Interim Period (Unaudited, in thousands except per share information)

 

     2012 Quarters  
     1st     2nd     3rd     4th  

Revenue

   $ 189,891      $ 197,112      $ 211,514      $ 218,687   

Gross profit

   $ 43,547      $ 46,681      $ 46,472      $ 47,673   

Net loss

   $ (12,810   $ (10,245   $ (8,866   $ (9,526

Net loss per share

   $ (2.12   $ (1.73   $ (1.39   $ (1.52

Current assets

   $ 205,819      $ 200,703      $ 211,266      $ 209,097   

Current liabilities

   $ 166,226      $ 152,200      $ 166,520      $ 157,503   
     2011 Quarters  
     1st     2nd     3rd     4th  

Revenue

   $ 200,768      $ 202,551      $ 192,797      $ 191,198   

Gross profit

   $ 45,254      $ 47,549      $ 47,053      $ 43,977   

Net loss

   $ (11,132   $ (9,667   $ (11,476   $ (12,109

Net loss per share

   $ (1.97   $ (1.74   $ (1.98   $ (2.14

Current assets

   $ 194,812      $ 205,590      $ 182,506      $ 207,268   

Current liabilities

   $ 142,909      $ 147,948      $ 134,837      $ 160,672   

(26) Subsequent Event

In December 2012, Alion and its lenders amended the Credit Agreement to increase the maximum fees the Company is permitted to pay outside directors and to retroactively waive non-compliance with the former limitation in the Credit Agreement.

 

 

86


Table of Contents

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Disclosure Controls and Procedures. The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports it is required to file or submit under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified by the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its Chief Executive and Chief Financial Officers, as appropriate to allow timely decisions regarding required disclosures. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were timely and effective at a reasonable assurance level.

Limitations on the Effectiveness of Controls. Because of their inherent limitations, disclosure controls and procedures and internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures.

Management’s Annual Report on Internal Control Over Financial Reporting. The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 15(d)—15(f) under the Exchange Act). The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of published financial statements in accordance with generally accepted accounting principles.

The Company’s management assessed the effectiveness of our internal control over financial reporting as of September 30, 2012. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework. Based on our assessment, we believe that as of September 30, 2012, our internal control over financial reporting was effective based on criteria set forth by COSO in Internal Control — Integrated Framework.

Changes in Internal Control Over Financial Reporting. During the quarter ended September 30, 2012, there were no changes in our internal control over financial reporting (as such term is defined in Rule 15(d) – 15(f) under the Exchange Act) that materially affected, or are reasonably likely to materially affect, our internal control for financial reporting.

Scope of the Assessment. This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to the exemption provided to issuers that are neither “large accelerated filers” nor “accelerated filers” under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.

Item 9B. Other Information

None.

 

87


Table of Contents

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Information Regarding the Directors of the Registrant

The names, ages and positions of our current directors are set forth below:

 

                 Term      Director  

Name

   Age      Position    Expires      Since  

Bahman Atefi

     59       President, Chief Executive
Officer and Chairman
     2014         2001   

Edward C. (Pete) Aldridge, Jr.

     74       Director      2015         2003   

Leslie L. Armitage

     44       Director      2013         2002   

Lewis Collens

     77       Director      2013         2002   

Admiral Harold W. Gehman, Jr., USN (Ret.)

     69       Director      2013         2002   

General Michael V. Hayden, USAF (Ret.)

     67       Director      2015         2010   

General George A. Joulwan, USA (Ret.)

     73       Director      2014         2002   

General Michael E. Ryan, USAF (Ret.)

     70       Director      2014         2002   

David J. Vitale

     66       Director      2015         2009   

The Company’s directors are divided into three classes. The first class of directors: Edward C. Aldridge, Jr., General Michael V. Hayden and David J. Vitale; have terms expiring on the date of Alion’s 2015 annual shareholder meeting. The second class of directors: Leslie Armitage, Lewis Collens and Admiral Harold W. Gehman, Jr.; have terms expiring on the date of Alion’s 2013 annual shareholder meeting. The third class of directors: Bahman Atefi, General George A. Joulwan and General Michael E. Ryan; have terms expiring on the date of Alion’s 2014 annual shareholder meeting.

The following sets forth the business experience, principal occupations and employment of each of our directors, as well as their specific experience, qualifications, attributes and skills relevant to our business that led to the conclusion that each of these individuals should serve as an Alion director.

Bahman Atefi was appointed president and chief executive officer of Alion in December 2001. He is also chairman of Alion’s Board of Directors. Dr. Atefi also serves as chairman of the ESOP committee. Dr. Atefi served as president of IITRI from August 1997 and as its chief executive officer from October 2000 until December 20, 2002, when Alion purchased substantially all of IITRI’s assets. From June 1994 to August 1997, Dr. Atefi served as manager of the energy and environmental group at Science Applications International Corporation. In this capacity, he was responsible for a business unit, which provided scientific and engineering support to the U.S. Department of Energy, Nuclear Regulatory Commission, Environmental Protection Agency, Department of Defense, and commercial and international customers. Dr. Atefi is a member of the Board of Directors of The Wolf Trap Foundation for the Performing Arts. Dr. Atefi received a BS in Electrical Engineering from Cornell University, an MS in Nuclear Engineering and a Doctor of Science in Nuclear Engineering from the Massachusetts Institute of Technology.

Dr. Atefi was selected and continues to serve as a director of the company because of his institutional and operational knowledge of the Company’s business, his financial acumen, his service as the Company’s chief executive officer and his more than twenty-five years of experience in the government contracting professional services market.

Edward C. (Pete) Aldridge, Jr. has served as a director of Alion since November 2003. Mr. Aldridge retired from government service in May 2003 as the Under Secretary of Defense for Acquisition, Technology, and Logistics, a position he held since May 2001. In this position, Mr. Aldridge was responsible for all matters relating to Department of Defense acquisition, research and development, advanced technology, international programs, and the industrial base. From March 1992 to May 2001, Mr. Aldridge also served as president and CEO of the Aerospace Corporation, president of McDonnell Douglas Electronic Systems, Secretary of the Air Force, and numerous other positions within the Department of Defense. He was a director of Lockheed Martin Corporation from June 2003 to April 2011 and was a director of Global Crossing, Ltd. from December 2003 to October 2011.

Mr. Aldridge was selected and continues to serve as a director of the Company because of his extensive domain expertise which he developed over a long, exemplary career that includes prior leadership positions in both public and private government contracting professional services organizations and his service as Secretary of the Air Force.

 

88


Table of Contents

Leslie L. Armitage has served as a director of Alion since May 2002. Ms. Armitage currently serves as a Senior Managing Director and Co-Founder of Relativity Capital, a position she has held since January 2006. Ms. Armitage served as a Managing Director and Partner of The Carlyle Group from January 1999 until May 2005 and held various positions at Carlyle from 1990 to 1999. Ms. Armitage has served on the Board of Directors of MHF Services, Inc. since June 2009 and Tactical Micro, Inc. since December 2010. She previously served on the Board of Directors of Vought Aircraft Industries, Inc., Honsel International Technologies, United Components, Inc., Nivisys Industries and Berkshire Manufactured Products.

Ms. Armitage was selected and continues to serve as a director of the Company because of her extensive financial and board experience and acumen developed over the course of more than twenty years in the private equity market, in addition to her familiarity with companies in the government contracting professional services industry.

Lewis Collens has served as a director of Alion since May 2002. From 1990 to 2009, Mr. Collens served as president of Illinois Institute of Technology (“IIT”). He is currently President Emeritus and Professor of Law Emeritus at IIT, Chicago-Kent College of Law, a position he has held since August 2009. He also currently serves as Senior Advisor for Charles Dobrusin Associates. Mr. Collens previously served as a director of Amsted Industries since February 1991 and as a director and Chairman of Colson Company from March 2002 to March 2012.

Mr. Collens was selected and continues to serve as a director of the Company because of his familiarity with the Company’s business from his prior roles as the Chief Executive Officer and Board Chairman of the company’s predecessor IIT Research Institute, as well as the financial and legal expertise he has developed over his career.

Admiral Harold W. Gehman, Jr.,USN (Ret.) has served as a director of Alion since September 2002. Admiral Gehman retired from over 35 years of active duty in the U.S. Navy in October 2000. While in the U.S. Navy, Admiral Gehman served as NATO’s Supreme Allied Commander, Atlantic and as the Commander in Chief of the U.S. Joint Forces Command from September 1997 to September 2000. Since his retirement in November 2000, Admiral Gehman has served as an independent consultant to the U.S. Government from October 2000 to present. Admiral Gehman has served on the Boards of Directors of Maersk Lines, Ltd. since April 2001, Transystems Corp since January 2002 and Nivisys Corp. since July 2008 to July 2011. He also served on the board of visitors of Old Dominion University. Admiral Gehman is a senior fellow at the National Defense University and was the chairman of the Governor of Virginia’s Advisory Commission for Veterans Affairs. Admiral Gehman served as co-chairman of the Defense Department’s investigation into the October 2000 attack on the U.S.S. Cole in Aden Harbor, Yemen, as chairman of the Space Shuttle Columbia Accident Investigation Board, and as the Commissioner of the 2005 National Base Realignment and Closure Act.

Admiral Gehman was selected and continues to serve as a director of the Company because of his extensive domain expertise developed over the course of his service as a naval officer, as well as his years of leadership in the most senior levels of the U.S. defense establishment.

General Michael V. Hayden, USAF (Ret.) has served as a director of Alion since July 2010. General Hayden retired from 39 years of service in the United States Air Force in July 2008. General Hayden served as Director of the Central Intelligence Agency from May 2006 until February 2009, and as Director of the National Security Agency from 1999 until 2005. He entered active duty in 1969 after earning a bachelor’s degree in history in 1967 and a master’s degree in modern American history in 1969, both from Duquesne University. He is a distinguished graduate of Duquesne’s ROTC program. General Hayden served as Commander of the Air Intelligence Agency and as Director of the Joint Command and Control Warfare Center. He has also served in senior staff positions at the Pentagon, Headquarters U.S. European Command, National Security Council and the U.S. Embassy to the People’s Republic of Bulgaria. General Hayden served as Deputy Chief of Staff, United Nations Command and U.S. Forces Korea, Yongsan Army Garrison, South Korea. He currently serves as a Distinguished Visiting Professor at George Mason University School of Public Policy and as a Principal at the Chertoff Group. General Hayden has served on the Board of Directors of Motorola Corporation since January 2011and Accenture Federal Services, LLC since May 2012. He served on the Board of Directors of National Interest Security Company from April 2009 to March 2010. General Hayden also serves as a Consultant and Advisory Board Member for Cubic Defense Applications, Computer Sciences Corporation, Kaseman LLC, Draper Labs, Next Century Corporation, Accenture, Orbis Operations, IBM and the Commonwealth Bank of Australia.

General Hayden was selected and continues to serve as a director of the Company because of his extensive domain expertise developed over the course of his service as an Air Force officer, as well as his years of leadership in the senior-most levels of the U.S. defense and intelligence establishments, having served as director both the Central Intelligence Agency and the National Security Agency.

 

89


Table of Contents

General George A. Joulwan, USA (Ret.) has served as a director of Alion since May 2002. General Joulwan retired from 36 years of service in the military in September 1997. While in the military, General Joulwan served as Commander in Chief for U.S. Southern Command in Panama from 1990-1993 and served as Commander in Chief of the U.S. European Command and NATO Supreme Allied Command from 1993-1997. From 1998 to 2000, General Joulwan served as an Olin Professor at the U.S. Military Academy at West Point. General Joulwan has also served as an adjunct professor at the National Defense University from 2001 to 2002. Since 1998, General Joulwan has served as President of One Team, Inc., a strategic consulting company. General Joulwan currently serves on the Board of Directors of Accenture Federal Services LLC since 2002, IAP Worldwide Services since 2005 and Freedom Group, Inc. since 2007. He also serves on the boards of several charity and non-profit organizations. General Joulwan has previously served on the Board of Directors for General Dynamics Corporation from 1998-2012, TRS-LLC from 2001-2012, and nGrain (Canada) Corporation from 2004-2011.

General Joulwan was selected and continues to serve as a director of the Company because of his extensive domain expertise developed over the course of his service as an Army officer, as well as his years of leadership in the senior-most levels of the U.S. defense establishment.

General Michael E. Ryan, USAF (Ret.) has served as a director of Alion since May 2002. General Ryan retired from the military in 2001 after 36 years of service. He served his last four years as the 16th Air Force Chief of Staff, responsible for organizing, training and equipping over 700,000 active duty, reserve and civilian members. He is currently president of the consulting firm, Ryan Associates, focusing on national defense issues, a position he has held since January 2001. He is Chairman of the Board of CAE USA, Inc., SELEX Galileo Inc. and the Air Force Village Charitable Foundation. He has served on the Board of Directors of United Services Automobile Association since November 2002, Circadence Corporation since December 2003, VT Services, Inc. from December 2004 to July 2012, CAE USA since August 2002, SELEX Galileo Inc. since June 2005 and Nivisys Industries LLC from July 2008 to July 2011. He is a senior trustee of the Air Force Academy Falcon Foundation.

General Ryan was selected and continues to serve as a director of the company because of his extensive domain expertise developed over the course of his service as an Air Force officer, as well as his years of leadership in the senior-most levels of the U.S. defense establishment, including as a Chief of Staff of the Air Force.

David J. Vitale has served as a director of Alion since September 2009. He was the Chief Administrative Officer of the Chicago Public School System from 2003 -2008. From February of 2001 through November of 2002, Mr. Vitale served as President and Chief Executive Officer of the Chicago Board of Trade and as a member of its Board of Directors and Executive Committee. Mr. Vitale also served as President and CEO of the MidAmerica Commodity Exchange, an affiliate of the Chicago Board of Trade. He is a former Vice Chairman and Director of Bank One Corporation, where he was responsible for Bank One’s Commercial Banking, Real Estate, Private Banking, Investment Management and Corporate Investments businesses. Mr. Vitale has served on the Boards of Directors of United Continental Holdings, Inc. since February 2006, ISO New England, Inc. (“ISO”) since September 2004, Wheels Inc. since September 1999, DNP Select Income Fund, Inc. (“DNP”) since April 2000, DTF Tax-Free Income Inc. (“DTF”) since May 2005, Duff & Phelps Utility & Corp. Bond Trust Inc. (“Duff & Phelps”) since May 2005, Ariel Capital Management Holdings, Inc. since November 2000 and Urban Partnership Bank (“UPB”) since August 2010. He has served as Chairman of ISO since October 2010, of UPB since August 2010, and of DNP, DTF and Duff & Phelps since May 2009.

Mr. Vitale was selected and continues to serve as a director of the company because of his extensive financial experience and acumen and his experience as a senior officer and director of Fortune 500 companies.

Establishment of Committees

The Board of Directors has established four committees, an Audit and Finance Committee, a Compensation Committee, a Governance and Compliance Committee, and a Special Projects Committee. Each committee currently consists of the following members:

 

Committee

  

Chairperson

   Members

Audit and Finance Committee

   Leslie Armitage    Lewis Collens, Harold Gehman,
Michael Ryan, David Vitale

Compensation Committee

   Harold Gehman    Pete Aldridge, Leslie Armitage, Lewis
Collens, George Joulwan

Governance and Compliance Committee

   Michael Ryan    Bahman Atefi, Harold Gehman,
Michael Hayden, George Joulwan

Special Projects Committee

   Pete Aldridge    George Joulwan, Michael Ryan

 

90


Table of Contents

The Board of Directors has determined that Leslie Armitage qualifies as “audit committee financial expert” as defined in Item 407(d)(5)(ii) of Regulation S-K, and that she is “independent” as independence for audit committee members is defined in the listing standards of the NYSE Amex.

Audit and Finance Committee

The responsibilities of the Audit and Finance Committee are set forth in its charter and include periodically reviewing and making recommendations to the Board of Directors and management of the Company concerning:

 

   

professional services provided by our independent registered public accounting firm;

 

   

independence of our independent registered public accounting firm from our management;

 

   

our quarterly and annual financial statements and our system of internal control over financial reporting;

 

   

our capital structure, including the issuance of equity and debt securities, the incurrence of indebtedness, and related matters;

 

   

general financial planning, including cash flow and working capital management, capital budgeting and expenditures, tax planning and compliance and related matters;

 

   

mergers, acquisitions and strategic transactions;

 

   

investment policies, financial performance and funding of our employee benefit plans; and

 

   

other transactions or financial issues that the Board of Directors or management presents to the committee to review.

The Audit and Finance Committee met five times during fiscal year 2012.

Compensation Committee

The responsibilities of the Compensation Committee set forth in its charter include:

 

   

determining the compensation of our Chief Executive Officer and reviewing and approving the compensation of our other executive officers;

 

   

exercising all rights, authority and functions under our KSOP, retirement and other compensation plans;

 

   

approving and making recommendations to the Board regarding non-employee director compensation;

 

   

preparing an annual report on executive compensation for inclusion in our annual report on Form 10-K in accordance with the rules and regulations of the Securities and Exchange Commission;

 

   

establishing, implementing and monitoring adherence to the Company’s compensation philosophy; and

 

   

evaluating performance and compensation to ensure that the Company maintains its ability to attract and retain superior employees in key positions and that compensation provided to key employees remains competitive relative to the compensation paid to similarly situated executives of other companies.

The Compensation Committee met three times during fiscal year 2012.

Corporate Governance and Compliance Committee

The Corporate Governance and Compliance Committee oversees and reviews nominations for our Board of Directors and evaluates and recommends corporate governance policies and procedures. The Corporate Governance and Compliance Committee is charged with annually assessing the performance of the Board of Directors and its committees. This includes overseeing each committee’s annual self-assessment, including the Corporate Governance and Compliance Committee itself. These assessments are intended to monitor the effectiveness of the Board of Directors and each of its committees; gather information regarding the ability of the Board and its committees to fulfill their mandates and responsibilities; and provide a basis to further evaluate and improve policies of the Board and its committees.

The Corporate Governance and Compliance Committee met four times during fiscal year 2012.

Special Projects Committee

The Special Projects Committee’s primary purpose and function is to oversee special projects and programs of a significant nature as determined jointly by the Committee and the management of Alion, or by the Board of Directors; and develop, recommend to the Board, and assess policies and procedures with regard to such special projects.

 

91


Table of Contents

The Special Projects Committee met once during the year 2012.

Board of Directors Diversity

Alion’s Corporate Governance and Compliance Committee is charged with recommending director candidates to the full Board. The Board of Directors nominates directors for election by Alion’s sole stockholder, the ESOP Trust. The Governance and Compliance Committee does not have a formal policy regarding diversity when identifying and considering director nominees. In evaluating director nominees, the Governance and Compliance Committee typically considers an individual’s overall experience, subject matter expertise, military service, financial knowledge, and international business and military experience. The Corporate Governance and Compliance Committee is focused on constructing a board with a well-balanced distribution of experience among its members to support the Company’s growth and performance in the government contracting professional services industry.

Registrant Chief Executive Officer and Chairman of the Board

Dr. Atefi was selected to act as both the first CEO and Chairman of the Board of Directors of Alion in 2002 largely because both Illinois Institute of Technology (IIT) and the ESOP Trustee (initially the two largest holders of Alion’s debt and common stock at the time) required him to act as CEO to successfully conclude Alion’s employee buyout of IITRI’s assets. Both IIT and the ESOP Trustee also believed Dr. Atefi was the individual most qualified to serve as Chairman because of his institutional and operational knowledge and his financial acumen. The Company continues to believe this leadership structure remains the most appropriate structure for Alion. Dr. Atefi’s leadership as both the CEO and Board Chairman over the past ten years has been instrumental in growing Alion’s revenue by more than four hundred percent during his tenure, establishing the Company’s long term capital structure and increasing shareholder value through overall growth in Alion’s share price.

Board of Directors’ Role in Risk Oversight

The Board of Directors actively oversees potential risks and risk management activities, including discussing Alion’s with management and evaluating such risks at meetings of the Board and its Committees. Members of the Board of Directors also use their independent knowledge and understanding the risks Alion and other professional services government contractors face. The Board of Directors regularly reviews Alion’s corporate strategy in light of the evolving nature of the risks the Company faces and adjusts strategy when appropriate.

The Board of Directors has also delegated risk oversight to certain of its standing committees within their areas of responsibility. The Corporate Governance and Compliance Committee and the Audit and Finance Committee assist the Board of Directors in its risk oversight function with regard to internal control over financial reporting, periodic filings, procedures relating to the receipt and treatment of complaints, and policies and procedures designed to ensure adherence to applicable laws and regulations.

The Board of Directors has delegated to the Corporate Governance and Compliance Committee responsibility for oversight of certain of the Company’s risk oversight and compliance matters, including oversight of (i) material legal proceedings and material contingent liabilities, (ii) the Company’s policies regarding risk assessment and management, (iii) the Company’s compliance programs with respect to legal and regulatory requirements and the Company’s Code of Conduct, and (iv) related party transactions and conflicts of interest.

The Board of Directors has also delegated to the Audit and Finance Committee the responsibility for oversight of certain of the Company’s risk oversight and compliance matters, including reviewing the Company’s accounting policies, practices and disclosure controls and establishing procedures for the receiving and handling of complaints regarding accounting, internal accounting controls and auditing matters.

 

92


Table of Contents

Information Regarding the Executive Officers of the Registrant

The names, ages and positions of the Company’s current executive officers and the dates from which these positions have been held are set forth below.

 

Name

   Age   

Office

   Position Since
Bahman Atefi    59    President, Chief Executive Officer and Chairman of the Board of Directors (1)    December 2001
Stacy Mendler    49    Chief Operating Officer and Executive Vice President (1)    September 2006
Barry Broadus    53    Chief Financial Officer, Senior Vice President and Treasurer    September 2012
Scott Fry    63    Sector Senior Vice President – Engineering and Integration Solutions Sector (1)    September 2006
Robert Hirt    52    Sector Senior Vice President – Technology, Engineering and Operational Solutions Sector    July 2011
Thomas McCabe    57    Senior Vice President, General Counsel and Secretary    March 2010

(1) Member of the ESOP committee.

The following sets forth the business experience, principal occupations and employment of each of the current executive officers who do not serve on the Board of Directors. Please read “Information Regarding the Directors of the Registrant” above for the information with respect to Dr. Atefi.

Stacy Mendler has served as Chief Operating Officer and Executive Vice President of Alion since September 2006. She served as Executive Vice President and Chief Administrative Officer of Alion from September 2005 until September 2006, and as Senior Vice President and Chief Administrative Officer of Alion from May 2002 until September 2005. She is also a member of Alion’s ESOP committee. Ms. Mendler served IITRI as Senior Vice President and Director of Administration from October 1997 until December 20, 2002, when Alion purchased substantially all of IITRI’s assets. As of May 2002, Ms. Mendler was IITRI’s Chief Administrative Officer, as well as Senior Vice President. She also served as IITRI’s Assistant Corporate Secretary from November 1998 through December 2002. From February 1995 to October 1997, Ms. Mendler was Vice President and Group Contracts Manager for the Energy and Environment Group at Science Applications International Corporation where she managed strategy, proposals, contracts, procurements, subcontracts and accounts receivable. She currently serves on the Board of Directors of NVTC, the VA Chamber of Commerce (VCOC) and the Professional Services Council (PCS) and on the executive committees of NVTC and VCOC and is the Secretary of NVTC. Ms. Mendler received a BBA in Marketing from James Madison University and a MS in Contracts and Acquisition Management from Florida Institute of Technology.

Barry Broadus has served as Chief Financial Officer, Senior Vice President and Treasurer since September 2012. He served as (Acting) Chief Financial Officer from April 2012 until September 2012 and Director of Financial Planning from September 2008 until April 2012. Prior to joining Alion, from November 2004 to September 2008, Mr. Broadus served as Vice President and Business Unit Controller at Science Applications International Corporation (SAIC) where he was responsible for the financial oversight of the Energy, Environment & Infrastructure Business Unit. Prior to SAIC, from September 2000 to July 2004 he was the Chief Financial Officer for Brainbench, Inc. Prior to Brainbench, Mr. Broadus served for 12 years at EDS, as the Military Systems Business Unit Controller. He also worked for Andersen Consulting. In his earlier career, he was an Officer in the U.S. Army from 1982 to 1985. Mr. Broadus received a Bachelor of Science in Business Administration with a major in Accounting from the University of Alabama.

Scott Fry has served as Sector Senior Vice President for Alion’s Engineering and Integration Solutions Sector since September 2006. Mr. Fry served as Senior Vice President and Sector Manager of Alion’s JJMA Maritime Sector from October 2005 until September 2006, and as Senior Vice President and Deputy Sector Manager for the JJMA Maritime Sector from April 2005 to October 2005. Between January 2004 and April 2005 Mr. Fry was a Group Senior Vice President for Alion’s Strategic Systems Group. Prior to joining Alion in January 2004, Mr. Fry served in the U.S. Navy for 32 years, retiring at the rank of Vice Admiral. His career included command and staff positions both at sea and ashore with the Navy, NATO, and Joint Chiefs of Staff. In his last active duty assignment he commanded the United States Sixth Fleet during Operation Iraqi Freedom and the Global War on Terrorism. Mr. Fry received a BS from the United States Naval Academy in Annapolis, Maryland.

 

93


Table of Contents

Robert Hirt has served as Senior Sector Vice President for the Technology Engineering and Operational Solutions Sector since July 2011 and the Engineering and Information Technology Sector since March 2011. Mr. Hirt joined Alion in April of 2009 as the Deputy Sector Manager for the Engineering and Information Technology Sector. Prior to joining Alion, Mr. Hirt served as a Senior Manager and Chief Technology Officer at SAIC for over 23 years. In this tenure he managed the corporation’s CBRN Weapons Effect, Planning and Simulation Division (DTRA, STRATCOM, NATO), Command and Control Operations (GCCS-J, M, A, GCSS, NCES) and Logistics Service Operation (Asset Visibility, Repairables Management, RFID, Data Center consolidation, MRAP Joint Logistic Integrator, DEAMS, ECSS). Mr. Hirt received his BA in Economics and Mathematics from the University of California and a MS in Systems Engineering from George Washington University.

Thomas McCabe has served as Alion’s Senior Vice President, General Counsel and Secretary since 2010. Prior to joining Alion, he served from 2008 to 2010 as Executive Vice President and General Counsel, and President of the Federal business, of publicly-traded Braintech, Inc., which provided automated vision systems for industrial and military robots. He was Vice President and Deputy General Counsel of publicly-traded XM Satellite Radio from 2005 through its merger with Sirius Satellite Radio in 2008. He was President, CEO and a director of software provider MicroBanx Systems from 2001 to 2005, and President, CEO and a director of its parent company, COBIS Corporation, from 2004 to 2005. From 1992 to 2000, he was a senior executive at GRC International, Inc., a publicly-traded defense contractor, serving as Senior Vice President, General Counsel, Secretary and Director of Corporate Development through its sale to AT&T in 2000. Mr. McCabe was an attorney in private practice from 1982 to 1991. He began his career as judicial clerk for Judge Charles R. Richey at the United States District Court for the District of Columbia from 1981 to 1982. Mr. McCabe has a BA from Georgetown University and an MBA and JD from the University of Notre Dame.

There is no known family relationship between any director and executive officer.

Code of Ethics

In December 2001, Alion adopted a Code of Ethics, Conduct, and Responsibility that applied to all employees, executive officers and directors of the Company and served as a code of ethics for the Company’s chief executive officer, chief financial officer, director of finance, controller, and any person performing similar functions. In 2004, Alion reviewed the Company’s 2001 Code of Ethics and in September 2004, adopted a revised Code applicable to all Alion employees, including Alion’s CEO and CFO. The 2001 Code met the definitional requirements set forth in the rules and regulations of the Securities and Exchange Commission. In November 2009, the Company adopted a newly revised Code of Ethics that applied to all Alion employees and meets the definitional requirements set forth in the rules and regulations of the Securities and Exchange Commission. In November 2010 and October 2011, the Company adopted a further revised Code of Ethics. In November 2012, the Company adopted its currently revised Code of Ethics. Alion provides access to a telephone hotline so employees can report suspected instances of improper business practices such as fraud, waste, and violations of the Company’s Code of Ethics. A copy of the 2012 Code of Ethics is posted for all employees on the Company’s internal website and can also be found on the Company’s Investor Relations website at: http://www.alionscience.com/en/Investor-Relations/~/media/Files/Ethics/Ethics-Code-11-12.ashx. A printed copy without charge may be obtained from the Company’s Secretary upon request.

 

94


Table of Contents

Item 11. Executive Compensation

Compensation Discussion and Analysis

Objectives of Executive Compensation Program

Our executive compensation program’s primary objective is to attract and retain qualified, energetic employees who are enthusiastic about Alion’s mission and to reward them for their contributions to Alion. Our executive compensation program is designed to create strong financial incentive for our officers to increase revenue, profit, cash flow, operating efficiency and returns, which we expect will lead to increased shareholder value. We strive to promote an ownership mentality in our key leaders and our Board of Directors. We endeavor to ensure that our compensation program is perceived as fundamentally fair to all stakeholders.

The Compensation Committee of the Board of Directors (the “Compensation Committee”) evaluates both performance and compensation to ensure Alion maintains its ability to attract and retain employees in key positions. We seek to compensate key employees at levels that are competitive with what our peer group companies pay similarly situated executives. The Compensation Committee believes Alion’s compensation packages for named executives and other officers should include current cash and long-term incentives to reward performance as measured against established goals.

What Our Compensation Program is Designed to Reward

We believe we designed our compensation program to reward each employee’s contribution to Alion. The Compensation Committee considers numerous factors including the Company’s growth and financial performance in measuring named executive officers’ contributions. Throughout this Form 10-K, we refer to the individuals who served as the Company’s Chief Executive Officer and Chief Financial Officer during the current fiscal year, as well as the other individuals included in the Summary Compensation Table, as “named executive officers.”

Roles and Responsibilities for Our Compensation Program

Role of the Compensation Committee

The Compensation Committee is responsible for establishing, implementing and monitoring adherence to Alion’s compensation philosophy and for setting the individual cash and incentive compensation levels for executive officers. The Compensation Committee’s responsibilities are set forth in its charter and discussed in Item 10 under “Establishment of Committees.”

Role of the Chief Executive Officer

Our Chief Executive Officer makes recommendations to the Compensation Committee in evaluating Alion’s executive officers, including recommendations of individual cash and incentive compensation amounts for executive officers. Dr. Atefi relies on his personal experience as Alion’s Chief Executive Officer in evaluating other executive officers and on comparable compensation guidance provided by an outside compensation consultant. Dr. Atefi was not present during Compensation Committee deliberations and voting pertaining to the determination of his own compensation.

Role of the Compensation Consultant

The Compensation Committee annually retains a consultant to provide independent advice on executive compensation matters and to perform specific project-related work. In 2012, we engaged AON Hewitt to review the compensation of our named executive officers and to provide competitive data and analysis to the Compensation Committee. They performed no other services for the Company.

Elements of Company’s Executive Compensation Program

Alion’s compensation program includes several major elements. We pay our named executive officers salaries that are competitive and non-discriminatory to attract, retain, and motivate them. We offer an incentive program designed to encourage exceptional employee performance. As an employee-owned company, we offer our named executive officers the ability to invest in the future of our company through our ESOP. The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan, includes an ESOP, which allows employees to own an interest in the company’s stock, and a 401(k) salary deferral component that allows employees to have diversified retirement savings in other investments. ESOP investments are indirect investments in Alion common stock. 401(k) investments are investments in a variety of mutual funds. We offer fringe benefit and employee morale and wellness programs designed to attract and retain our named executive officers.

 

95


Table of Contents

Base Salary

Alion pays each named executive officer a base salary for services rendered during the fiscal year. This fixed annual amount for performing specific job responsibilities is the minimum income the named executive officer may receive in any given year. Each Alion executive’s base salary is determined by his or her responsibilities and performance as well as comparative compensation levels for his or her peers. The Compensation Committee determines the Chief Executive Officer’s base salary, including periodic changes, and determines base salaries and changes, for other named executive officers following recommendations by the Chief Executive Officer.

Base salaries for our named executive officers as of September 30, 2012 were:

 

Named Executive Officer

   Fiscal 2012 Base Salary  

Bahman Atefi

   $ 735,000   

Stacy Mendler

   $ 425,000   

Barry Broadus

   $ 280,000   

Scott Fry

   $ 360,000   

Robert Hirt

   $ 320,000   

Each year, the Compensation Committee utilizes salary survey information provided by its outside compensation consultant for appropriate salary data for Alion’s senior positions.

In reviewing base salaries for our named executive officers, the Compensation Committee considers:

 

   

market data provided by the Company’s outside compensation consultant;

 

   

the executive’s compensation, individually and relative to other officers;

 

   

the executive’s individual performance; and

 

   

Alion’s financial and operating results.

The Compensation Committee and its outside consultant use publicly available data from other professional services government contracting companies to benchmark compensation for Alion’s named executive officers. The benchmark companies include some of the publicly-traded companies Alion uses in its market analyses to calculate enterprise value for goodwill impairment testing. The Compensation Committee compares Alion data to median data for the benchmark group in evaluating total named executive officer compensation and individual elements of total compensation. Among other factors, the Compensation Committee evaluates base salaries, total cash compensation and various types of long term incentive compensation provided to named executives at benchmark companies in making decisions about the components and levels of compensation for Alion’s named executive officers. The Compensation Committee sets these levels of total compensation to be within the range of the peer companies.

For fiscal 2012, the Compensation Committee reviewed a peer group of companies from the information technology, professional services, and defense and aerospace industries. In its analysis, the Compensation Committee compared data for the selected peer group with data from several broader, national compensation surveys and Alion’s current executive compensation levels. The following companies made up the compensation peer group.

 

CACI International Inc.    Exponent, Inc.    Kratos Defense & Security    SRA International Inc.
CIBER Inc.    Harris Corp.    ManTech International Corp.    VSE Corp.
Cubic Corp.    Heico Corp.    Maximus Inc.   
Dynamics Research Corp.    ICF International, Inc.    NCI, Inc.   
Engility Holdings, Inc.    IHS, Inc.    Orbital Sciences Corp.   

The Compensation Committee decided to maintain but not to increase base salaries for Dr. Atefi, Ms. Mendler and Mr. Fry for next year. Based on new and expanded responsibilities, the Compensation Committee increased base salaries for Mr. Hirt and Mr. Broadus for next fiscal year. This is the first year that Mr. Broadus is a named executive officer.

 

96


Table of Contents

Annual Bonus

We use annual bonuses in our compensation program to motivate and reward our named executive officers for current, short term performance such as meeting annual financial performance goals, and achieving certain milestones and other non-financial performance goals within a given year. The Compensation Committee believes it is important to encourage and reward both short-term and long-term performance. The Compensation Committee has the discretion to set goals and objectives it believes are consistent with creating shareholder value, including financial measures, operating objectives, growth goals and other measures. Objectives may be based upon Alion achieving revenue or operating income targets as well as other financial and business objectives. Revenue growth and operating profitability are weighted as the most significant factors. The Compensation Committee evaluates achievement of objectives following the end of each year and makes annual bonus awards based on this assessment. The Compensation Committee considers individual achievement and also relies on the Chief Executive Officer’s recommendations with respect to other executive officers.

Long-term Incentives/Awards

We use our long-term incentives to motivate, retain and reward our named executive officers for both short-term and sustained performance. The Compensation Committee establishes performance-based award opportunities specific to Alion’s financial performance and the specific business unit and/or corporate department an individual leads.

Long-Term Incentive Plan

We established the Alion Science and Technology Corporation Long-Term Incentive Plan (LTIP) in November 2008. The LTIP provides for award opportunities based on the achievement of predefined individual performance goals the Compensation Committee sets. LTIP awards are paid in cash. Our named executive officers and other key employees are eligible to receive LTIP awards.

We established the LTIP to:

 

   

provide certain employees an incentive for excellence in achieving certain Company and business unit or departmental goals;

 

   

facilitate key employee retention and recruitment;

 

   

provide at-risk awards contingent on achievement of selected performance criteria over an extended period; and

 

   

provide a meaningful incentive to achieve long-term growth and improve profitability.

Under the LTIP, our Compensation Committee is responsible for:

 

   

selecting which of our key employees may participate in the LTIP;

 

   

determining the period over which a participant must achieve his or her performance goals, (performance period);

 

   

setting each participant’s award opportunities for a given performance period; and

 

   

establishing award vesting conditions.

Following consultation with the outside compensation consultant retained by the Compensation Committee, we determined Alion needed a non-equity based long-term incentive compensation plan to motivate and appropriately reward named executive officers and other key employees. Subject to certain limitations, LTIP compensation costs are allowable indirect expenses that can be reimbursed through government contracts. We do not expect to recover all LTIP compensation costs. Our LTIP is intended to differ from our prior equity-based compensation plans which were not an allowable indirect expense and could not be reimbursed through our government contracts.

The Board of Directors has adopted separate forms of LTIP award agreements for named and other executive officers. In 2012, the Board of Directors granted each named executive officer an LTIP award which vests over a three year period ending November 2015. In 2008, the Board of Directors established five initial LTIP award categories for named executive officers; it has created a new LTIP award category each year thereafter. All initial LTIP grants vested and have been paid out. The LTIP grants issued to named executive officers in 2009 vested in November 2012. The vested 2009 LTIP grants are the only named executive officer grants outstanding in addition to the LTIP grants listed in the named executive officer compensation table below.

Performance goals under these award agreements include, among others, reaching certain company-planned revenue targets; achieving certain levels of Consolidated EBITDA (as determined for our debt covenants); achieving certain levels of reporting unit revenue and operating income; complying with debt covenants; and achieving targeted levels of days’ sales outstanding.

 

97


Table of Contents

Some LTIP grants to our named executive officers involve a three-year performance cycle with one third of each three-year grant related to each annual performance cycle during the term of the grant. Most LTIP grants to named executive officers are evaluated by the Compensation Committee evaluates performance for three-year grants only at the end of each three-year performance cycle. This fiscal year was the first three-year performance cycle for grants evaluated only at the end of a three-year performance period.

Subject to the Compensation Committee’s discretion, each executive’s performance is evaluated at the end of each year, and then at the end of the three-year performance cycle. A recipient may receive anywhere from 50% to 150% of the target amount up through the end of a performance cycle depending on whether the individual and the company achieve performance goals, or substantially under- or over-achieve performance goals. The 50% floor was established in order to foster executive retention, while the 150% ceiling is intended to reward outstanding performance. Subject to the annual evaluations on this percentage-based scale, each earned award vests in full on its vesting date, provided that the named executive officer is still employed with us.

The following table sets forth the target LTIP amounts approved by our Compensation Committee and Board of Directors, for each of our named executive officers. Consistent with the design of the LTIP, the Compensation Committee and the Board of Directors approved LTIP awards to senior corporate officers in addition to our named executive officers listed below.

 

Name

   Initial Target Value
2012 LTIP Awards
 

Bahman Atefi

   $ 1,100,000   

Stacy Mendler

   $ 385,000   

Barry Broadus

   $ 160,000   

Scott Fry

   $ 275,000   

Robert Hirt

   $ 220,000   

The ranges reflect LTIP award levels for each named executive officer based on market information provided to us by our compensation consultant. Each named executive officer’s LTIP award is based on his or her specific position, responsibilities, accountabilities and impact within our company. We vet these target participation levels against the participation levels of similarly situated executive officers at peer companies. The Compensation Committee established this year’s named executive officer LTIP award target values as part of each executive’s total compensation package, including salary and other cash compensation. Some LTIP awards were less than last year’s grant levels to reflect risks the Company faces from sequestration and potential Department of Defense spending cuts. Other LTIP awards increased from last year to reflect changes in duties and responsibilities for certain named executive officers.

Phantom Stock Plans

Phantom stock refers to hypothetical shares of Alion common stock. Each recipient of a phantom stock award receives a grant of a specified number of shares. Recipients, upon vesting, are generally entitled to receive cash equal to the number of hypothetical vested shares times the current value of Alion common stock, based on the most recent stock valuation performed for the ESOP Trust. Phantom stock may increase or decrease in value over time, resulting in cash payments greater or less than the phantom stock’s grant date value. The Compensation Committee administers Alion’s phantom stock plans and is authorized to grant phantom stock to the named executive officers. There have been no phantom stock awards to named executive officers since 2008.

Stock Appreciation Rights (SAR) Plan

In January 2005, the Board of Directors adopted the Alion Science and Technology Corporation 2004 Stock Appreciation Rights Plan (the SAR Plan). The Compensation Committee, or the administrative committee as delegated, administers the SAR Plan. The SAR Plan has a 10-year term and permits grants to Alion directors, officers, employees and consultants. The SAR Plan permits the Chief Executive Officer to award SARs as he deems appropriate. Awards to executive officers are subject to the approval of the administrative committee of the Plan. There were no SAR awards to named executive officers in 2012.

Severance/Change in Control and Provisions in Employment Agreements

We maintain employment agreements with certain named executive officers to help ensure they will perform their roles for an extended period of time. These agreements provide for severance payments if an executive’s employment is terminated under certain conditions, such as following a change of control or a termination “without cause” as defined in the agreements.

 

98


Table of Contents

Change in Control

As part of our normal course of business, we engage in discussions with other companies about possible collaborations and/or other ways to work together to further our respective long-term objectives. Many larger, established companies consider companies at stages of development similar to ours as potential acquisition targets. In certain circumstances, a potential merger, acquisition or material investment could be in the best interests of our shareholders. We provide severance compensation if an executive’s employment is terminated following a change in control transaction.

Termination without Cause

If we terminate the employment of a named executive officer without cause as defined in his or her employment agreement, we are obligated to continue to pay certain amounts as described below under Other Potential Post-Termination Payments. This provides us with flexibility to make a change in senior management if such a change is in the best interests of Alion and its shareholders.

Health and Welfare Benefits and Other Fringe Benefits

Alion provides all its named executive officers a comprehensive, balanced, and flexible fringe benefit program. Our fringe benefit program’s design plays an important role in attracting new employees and retaining our named executive officers. We review industry-wide fringe benefit packages annually to ensure that Alion’s fringe benefit program continues to provide the best value to our named executive officers. Benefits include medical, prescription drug, vision and dental coverage; life insurance; accidental death and dismemberment insurance, short and long-term disability insurance; business travel accident, kidnap and ransom insurance; an employee assistance program and flexible spending accounts for medical expense reimbursement and child care. Alion provides worker’s compensation insurance and unemployment benefits required by law to all employees, including named executive officers. We purchase worker’s compensation and unemployment insurance. Our benefit plans do not discriminate in favor of our named executive officers. Alion provides the major portion of its fringe benefit program as a core package of standard benefits supplemented by a set of employee-selected optional benefits. All eligible employees, including named executive officers contribute to the cost of certain benefits at the same rates and in the same manner. The Company also provides named executive officers a monthly automobile allowance.

KSOP

Alion’s KSOP is a qualified retirement plan that includes an ESOP and a 401(k). The ESOP Trust owns all of the Company’s outstanding shares of common stock. Through June 2011, Alion made retirement plan contributions to both the ESOP and 401(k) components on behalf of all eligible employee KSOP participants. We now make all retirement contributions to the ESOP along with matching contributions based on eligible employee pre-tax salary deferrals. Named executive officers do not receive preferential KSOP benefits.

Compensation Risk Assessment

The Compensation Committee believes that the design and mix of our compensation program appropriately encourages our employees to focus on the creation of long-term shareholder value while also serving to attract, retain and motivate needed talent. We believe our approach to setting company and individual goals with target payouts at multiple performance levels encourages a level of risk-taking behavior appropriate for our business. We also believe we have allocated our compensation among base salary, annual cash incentives and long-term incentive compensation in such a way as not to encourage excessive risk-taking. In its discussions, the Compensation Committee noted the following attributes of our compensation program.

 

   

There is a balance between short- and long-term financial and strategic objectives, intended to reward managers for continuous improvement in revenue and operating income and growth in shareholder value.

 

   

A significant portion of management compensation is “at risk” and depends on achieving specific company-wide strategic operational and financial goals, as well as individual performance goals that can be objectively determined. These corporate goals have pre-established minimum, target and stretch performance levels, with individual metrics and overall maximums.

 

99


Table of Contents
   

The Compensation Committee considers other qualitative matters in determining annual performance payments and achievement of long term incentive goals.

 

   

In 2012, the Compensation Committee considered Alion’s overall financial performance and its improved performance compared to fiscal 2011 in deciding to increase non-equity incentive compensation payments to Dr. Atefi, Ms. Mendler, and Mr. Fry from last year’s lower levels. In 2012, non-equity incentive compensation for these named executive officers was comparable to their 2010 non-equity incentive compensation. The Compensation Committee maintained base salaries for these named executive officers for next fiscal year at current year levels based on the Company’s need to continue improving performance and the industry risks Alion faces.

 

   

The Compensation Committee increased Mr. Hirt’s non-equity incentive compensation based on his expanded duties and his reporting unit operating results for the past year. This was the first year that Mr. Broadus served as principal financial officer. The Compensation Committee increased base salaries for Mr. Hirt and Mr. Broadus to acknowledge their increased responsibilities.

 

   

Our named executives’ ongoing long term compensation grants vest over a three year period with performance goals measured only at the end of a three-year period. We believe this encourages our executives to focus on Alion’s long term performance.

Based on this review and currently known facts and circumstances, the Compensation Committee believes Alion’s compensation policies and practices, individually and in the aggregate, do not create known risks that are reasonably likely to materially adversely affect the Company.

Summary Compensation Table

The following table sets forth all compensation with respect to our Chief Executive Officer and our other named executive officers for the years ended September 30, 2012, 2011, and 2010.

 

Name and Principal Position    Year      Salary      Bonus      Long-
Term
Incentive
Plan
Awards
     Non-
Equity
Incentive
Plan
Awards (1)
     All other
(2)
     Total  

Bahman Atefi

     2012       $ 763,929       $ —         $ 1,100,000       $ 700,000       $ 106,612       $ 2,670,540   

Chief Executive Officer

     2011       $ 757,449       $ —         $ 1,200,000       $ 560,000       $ 120,477       $ 2,637,926   

and President

     2010       $ 718,940       $ —         $ 1,000,000       $ 700,000       $ 117,023       $ 2,535,963   

Barry Broadus

     2012       $ 272,610       $ 33,000       $ 160,000       $ 165,000       $ 49,842       $ 680,451   

Senior Vice President and

     2011         N/A         N/A         N/A         N/A         N/A         N/A   

Chief Financial Officer

     2010         N/A         N/A         N/A         N/A         N/A         N/A   

Michael Alber

     2012       $ 264,404       $ 15,000       $ N/A       $ N/A       $ 52,195       $ 331,598   

Senior Vice President and

     2011       $ 346,718       $ —         $ 225,000       $ 160,000       $ 60,902       $ 792,620   

Chief Financial Officer (former)

     2010       $ 320,735       $ 50,000       $ 200,000       $ 200,000       $ 52,849       $ 823,584   

Stacy Mendler

     2012       $ 441,606       $ —         $ 385,000       $ 300,000       $ 74,873       $ 1,201,479   

Chief Operating Officer

     2011       $ 436,984       $ —         $ 400,000       $ 240,000       $ 80,086       $ 1,157,070   

and Executive Vice President

     2010       $ 411,601       $ —         $ 350,000       $ 300,000       $ 79,188       $ 1,140,789   

Scott Fry

     2012       $ 374,389       $ —         $ 275,000       $ 220,000       $ 50,066       $ 919,455   

Engineering and Integration Solutions Sector,

     2011       $ 364,701       $ —         $ 300,000       $ 176,000       $ 45,794       $ 886,495   

Senior Vice President

     2010       $ 362,228       $ —         $ 250,000       $ 220,000       $ 49,621       $ 881,849   

Robert Hirt

     2012       $  318,495       $  20,000       $ 220,000       $  190,000       $ 50,150       $ 798,644   

Technology, Engineering

     2011       $ 259,482       $ 20,000       $ 200,000       $ 160,000       $ 45,699       $ 685,181   

and Operational Solutions

     2010         N/A         N/A         N/A         N/A         N/A         N/A   

Senior Vice President

                    

 

100


Table of Contents

Bonuses include non-incentive based cash bonuses, such as special performance bonuses, paid to named executive officers.

Amounts reported for long term incentive plan awards represent initial target values of current year grants to named executive officers.

Non-equity incentive plan compensation includes cash bonuses awarded to our named executive officers for current fiscal year service.

Other compensation includes: 401(k) matching and profit sharing contributions under Alion’s KSOP; Company contributions for long and short term disability; amounts paid for life insurance premiums; amounts paid or reimbursed with respect to health and welfare; amounts paid or reimbursed with respect to social club membership; and amounts paid or reimbursed with respect to leased cars.

Detail of All Other Compensation for Fiscal Year 2012, 2011, 2010

Recorded in the Summary Compensation Table

 

Name and Principal

Position

   Year      Company
Matching
Contributions
Under
Alion’s
KSOP
     Health and
Welfare
Benefits
     Long and
Short Term
Disability
Paid by the
Company
 

Bahman Atefi

     2012       $ 16,250       $ 51,209       $ 5,250   
     2011       $ 15,925       $ 65,630       $ 5,219   
     2010       $ 15,925       $ 67,249       $ 5,130   

Barry Broadus

     2012       $ 20,099       $ 26,163       $ 2,419   
     2011         N/A         N/A         N/A   
     2010         N/A         N/A         N/A   

Michael Alber

     2012       $ 16,250       $ 25,038       $ 1,863   
     2011       $ 15,925       $ 27,714       $ 2,840   
     2010       $ 6,213       $ 27,516       $ 2,901   

Stacy Mendler

     2012       $ 16,250       $ 35,144       $ 3,387   
     2011       $ 15,925       $ 40,707       $ 3,365   
     2010       $ 15,925       $ 41,794       $ 3,354   

Scott Fry

     2012       $ 15,842       $ 18,733       $ 2,998   
     2011       $ 11,117       $ 18,330       $ 2,989   
     2010       $ 11,129       $ 20,231       $ 3,069   

Robert Hirt

     2012       $ 7,459       $ 28,043       $ 2,709   
     2011       $ 6,901       $ 24,494       $ 2,397   
     2010         N/A         N/A         N/A   

 

101


Table of Contents

Detail of All Other Compensation for Fiscal Year 2012, 2011, 2010

Recorded in the Summary Compensation Table (continued)

 

Name and Principal

Position

   Year      Club
Membership
Fees
     Term Life
Insurance
Paid by the
Company
     Leased
Cars
     Total  

Bahman Atefi

     2012       $ 5,780       $ 300       $ 27,823       $ 106,612   
     2011       $ 5,580       $ 300       $ 27,823       $ 120,477   
     2010       $ 5,490       $ 457       $ 22,772       $ 117,023   

Barry Broadus

     2012       $ —         $ 158       $ 1,002       $ 49,842   
     2011         N/A         N/A         N/A         N/A   
     2010         N/A         N/A         N/A         N/A   

Michael Alber

     2012       $ —         $ 132       $ 8,912       $ 52,195   
     2011       $ —         $ 201       $ 14,222       $ 60,902   
     2010       $         $ 289       $ 15,930       $ 52,849   

Stacy Mendler

     2012       $ —         $ 256       $ 19,836       $ 74,873   
     2011       $ —         $ 253       $ 19,836       $ 80,086   
     2010       $ —         $ 359       $ 17,756       $ 79,188   

Scott Fry

     2012       $ —         $ 217       $ 12,276       $ 50,066   
     2011       $ —         $ 216       $ 13,142       $ 45,794   
     2010       $ —         $ 318       $ 14,874       $ 49,621   

Robert Hirt

     2012       $ —         $ 188       $ 11,751       $ 50,150   
     2011       $ —         $ 156       $ 11,751       $ 45,699   
     2010         N/A         N/A         N/A         N/A   

Summary of Prior Year LTIP Award Agreements

In 2009, the Board of Directors adopted several separate forms of LTIP award agreements. Some named executive officers were eligible to receive awards under more than one category. Only Category F grants remain outstanding. Category F LTIP grants had a three-year performance period ending October 2012, vesting on November 15, 2012. Awards had a potential final value of 50% to 150% of their initial target value.

Performance goals for Category F agreements include, among others, reaching certain company-planned revenue targets; achieving certain levels of Consolidated EBITDA (as determined for our debt covenants); achieving certain levels of reporting unit revenue and operating income; complying with debt covenants; and achieving targeted levels of days’ sales outstanding. The following table sets out the initial target values for Category F grants approved by our Compensation Committee and Board of Directors in 2009 for the named executive officers listed below.

 

Name

   Category F  

Bahman Atefi

   $ 1,000,000   

Stacy Mendler

   $ 350,000   

Scott Fry

   $ 250,000   

 

102


Table of Contents

Grants of Plan-Based Awards

There were no grants of plan-based awards to named executive officers in 2012.

Outstanding Equity Awards at Fiscal Year-End

The following table lists SAR awards held by named executive officers as of September 30, 2012.

 

Name

   Number of
securities
underlying
unexercised
SARs (#)
Exercisable
     Number of
securities
underlying
unexercised
SARs (#)
Unexercisable
     SAR
Exercise
Price
     SAR
Expiration
Date
 

Barry M. Broadus (1)

     —           2,000       $ 34.30         December 2014   

Barry M. Broadus (2)

     —           2,000       $ 26.65         December 2015   

Barry M. Broadus (3)

     —           2,000       $ 20.95         December 2016   

 

(1) In December 2009, Mr. Broadus was awarded 2,000 SARs at an exercise price of $34.30 per share which vest in 2013.
(2) In December 2010, Mr. Broadus was awarded 2,000 SARs at an exercise price of $26.65 per share which vest in 2014.
(3) In December 2011, Mr. Broadus was awarded 2,000 SARs at an exercise price of $20.95 per share which vest in 2015.

All grants were outstanding as of September 30, 2012.

SAR Exercises

No named executive officers exercised any SARs in 2012.

Deferred Compensation Plans

We maintain two Deferred Compensation Plans. One plan, the Executive Deferred Compensation Plan, covers members of management and other highly compensated officers of the Company. The other plan, the Directors Deferred Compensation Plan, covers members of the Company’s Board of Directors. Neither plan is a qualified plan under the Internal Revenue Code.

Each plan permits an individual to make a qualifying election to forego current payment and defer a portion of his or her compensation. Officers may defer up to 50% of their annual base salary and up to 100% of bonus and/or stock-based compensation payments. Directors may defer up to 100% of their fees and their stock-based compensation payments.

Each Plan permits an individual to defer payment to a specified future date and to specify whether deferrals are to be paid in a lump sum or installments. Under certain limited circumstances, deferrals may be paid out early or further deferred. Typically, individuals may only make one qualifying deferral election per year.

Scott Fry is the only named executive officer who has elected to participate in the Executive Deferred Compensation in fiscal year 2012.

 

Name

   Executive
Contributions
in Last FY
($)
     Registrant
Contributions
in Last FY
($)
     Aggregate
Earnings in
Last FY
($)
     Aggregate
Withdrawals/
Distributions
($)
     Aggregate
Balance at
Last FYE
($)
 

Scott Fry

   $ —         $ —         $ 109,537       $ —         $ 648,756   

Potential Payments Upon Termination or Change in Control

We have employment agreements with four named executive officers, which provide that if the officer is involuntarily terminated without cause or terminated following a change in control, he or she will be entitled to receive a lump sum cash payment as set forth in his or her individual agreement. The named executive officers’ employment agreements define “termination for cause,” “good reason” and “change in control” for purposes of determining payments upon termination of employment. The four named executive officers are also entitled to accelerated vesting of certain outstanding LTIP awards under the terms of their LTIP award agreements.

 

103


Table of Contents

The named executive officer employment agreements provide for salary- and bonus-based severance payments for termination without cause or termination related to a change in control. Under such circumstances, the named executive officers are also eligible for up to $25,000 in outplacement services from a firm selected and paid by Alion, 18 months of company-subsidized health care benefits and a related 40% tax gross up. The Company will provide outplacement services up through December 31 of the second calendar year following the calendar year in which the named executive’s employment terminated. The LTIP award agreements provide for accelerated vesting upon a change in control, termination without cause, death or disability, and a change in responsibility.

In order to receive termination-related payments under their employment agreements, named executive officers must execute a release and agree to non-compete, non-interference and non-solicitation covenants that run the same length of time as their salary-based severance. Named executive officers must also agree to a two-year trade-secret non-disclosure covenant and a non-disparagement covenant that runs the life of their agreement.

The tables below set out the estimated payments and benefits that would be provided to each named executive officer as a result of (a) termination without cause; (b) termination on death or disability; (c) termination for cause, voluntary termination or retirement, and; (d) termination or change in responsibility upon a change in control. The calculations in these tables are based on the assumption that termination occurred on September 30, 2012, the last day of the Company’s most-recently completed fiscal year. Amounts in the tables below do not include payments and benefits to the extent they are provided on a non-discriminatory basis to salaried employees generally upon termination of employment.

Potential Termination-Related Payments to

Bahman Atefi, Chief Executive Officer

 

                  Unrelated to a Change in Control      Change in
Control
 

Incremental Compensation and Benefit Payment

   Applicable
Percentage
    Base
Dollars
     Termination
without
Cause
     Death/
Disability
     Termination
for Cause,
Voluntary
Termination,
Retirement
     Termination,
Change in
Responsibility
or Other
Good Reason
 

Salary-based severance

     200   $ 735,000       $ 1,470,000       $ —         $ —         $ 1,470,000   

Bonus-based severance

     200   $ 700,000       $ 1,400,000       $ —         $ —         $ 1,400,000   

Health care benefits

     $ 14,058       $ 21,086       $ —         $ —         $ 21,086   

Tax Gross Up

     40      $ 8,435         —           —         $ 8,435   

Outplacement services

     $ 25,000       $ —         $ —         $ —         $ 25,000   

LTIP Acceleration

        $ 500,000       $ 2,200,000       $ —         $ 2,200,000   
       

 

 

    

 

 

    

 

 

    

 

 

 

Total

        $ 3,399,521       $ 2,200,000       $ —         $ 5,124,521   
       

 

 

    

 

 

    

 

 

    

 

 

 

 

104


Table of Contents

Potential Termination-Related Payments to

Stacy Mendler, Chief Operating Officer

 

                  Unrelated to a Change in Control      Change in
Control
 

Incremental Compensation and Benefit Payment

   Applicable
Percentage
    Base
Dollars
     Termination
without
Cause
     Death/
Disability
     Termination
for Cause,
Voluntary
Termination,
Retirement
     Termination,
Change in
Responsibility
or Other
Good Reason
 

Salary-based severance

     150   $ 425,000       $ 637,500       $ —         $ —         $ 637,500   

Bonus-based severance

     150   $ 300,000       $ 450,000       $ —         $ —         $ 450,000   

Health care benefits

     —        $ 14,337       $ 21,505       $ —         $ —         $ 21,505   

Tax Gross Up

     40        8,602         —           —         $ 8,602   

Outplacement services

     —        $ 25,000       $ —         $ —         $ —         $ 25,000   

LTIP Acceleration

        $ 175,000       $ 750,000       $ —         $ 750,000   
       

 

 

    

 

 

    

 

 

    

 

 

 

Total

        $ 1,292,607       $ 750,000       $ —         $ 1,892,607   
       

 

 

    

 

 

    

 

 

    

 

 

 

Potential Termination-Related Payments to

Scott Fry, Sector Senior Vice President

 

                  Unrelated to a Change in Control      Change in
Control
 

Incremental Compensation and Benefit Payment

   Applicable
Percentage
    Base
Dollars
     Termination
without
Cause
     Death/
Disability
     Termination
for Cause,
Voluntary
Termination,
Retirement
     Termination,
Change in
Responsibility
or Other
Good Reason
 

Salary-based severance

     100   $ 360,000       $ 360,000       $ —         $ —         $ 360,000   

Bonus-based severance

     100   $ 220,000       $ 220,000       $ —         $ —         $ 220,000   

Health care benefits

     —        $ 367       $ 551       $ —         $ —         $ 551   

Tax Gross Up

     40        220         —           —         $ 220   

Outplacement services

     —        $ 25,000       $ —         $ —         $ —         $ 25,000   

LTIP Acceleration

        $ 125,000       $ 550,000       $ —         $ 550,000   
       

 

 

    

 

 

    

 

 

    

 

 

 

Total

        $ 705,771       $ 550,000       $ —         $ 1,155,771   
       

 

 

    

 

 

    

 

 

    

 

 

 

 

105


Table of Contents

Potential Termination-Related Payments to

Robert Hirt, Sector Senior Vice President

 

                  Unrelated to a Change in Control      Change in
Control
 

Incremental Compensation and Benefit Payment

   Applicable
Percentage
    Base
Dollars
     Termination
without
Cause
     Death/
Disability
     Termination
for Cause,
Voluntary
Termination,
Retirement
     Termination,
Change in
Responsibility
or Other
Good Reason
 

Salary-based severance

     100   $ 340,000       $ 340,000       $ —         $ —         $ 340,000   

Bonus-based severance

     100   $ 190,000       $ 190,000       $ —         $ —         $ 190,000   

Health care benefits

     —        $ 14,337       $ 21,505       $ —         $ —         $ 21,505   

Tax Gross Up

     40        8,602         —           —         $ 8,602   

Outplacement services

     —        $ 25,000       $ —         $ —         $ —         $ 25,000   

LTIP Acceleration

        $ 25,000       $ 250,000       $ —         $ 250,000   
       

 

 

    

 

 

    

 

 

    

 

 

 

Total

        $ 585,107       $ 250,000       $ —         $ 835,107   
       

 

 

    

 

 

    

 

 

    

 

 

 

Director Compensation

The following table sets forth certain information regarding the compensation paid to the Company’s non-employee directors for their service during the fiscal year ended September 30, 2012.

 

Name

   Fees earned
or paid in cash ($)
(1)
     All other
compensation ($)
(2)
     Total  

Edward C. Pete Aldridge, Jr.

   $ 84,995       $ 1,755       $ 86,750   

Leslie Armitage

   $ 96,500       $ —         $ 96,500   

Lewis Collens

   $ 86,492       $ 1,008       $ 87,500   

Admiral (Ret.) Harold W. Gehman, Jr.

   $ 90,500       $ —         $ 90,500   

Michael Hayden

   $ 84,000       $ —         $ 84,000   

General (Ret.) George A. Joulwan

   $ 88,000       $ —         $ 88,000   

General (Ret.) Michael E. Ryan

   $ 95,159       $ 841       $ 96,000   

David Vitale

   $ 78,750       $ 1,750       $ 80,500   

 

(1) This column represents the total fees including the annual retainer fee to non-employee directors. Alion employee directors do not receive any additional compensation for service as a member of the Board of Directors. For the year ended September 30, 2012, Alion’s non-employee directors received an annual retainer and compensation of $70,000, payable in quarterly installments. Each director also receives a fee of $2,500 for in-person attendance or $1,000 for telephone attendance at a Board of Directors meeting. The Audit and Finance Committee chairperson receives $7,500 per year for each year he or she serves in such capacity. Other board committee chairpersons receive $5,000 per year for each year he or she serves in such capacity. Board committee members receive $1,000 per committee meeting when a committee meeting occurs on other than the day of a Board of Directors meeting. Alion reimburses directors for reasonable travel expenses in connection with attendance at Board of Directors and board committee meetings.
(2) This column represents amounts paid by Alion for travel expenses to attend Board of Directors and board committee meetings.

 

106


Table of Contents

Compensation Committee Interlocks and Insider Participation

The members of the Compensation Committee are Harold Gehman (Chairman), Leslie Armitage, Lewis Collens, George Joulwan, and Pete Aldridge. None of the members, during the fiscal year, was an Alion officer or employee, formerly an Alion officer, or involved in a related party transaction. Dr. Atefi is the President and Chief Executive Officer of Alion.

During the last completed fiscal year:

(A) No executive officer of the Company served as a member of the compensation committee (or other board committee performing equivalent functions or, in the absence of any such committee, the entire board of directors) of another entity, one of whose executive officers served on the Compensation Committee of the Company;

(B) No executive officer of the Company served as a director of another entity, one of whose executive officers served on the Compensation Committee of the Company; and

(C) No executive officer of the Company served as a member of the compensation committee (or other board committee performing equivalent functions or, in the absence of any such committee, the entire board of directors) of another entity, one of whose executive officers served as a director of the Company.

Compensation Committee Report

The Compensation Committee of the Company has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with management and, based on such review and discussions, the Compensation Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Annual Report.

THE COMPENSATION COMMITTEE

Harold Gehman, Jr., Chairman

Pete Aldridge, Jr., Committee Member

Leslie Armitage, Committee Member

Lewis Collens, Committee Member

George Joulwan, Committee Member

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters

Security Ownership of Certain Beneficial Owners and Management

The following table sets forth certain information as of September 30,2012, regarding beneficial ownership of Alion common stock by (i) all persons known by the Company that beneficially own more than 5% of the Company’s common stock, (ii) all directors and (iii) all named executive officers, individually and as a group.

 

Name and Address of Beneficial Owner

   Title of Class      Amount
and Nature
of
Beneficial
Ownership
    Percentage
of Class
 

Five Percent Security Holders:

       

Alion Science and Technology Corporation Employee Ownership,

       

Savings and Investment Trust

     Common Stock         6,731,889        100

Directors and Executive Officers

       

Bahman Atefi

     Common Stock         60,806 (5)      0.9   

Stacy Mendler

     Common Stock         76,497 (5)      1.1   

Michael Alber

     Common Stock         1,507 (5)         ** 

Barry Broadus

     Common Stock         1,835 (5)         ** 

Scott Fry

     Common Stock         8,369 (5)      0.1   

Robert Hirt

     Common Stock         689 (5)         ** 

All Directors and Executive Officers as a Group (6 persons)

     Common Stock         149,702 (5)      2.2   

 

** Less than 1 percent.

 

107


Table of Contents
   

The address of all persons listed is 1750 Tysons Boulevard, Suite 1300, McLean, Virginia 22101.

 

   

Voting power with respect to the Alion common stock is held by the ESOP Trust. The ESOP Committee instructs the ESOP Trustee on most matters coming before the shareholders for a vote except for a limited number of matters which pursuant to the Plan require a pass-through vote by the beneficial holders.

 

   

Applicable percentages are based on 6,731,889 shares outstanding on September 30, 2012, and are calculated with respect to each person pursuant to Rule 13d-3(d) of the Exchange Act.

 

   

No directors (other than Dr. Atefi) are beneficial owners of the Company’s common stock.

 

   

Includes beneficial ownership of shares of Alion’s common stock held by the ESOP Trust.

Changes in Control

We do not know of any arrangements, the operation of which may at a subsequent date result in a change in control of Alion.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Transactions with related persons

Since the beginning of the Company’s last fiscal year, including any currently proposed transactions, no directors, executive officers or immediate family members of such individuals were engaged in transactions with us or any subsidiary involving more than $120,000 other than the arrangements described in the section “Executive Compensation.”

Review, approval or ratification of transactions with related persons

In accordance the procedures it has established, our Audit and Finance Committee is responsible for reviewing and approving the terms and conditions of all related party transactions. Any material transaction with a director or executive officer of the Company or a member of the immediate family of a director or officer is required to be approved by our Audit and Finance Committee prior to Alion entering into such transaction.

Director Independence

A majority of the Company’s directors meet the test of “independence” as defined by the NYSE Amex rules. The NYSE Amex rules provide that to qualify as an “independent” director, in addition to satisfying certain bright-line criteria, the board of directors must affirmatively determine that a director has no material relationship with the Company (either directly or as a partner, shareholder or officer of an organization that has a relationship with the Company). Our board of directors has determined that Pete Aldridge, Jr., Leslie Armitage, Lewis Collens, Harold Gehman, Jr., Michael Hayden, George Joulwan, Michael Ryan and David Vitale satisfy the bright-line criteria and that none has a relationship with Alion that would interfere with his or her ability to exercise independent judgment as a member of the board. Therefore, we believe that each of these directors is independent under the NYSE Amex rules.

The Audit and Finance Committee currently consists of Leslie Armitage, Lewis Collens, Harold Gehman, Jr., Michael Ryan and David Vitale. All members of the Audit and Finance Committee are independent in accordance with the NYSE Amex Rules.

The Compensation Committee currently consists of Harold Gehman, Jr., Pete Aldridge, Jr., Leslie Armitage, Lewis Collens and George Joulwan. All members of the Compensation Committee are independent in accordance with the NYSE Amex rules.

The Governance and Compliance Committee currently consists of Michael Ryan, Bahman Atefi, Michael Hayden, George Joulwan and Harold Gehman, Jr. All members of the Governance and Compliance Committee, excluding Bahman Atefi, are independent in accordance with the NYSE Amex rules.

The Special Projects Coordination Committee currently consists of Pete Aldridge, Jr., Michael Ryan, and George Joulwan. All members of the Special Projects Coordination Committee are independent in accordance with the NYSE Amex rules.

 

108


Table of Contents

Item 14. Principal Accountant Fees and Services

Consistent with its charter, the Audit and Finance Committee is responsible for engaging Alion’s independent public accountants. All audit and permitted non-audit services require advance approval by the Audit and Finance Committee. The full committee approves proposed services and estimated fees for these services. The Audit and Finance Committee approved in advance all services performed by our auditors in fiscal 2012 and 2011.

The following table summarizes the fees that Deloitte & Touche LLP, our independent registered public accounting firm, billed Alion for each of our past two fiscal years for audit services and other services:

Fee Category

 

     2012      2011  

Audit Fees(1)

   $ 1,025,000       $ 1,200,000   

Audit-Related Fees(2)

     100,000         100,000   

Tax Fees

     118,863         182,442   
  

 

 

    

 

 

 

Total Fees

   $ 1,243,863       $ 1,482,442   
  

 

 

    

 

 

 

 

(1) Audit fees include fees for auditing Alion’s financial statements, reviewing interim financial statements included in quarterly reports on Form 10-Q, and providing other professional services in connection with statutory and regulatory filings or engagements.
(2) Audit-related fees are fees for assurance and similar services for employee benefit plan audits and accounting consultation services. The Audit and Finance Committee approved these services.

 

109


Table of Contents

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a)(1) Financial Statements

Consolidated Financial Statements of Alion Science and Technology Corporation

 

Report of Independent Registered Public Accounting Firm

     46   

Consolidated Financial Statements:

  

Consolidated Balance Sheets as of September 30, 2012 and 2011

     47   

Consolidated Statements of Comprehensive Loss for the years ended September  30, 2012, 2011, and 2010

     48   

Consolidated Statements of Redeemable Common Stock, Common Stock Warrants, and Accumulated Deficit for the years ended September 30, 2012, 2011, and 2010

     49   

Consolidated Statements of Cash Flows for the years ended September 30, 2012, 2011, and 2010

     50   

Notes to Consolidated Financial Statements

     51   

(a)(2) Financial Statement Schedules

Consolidated Financial Statement Schedule

 

Schedule II — Valuation and Qualifying Accounts

     111   

 

110


Table of Contents

Schedule II — Valuation and

Qualifying Accounts

 

Allowance for Doubtful Accounts Receivable

   Balances at
Beginning
of Year
     Additions
Charged to
Costs and
Expenses
     Deductions (1)     Balance at
End of Year
 

Fiscal year ended 2012

   $ 3,411       $ 802       $ (68   $ 4,145   

Fiscal year ended 2011

   $ 3,798       $ —         $ (387   $ 3,411   

Fiscal year ended 2010

   $ 4,419       $ —         $ (621   $ 3,798   

 

(1) Accounts receivable written off against the allowance for doubtful accounts.

 

Deferred Tax Asset Valuation

   Balance at
Beginning
of Year
     Additions
Charged to
Costs and
Expenses
     Deductions      Balance at
End of Year
 

Fiscal year ended 2012

   $ 58,264       $ 20,150       $ —         $ 78,414   

Fiscal year ended 2011

   $ 36,929       $ 21,335       $ —         $ 58,264   

Fiscal year ended 2010 (2)

   $ —         $ 36,929       $ —         $ 36,929   

 

(2) Change in Alion’s tax status. Establish deferred tax assets and corresponding full valuation allowance.

 

111


Table of Contents

(a)(3) Exhibits

 

Exhibit
No.

 

Description

3.1   Third Amended and Restated Certificate of Incorporation of Alion Science and Technology Corporation. (1)
3.2   Amended and Restated By-laws of Alion Science and Technology Corporation. (2)
4.1   Indenture dated as of February 8, 2007, among Alion Science and Technology Corporation, certain subsidiary guarantors and Wilmington Trust Company, as trustee. (3)
4.2   Form of 10.25% Senior Notes due 2015. (3)
4.3   Amended and Restated Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan. (4)
4.4   First Amendment to Amended and Restated Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan. (5)
4.5   Second Amendment to Amended and Restated Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan. (6)
4.6   Third Amendment to Amended and Restated Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan. (7)
4.7   Fourth Amendment to Amended and Restated Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan. (7)
4.8   Indenture, dated as of March 22, 2010, among the Company, certain subsidiary guarantors of the Company and Wilmington Trust Company, as trustee. (2)
4.9   Form of 12% Senior Secured Notes due 2014. (2)
4.10   Form of Warrant. (2)
4.11   Form of Unit. (2)
10.1   Employment Agreement between Alion Science and Technology Corporation and Dr. Bahman Atefi. (8)*
10.2   Employment Agreement between Alion Science and Technology Corporation and Stacy Mendler. (9)*
10.3   Employment Agreement by and between Alion Science and Technology Corporation and Michael J. Alber. (10)*
10.4   Employment Agreement between Alion Science and Technology Corporation and Scott Fry. (11) *
10.5   Employment Agreement between Alion Science and Technology Corporation and Buck Buchanan*. (12)
10.6   Alion Science and Technology Corporation Long-Term Incentive Plan. (6)*
10.7   Form of Alion Science and Technology Corporation Category A Long Term Incentive Plan Award Agreement. (6)*
10.8   Form of Alion Science and Technology Corporation Category B Long Term Incentive Plan Award Agreement. (6)*
10.9   Form of Alion Science and Technology Corporation Category C Long Term Incentive Plan Award Agreement. (6)*
10.10   Form of Alion Science and Technology Corporation Category D Long Term Incentive Plan Award Agreement. (6)*
10.11   Form of Alion Science and Technology Corporation Ongoing Long Term Incentive Plan Award Agreement. (6)*
10.12   First Supplemental Indenture, dated as February 26, 2010, between Alion-IPS Corporation, Washington Consulting Government Services, Inc., Alion Canada (US) Corporation, Alion Science and Technology Corporation and Wilmington Trust Company, as trustee. (12)
10.13   Purchase Agreement dated as of March 11, 2010, by and between the Company and Credit Suisse Securities (USA) LLC. (2)
10.14   Warrant Agreement, dated as of March 22, 2010, by and between the Company and Wilmington Trust Company, as warrant agent. (2)
10.15   Credit Agreement, dated as of March 22, 2010, by and among the Company, the lenders party thereto and Credit Suisse AG, as administrative agent. (2)
10.16   Intercreditor Agreement, dated as of March 22, 2010, by and among the Company, the other grantors party thereto, Credit Suisse AG, as administrative agent, and Wilmington Trust Company, as collateral agent and trustee. (2)
10.17   Security Agreement dated as of March 22, 2010, by and among the Company, certain subsidiaries of the Company and Wilmington Trust Company, as collateral agent. (2)
10.18   Guarantee Agreement, dated as of March 22, 2010, by and among the Company, certain subsidiaries of the Company and Credit Suisse AG, as administrative agent. (2)
10.19   Registration Rights Agreement, dated March 22, 2010, by and between the Company and Credit Suisse Securities (USA) LLC. (2)

 

112


Table of Contents
10.20   Amendment, dated as of March 22, 2010, to the Stock Purchase Agreement, dated as of December 20, 2002, between the Company and the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Trust. (2)
10.21   Alion Science and Technology Corporation 2004 Stock Appreciation Rights Plan, as amended and restated effective January 1, 2007. (7)*
10.22   Alion Science and Technology Performance Shares and Retention Phantom Stock Plan, as amended and restated effective November 1, 2007. (7)*
10.23   Alion Science and Technology Director Phantom Stock Plan, as amended and restated effective January 1, 2007. (7)*
10.24   Alion Executive Deferred Compensation Plan, as amended and restated effective January 1, 2008. (7)*
10.25   Alion Director Deferred Compensation Plan, as amended and restated effective January 1, 2008. (7)*
10.26   First Amendment to Alion Science and Technology Corporation 2004 Stock Appreciation Rights Plan (as amended and restated), dated as of January 22, 2010. (7)*
10.27   First Amendment to Alion Science and Technology Corporation Director Phantom Stock Plan (as amended and restated), dated as of January 22, 2010. (7)*
10.28   First Amendment to Alion Science and Technology Corporation Long-Term Incentive Plan, dated as of January 22, 2010. (7)*
10.29   Incremental Assumption Agreement and Amendment No. 2 dated as of March 11, 2011, by and among the Company, the lenders party thereto (the “Lenders”), Credit Suisse AG, Cayman Islands Branch, as administrative agent (in such capacity, the “Administrative Agent”), Alion – CATI Corporation, Alion – METI Corporation, Alion – JJMA Corporation, Alion – BMH Corporation, Washington Consulting, Inc., Alion – MA&D Corporation, Alion – IPS Corporation, Alion Canada (US) Corporation, and Washington Consulting Government Services, Inc., related to the Credit Agreement and incorporating by reference therein the Amended and Restated Credit Agreement. (13)
10.30   Amended and Restated Credit Agreement dated as of March 11, 2011 by and among the Company, the Lenders as defined in Article I of the Amended and Restated Credit Agreement and Credit Suisse AG, Cayman Islands Branch, as administrative agent (in such capacity, including any successor thereto, the “Administrative Agent”) for the Lenders. (13)
10.31   Agreement and Amendment No. 3 dated as of August 2, 2011, by and among the Company, the lenders party thereto (the “Lenders”), Credit Suisse AG, Cayman Islands Branch, as administrative agent (in such capacity, the “Administrative Agent”), Alion – CATI Corporation, Alion – METI Corporation, Alion – JJMA Corporation, Alion – BMH Corporation, Washington Consulting, Inc., Alion – MA&D Corporation, Alion – IPS Corporation, Alion Canada (US) Corporation, and Washington Consulting Government Services, Inc., related to the Credit Agreement. (14)
10.32   First Amendment to Employment Agreement between Alion Science and Technology Corporation and Ms. Stacy Mendler. * (15)
10.33   First Amendment to Employment Agreement between Alion Science and Technology Corporation and Mr. Scott Fry. *(15)
10.34   Change in Control Severance Agreement between Alion Science and Technology Corporation and Mr. Thomas E. McCabe. * (16)
10.35   Employment Agreement between Alion Science and Technology Corporation and Mr. Robert Hirt. * (17)
12   Computation of Ratios (a)
21   Subsidiaries of Alion Science and Technology Corporation (a)
31.1   Certification of Chief Executive Officer of Alion Science and Technology Corporation pursuant to Rule 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.(a)
31.2   Certification of Chief Financial Officer of Alion Science and Technology Corporation pursuant to Rule 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended. (a)
32.1   Certification of Chief Executive Officer of Alion Science and Technology Corporation, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (a)
32.2   Certification of Chief Financial Officer of Alion Science and Technology Corporation, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.(a)
101.INS+   XBRL Instance Document.
101.SCH+   XBRL Taxonomy Extension Schema Document.
101.CAL+   XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF+   XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB+   XBRL Taxonomy Extension Label Linkbase Document.
101.PRE+   XBRL Taxonomy Extension Presentation Linkbase Document.

 

113


Table of Contents
(1) Incorporated by reference from the Company’s Form 10-Q filed with the SEC on May 13, 2005.
(2) Incorporated by reference from the Company’s Form 8-K filed with the SEC on March 25, 2010.
(3) Incorporated by reference from the Company’s Form 8-K filed with the SEC on February 8, 2007.
(4) Incorporated by reference from the Company’s Form S-4 filed with the SEC on April 30, 2007.
(5) Incorporated by reference from the Company’s Form 8-K filed with the SEC on July 13, 2007.
(6) Incorporated by reference from the Company’s Form 10-K filed with the SEC on December 23, 2008.
(7) Incorporated by reference from the Company’s Form 10-Q filed with the SEC on May 14, 2010.
(8) Incorporated by reference from the Company’s Form S-4 (8-K) filed with the SEC on June 21, 2007.
(9) Incorporated by reference from the Company’s Form 8-K filed with the SEC on July 20, 2007.
(10) Incorporated by reference from the Company’s Form 8-K filed with the SEC on April 8, 2008.
(11) Incorporated by reference from the Company’s Form 10-K filed with the SEC on December 28, 2007.
(12) Incorporated by reference from the Company’s Form 8-K filed with the SEC on March 3, 2010.
(13) Incorporated by reference from the Company’s Form 8-K filed with the SEC on March 16, 2011.
(14) Incorporated by reference from the Company’s Form 8-K filed with the SEC on August 8, 2011.
(15) Incorporated by reference from the Company’s Form 10-K filed with the SEC on December 20, 2011.
(16) Incorporated by reference from the Company’s Form 10-Q filed with the SEC on May 11, 2012.
(17) Incorporated by reference from the Company’s Form 8-K filed with the SEC on June 6, 2012.
(*) Denotes management contract and/or compensatory plan/arrangement.
(a) Filed with this Form 10-K for fiscal year 2012.
+ As provided in Rule 406T of Regulation S-T, this information is furnished herewith and not filed for purposes of Sections 11 and 12 of the Securities Act and Section 18 of the Exchange Act

 

 

114


Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

   

ALION SCIENCE AND TECHNOLOGY CORPORATION

(Registrant)

Date: December 17, 2012    
    By:   /s/ BAHMAN ATEFI
      Bahman Atefi
      Chairman, Chief Executive Officer and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature    Title   Date
/s/ Bahman Atefi    Chairman, Chief Executive Officer and Director   December 17, 2012
Bahman Atefi     
/s/ Barry M. Broadus    Senior Vice President and
Chief Financial Officer
  December 17, 2012
Barry M. Broadus     
/s/ Jeffrey L. Boyers    Senior Vice President and
Principal Accounting Officer
  December 17, 2012
Jeffrey L. Boyers     
/s/ Edward C. Aldridge, Jr.    Director   December 17, 2012
Edward C. (Pete) Aldridge, Jr.     
/s/ Leslie L. Armitage    Director   December 17, 2012
Leslie Armitage     
/s/ Lewis Collens    Director   December 17, 2012
Lewis Collens     
/s/ Harold W. Gehman, Jr.    Director   December 17, 2012
Harold Gehman     
/s/ Michael V. Hayden    Director   December 17, 2012
Michael V. Hayden     
/s/ George A. Joulwan    Director   December 17, 2012
George A. Joulwan     
/s/ Michael E. Ryan    Director   December 17, 2012
Michael E. Ryan     
/s/ David J. Vitale    Director   December 17, 2012

David J. Vitale

    

 

115


Table of Contents

Exhibit Index

 

Exhibit No.

  

Description

12    Computation of Ratios
21    Subsidiaries of Alion Science and Technology Corporation
31.1    Certification of Chief Executive Officer of Alion Science and Technology Corporation pursuant to Rule 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
31.2    Certification of Chief Financial Officer of Alion Science and Technology Corporation pursuant to Rule 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
32.1    Certification of Chief Executive Officer of Alion Science and Technology Corporation, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2    Certification of Chief Financial Officer of Alion Science and Technology Corporation, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS+    XBRL Instance Document.
101.SCH+    XBRL Taxonomy Extension Schema Document.
101.CAL+    XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF+    XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB+    XBRL Taxonomy Extension Label Linkbase Document.
101.PRE+    XBRL Taxonomy Extension Presentation Linkbase Document.

 

+ As provided in Rule 406T of Regulation S-T, this information is furnished herewith and not filed for purposes of Sections 11 and 12 of the Securities Act and Section 18 of the Exchange Act

 

116